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1. iNTROducTiON
Peripheral nerve injuries are devastating injuries, which can lead to severe disability. Nerve in-
juries are relatively common. It occurs with up to 3% of all patients admitted to Level I trauma 
centers. Most of the injuries to peripheral nerves occur in the upper extremities. Nerve injury 
will lead to significant impairment in motor function and causes sensory loss. Depending 
on the level of nerve injury the consequences can be devastating and have great impact on 
a patient’s life and ability to perform daily activities such as work and hobbies. Nerve injury 
not only causes physical disability. There is evidence it also has great consequences psycho-
logically. Cognitive, emotional and behavioral aspects influence recovery. It is important these 
factors are recognized so that the quality of patient care can be improved[1]. The last decades 
both experimental and clinical research has been focused on optimizing the reconstruction of 
nerve injuries. The studies in this thesis are focused on the optimization of nerve reconstruc-
tion.
2. ANATOmy
When nerve injury occurs and the nerve is transected the electrical signals are disrupted. 
Peripheral nerves start in the myelum and end in the designated end-point (either sensory 
or motory). The nerves consist of an outer layer, the epineurium, which protects the nerve 
fascicles. The vasa nervorum provide the vascularization of the nerves and are interconnected 
with the epineural collagen and fibrotic fibers. In small nerves (i.e. nerves with a small diam-
eter) these vasa nervorum will solely supply the nerve. In nerves with a larger diameter the 
Figure 1. The anatomy of a peripheral nerve with the different components. The epineurium, perineu-
rium and endoneutrium are depicted. (Published with permission of the Mayo Foundation for Medical 
Education and Research. All rights reserved, copyright © 2015)
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vascularization is not only based on the supply of the vasa nervorum but also of vascular 
bundles in the nerves endoneurium. Encapsulated by the epineurium, the perineurium is 
wrapped around the nerve fascicles. The fascicles comprise a complex ultrastructure. The 
basal membrane of the nerve consists of two domains: an internal basal lamina, which faces 
and is linked to cellular membranes, and an external fibrillar matrix. Schwann cells, undoubt-
edly, are essential for myelination and thus fast conducting signaling. The anatomy of the 
nerve is schematically depicted in Figure 1.
3. classification and Nerve injury
a. classification of nerve injury: seddon-sunderland
Nerve injury can be defined using different classifications. The most commonly used is the 
Seddon-Sunderland classification which makes a distinction between four different types of 
nerve injury and is widely accepted[2]. Basically there are three important differences between 
the groups. The first group is called neuropraxia where the epineurium and axons are still intact 
but damage has been made to the myelin sheaths which will cause a (temporarily) block of 
the nerve conduction. The second form of nerve injury is axonotmesis. Here the epineurium 
also remains intact but the axons are disrupted. The continuity of the epineural sheath will 
facilitate the regeneration. In neurotmesis, partial or complete, the nerve is transected as well 
as the supporting tissue.
b. Pathophysiology: nerve de- and regeneration
After both axonotmesis and neurontmesis, Wallerian degeneration of the nerve segment 
distal of the injury site occurs. This process starts within 48 hours. The Schwann cells in this 
distal segment, combined with macrophages, are activated to remove myelin and axonal 
debris. In the proximal nerve segment only minor traumatic degeneration occurs although 
important neurophysiological changes occur. The cells produce elements for axonal regrowth 
and repair.[3] Within twenty-four hours after nerve injury, axons will start to sprout from the 
proximal segment. The growth cone will proliferate along the intact basal lamina. When 
the endoneurial tubes have remained intact, as is the case in axonotmesis, the axons can 
regenerate through an intact scaffold. When neurotmesis occurs, this scaffold is disrupted 
which will inhibit successful nerve regeneration. As the alignment is disrupted, regenerat-
ing fascicles can escape leading to neuroma formation. Apart from the chance of neuroma 
formation, alignment of the nerve ends is also important for contact guidance. Without a 
scaffold the growth cones of the axons will have no haptotactic cues to be able to reach the 
target organ[4]. Apart from haptotactic cues, nerve regeneration is influenced by chemotactic 
cues such as neurotrophic factors. One of the important factors is nerve growth factor (NGF). 
Several other neurotrophic factors have been found to influence the regeneration. These 
include brain-derived neurotrophic factor (BDNF), vascular endothelial growth factor (VEGF), 
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glial cell line-derived neurotrophic factors, neurotrophin-4 (NT-3) and neurotrophin-4 (NT4)
[5, 6]. Although these factors are known, the application of these growth factors in a clinical 
setting for peripheral nerve reconstruction is not yet made. Nerve injury will also influence 
motor end plates and cause muscle atrophy. Muscle tissue can, over time, be replaced with 
fibrotic adipose tissue. When nerve regeneration takes place, the motor end plates will be 
activated again and the muscle can regain strength. However, after prolonged degeneration, 
damage to both motor end plates and muscle (i.e. atrophy and fibrosis) are irreversible.
4. NeRVe RecONsTRucTiON
When the trauma to the nerve is more severe, or a segment of the nerve is lost, a nerve gap 
occurs. Nerve reconstruction is key for the successful regrowth of an injured nerve. Recon-
struction with very little to no tension is of paramount importance to the outcome. When the 
nerve can be repaired without tension, the regeneration only needs to cross one suture line. 
When this criterion cannot be met, an interposition with a nerve graft is indicated which will 
inevitably cause two suture lines. The interposition with a nerve graft to bridge the gap has 
been extensively studied in the last decades.
a. Autograft: the gold standard.
The gold standard for the reconstruction of ‘large’ peripheral nerve segments is the nerve 
autograft. This technique was first introduced in 1978 by Milessi et al. With nerve autograft 
reconstruction a nerve elsewhere in the body is harvested to reconstruct a nerve gap. Sensory 
nerves are most commonly harvested, as their function is easiest to scarify. Of the sensory 
nerves, the sural nerve is the most commonly used, as a length up to 40 cm of nerve graft 
can be harvested. Nerves that are also used are the anterior medial antebrachial cutaneous 
nerves and the superficial radial nerve. The autograft can be cabled to increase diameter and 
should be 10 to 20 % longer than the nerve gap, to create a tension-free reconstruction. The 
autograft has the advantage of closely mimicking the ultrastructure, contains Schwann cells 
and provides neurotrophic factors. Disadvantages however, include donor site complications 
and morbidity such as second scar formation, sensory loss, neuroma formation, prolonged 
operation time and increased costs. Recent data show that motor nerve grafts are superior to 
sensory nerve grafts for the reconstruction of a motor nerve defect[7, 8]. However there is only 
a limited supply of motor nerves that can be harvested.
Several alternatives have been proposed to overcome these disadvantages. Nerve scaf-
folds have the advantage of unlimited availability, no donor side morbidity. They all strive to 
provide guidance for the regenerating axons and a tension-free repair. The alternatives can be 
subdivided into scaffolds made of nerve (i.e. autograft or allograft) or biological or synthetic 
conduits[9].
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b. Biological conduits (arterial and venous)
Biological conduits are made from autologous material such as veins or arteries of which veins 
are most commonly used. The advantages of vein graft over arterial graft are their abundant 
supply and minimal donor site morbidity. The possibility of lumen collapse impeding nerve 
regeneration has been marked as a disadvantage of vein conduits. Chiu et al reported the first 
use of a vein as a nerve conduit in 1982.[10] Ten years later, in 1990, the first clinical case was 
reported with a digital nerve reconstruction.[11] Meaningful recovery was reported in digital 
nerve gaps smaller than 3 cm with a vein graft. Although positive results have been reported, 
the vein graft cannot outperform the gold standard, the nerve autograft. The additional of a 
small muscle segment inside the vein has shown a beneficial effect by preventing collapse of 
the venous grafts.
c. synthetic conduits
As an alternative for biological conduits synthetic conduits [12] are proposed. Different 
materials have been used: collagen, polyglycolic acid, poly(DL-lactide-e-caprolactone) (PLC), 
poly(lactic-coglycolic acid) (PLHA), poly(carpolactone fumerate) (PLCF), hydrogel and capro-
lactone[13, 14]. Collagen nerve conduits are most commonly used. In animal studies collagen 
conduits have been challenged to nerve autografts and allografts. In rats, the poly-DL-lactide-
e-caprolactone conduits showed similar results to the autograft with regard to functional 
outcome[15]. Another study showed that a matrix in a collagen conduit showed superior 
results compared to an empty collagen conduit[16]. Unfortunately, they failed to replace the 
nerve autograft. In addition, when synthetic conduits were tested in larger animal models, 
the rabbit, the superior results of the collagen conduits with a matrix where not observed[17]. 
Animal studies have also shown that wrapping the nerve repair site with a conduit can reduce 
scar formation[18]. Several of these conduits are clinically available including Neurotube 
(Synovis), Neurolac (Ascension) and Neuragen (Integra).
d. Allograft
Compared to the gold standard, the nerve autograft, the advantages of the nerve allograft 
include potentially unlimited supply and length, no donor site morbidity and reduced op-
eration time. Therefore the allograft has gained popularity. The allograft, as the autograft, has 
the structure and framework of the nerve, which is hypothetically the perfect guidance for 
nerve regeneration. The first allografts that were used required the use of immunosuppressive 
drugs. The donor Schwann cells are immunogenic to the host, they activate a T-cell response, 
which required the administration of immunosuppression (cyclosporine A and/or FK506) for 
up to two years after the allograft transplantation. Tacrolimus, or FK506 has shown to have a 
beneficial effect on nerve regeneration[19-21]. Immunosuppressive drugs have well known 
disadvantages and leave recipients vulnerable to opportunistic infections or neoplastic pro-
cesses. This changed when the allografts were pre-treated in order to reduce the immune 
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reaction when implemented. Several techniques for decellularization of the allografts have 
been introduced. These methods include cold preservation, freeze-thawing, chemical decel-
lularization, lyophilisation and irradiation[22].
With the cold preservation method nerve grafts are stored in University of Wisconsin Solu-
tion (UWS) at 4-5°C for seven days will reduce the cells in the nerve allograft but the cells are 
not removed[23]. The allograft antibodies are reduced and the basal lamina of the grafts is 
maintained. However, as the cells are not removed, significant cellular debris remains which 
reduces axonal regeneration. [24-26] Therefore this method is inferior to other techniques 
as decellularization with chemical decellularization [24, 27]. Similar to the cold preservation 
method is the freeze-thawing of nerve allograft[22]. The cells are killed but not removed. 
Grafts are deep-freezed at -70⁰C and thawed repeatedly. This method was developed to kill 
antigen-presenting cells while preserving the structure of the extracellular matrix. Despite less 
cellular debris freeze-thawing seems inferior to chemical detergent nerve allografts.[28] The 
studies on freeze-thawed allograft have been of importance in understanding the role of the 
basal lamina in nerve allografts for the regeneration of axons. These studies have stimulated 
the development of chemical decellularization techniques in which the basal lamina was 
better preserved[22].
With chemical decellularization, detergents are used to eliminate cellular remnants[29-31]. 
This technique was first used by Johnson et al, who used Triton-X100 and sodium deoxy-
cholate[32] and later modified by Sondel et al. [31]. This technique was later optimized by 
Hudson et al. who used a combination of three detergents: Triton X-200, sulfobetaine-16 and 
sulfobetaine-10[28, 30]. This protocol balanced the need for cellular removal and preserva-
tion of the extracellular matrix. However after processing, cellular debris still remained in the 
nerve allografts. Irradiation of nerve grafts with gamma irradiation has shown to degrade 
the antigenicity of the graft [33, 34]. Although this method was not further developed as a 
single pre-treatment method it has been added to previously mentioned methods to further 
enhance the processing of the nerve allografts[22, 35]. The protocol was further enhanced 
by treatment with the enzyme Chondroïtinase ABC that showed degradation of chondroitin 
sulfate proteoglycans [36, 37]. These have shown to inhibit axonal growth and removing them 
should therefore be beneficial for the axon regeneration.
Up-to-date there are no high level (I or II) evidence clinical studies comparing allografts to 
the gold standard, the autograft or conduits for the reconstruction of large peripheral nerve 
defects. Evidence for the allograft is based on comparative animal studies and level III clinical 
studies. There is one clinically available decellularized human allograft made by Axogen Inc., 
Alachua, Florida. Animal studies with this Axogen allograft suggest that the allograft is still 
inferior to the nerve autograft, especially when looking at motor nerve regeneration. Whitlock 
et al. studied the effect of the commercially processed allograft in 14- and 28 mm nerve 
gaps in rats. Although the allograft and collagen conduits were comparable at 12 weeks, 
the allograft was not found to be comparable or superior to the autograft 12 weeks after 
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implementation[38]. Guisti et al. compared the Axogen processed allograft with the autograft 
and a collagen conduit both at early and late recovery time of 12 and 16 weeks in a rat model. 
The nerve autograft outperformed both the processed allograft and the collagen conduits at 
twelve and sixteen weeks.[39]
This allograft has been tested in three case reports and recently in a larger multicenter 
study.[40-44] The case reports investigate the use of the allografts but are not comparing 
them to other treatment options. Therefore the superiority of the allograft to the autograft is 
not proven. In the multicenter outcome study by Brooks et al. investigate the effect of Axogen 
processed grafts in nerve defect between 5 and 50 mm.[40] They report meaningful recovery, 
either S3+/S4 or M4/M5, in 87% of patients. The recovery in sensory nerve defects is higher 
compared to the mixed, or motor nerve defects. Outcomes of the same multicenter study 
where reported by Cho et al. who reported an overall meaningful recovery of 86%. When 
looking at type of nerve repair this study showed meaningful levels of recovery in 89% of 
digital nerve repairs, 75% of median nerve repairs and 67% in ulnar nerve repairs.[43] The high 
distribution of digital sensory nerves in this study should be considered when interpreting 
the high rate of recovery in this study. Similar to the case reports, these studies also lack a 
valid comparison to the nerve autograft. As such, it can be concluded that the introduction 
of a new allograft needs careful evaluation in both in vitro and in vivo studies to thoroughly 
investigate neuroregenerative capacity. Not before non-inferiority or superiority has been 
proven, clinical testing is justified.
e. Luminal additives
To further improve nerve regeneration several additives to the different grafts have been 
introduced. Both cells and supportive factors have been studied. Schwann cells have shown 
to increase functional regeneration of acellular nerve grafts of 14 mm in a rat model.[45] 
Bone marrow stromal cells (BMSCs), adipose-derived stromal cells (ADSCs), hair follicle stem 
cells, skin-derived mesenchymal stem cells, and amniotic fluid derived mesenchymal stem 
cells have been introduced as well.[46-51] BMSCs, of mesenchymal origin, have shown the 
capability to differentiate into neuron-like cells.[52] The BMSCs can be easily harvested from 
bones. The mechanism for their neuroregenerative effect is often discussed in literature. 
Some argue their neuroregenerative effect is caused by the transdifferentiation into Schwann 
cell-like phenotype.[53] Others argue that the stem cells will function as growth promoting 
factors. Adipose derived stem cells can be harvested even less invasive then BMSC’s and can 
be derived from belly fat. Their phenotype profile is comparable to the BMSCs and some 
studies even show that they have a more profound tendency to differentiate into Schwann 
cell-like phenotypes. More recently applied stem cells, such as hair follicle pluripotent stem 
cells and skin-derived stem cells, are also easily accessible and can also show the capability to 
transdifferentiate into Schwann cell–like cells as well.[54] Neurotrophic growth factors have 
also shown promise in enhancing axonal growth when added to a nerve graft.[55, 56]
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5.  eVALuATiON OF RecOVeRy OF FuNcTiON AFTeR NeRVe 
RecONsTRucTiON
Evaluation of recovery of function after nerve injury is important in both clinical and experi-
mental settings. In the clinical setting the rehabilitation of the patient can be closely followed. 
Patient and doctor can evaluate the recovery and different nerve reconstructions can be 
compared. In the experimental setting valid assessment techniques are essential when test-
ing new innovative options for the reconstruction of nerve defects[57]. In other words, to test 
hypotheses. During the last decades several different options have been proposed for both 
clinical and experimental testing
a. clinical outcome assessments
Most studies report recovery after nerve injury with the British Medical Research Council’s 
(MRC) scale for both motor and sensory recovery. Motor recovery is graded from M0 to M5 
and sensory recovery from S0 to S5[58, 59]. Power grip strength can be assessed with the 
Jamar dynamometer[60] and the tip-pinch grip strength with Jamar pinch gauge meter[60]. 
Sensory testing includes two-point discrimination (static and dynamic), monofilament testing 
(Semmes-Weinstein) and cold-heat testing[61]. Although important, this thesis is focused on 
motor function recovery and therefore testing of the sensory recovery will be discussed only 
shortly.
b. experimental outcome assessments
Functional assessment of motor nerve regeneration was first measured with the sciatic func-
tional index (SFI), based on the walking track analysis [62, 63]. The method was first developed 
by Medianceli et al. in 1982 and later modified by Bain et al. The SFI is based on characteristics 
of the footprint of the hind paw of the rat during the walking track. This method however, is 
influenced by various factors as toe contractures and auto-mutilation[64, 65]. Although this 
method is still widely used, several studies have shown the lack of association between out-
come measures in nerve regeneration studies[66, 67]. Lee et al. found that the sciatic function 
index, based on the walking track analysis, did not correlate with the isometric tetanic force 
measurements. And, of various measurements of the ankle angle, only the ankle angle in toe-
off phases correlated well with the isometric tetanic force[67]. Video analysis of the walking 
track has been proposed to improve the SFI[68]. The rat is filmed and the SFI is supplemented 
with gait kinematic informative such as ankle angle[69, 70]. Lin et al. found strong correlations 
between ankle angle at the midstance phase of the gait cycle with muscle weight[71].
After nerve injury, rats will have a (short) period of reduced activity level and will avoid 
using that foot for the first couple of weeks causing a joint flexion contracture. The angle of 
the ankle can be measured to express the joint flexion contracture. Measuring the ankle angle 
contraction is non-invasive, easy and is not time consuming. Lee at el.[67] showed that ankle 
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angle had excellent correlations with other outcome measures of nerve function. It was found 
to be less severe in rats that could produce higher isometric tetanic force.
Electrophysiology
Electrophysiological testing is widely used in experimental nerve studies. The nerve is stimu-
lated and different parameters are recorded. Different outcome assessments are reported as 
compound muscle action potentials (CMAP), mean conduction velocity (MCV), electromyog-
raphy and somatosensory evoked potentials (SEPs)[72]. Of these different methods the CMAP 
is considered to be the best discriminative tool[72].
Muscle Mass
The weight of the muscles, distally to the reconstructed nerve, is claimed to be a parameter of 
functional recovery. This method is also quick and easy to perform which is one of the reasons 
for its popularity. The gastrocnemius muscle is mostly used but the tibial muscle is also used.
Isometric Tetanic Force
Shin et al. developed a reproducible and accurate model to measure nerve regeneration, the 
isometric tetanic force measurement. After stimulation of the nerve the maximal tetanic force 
of the tibial muscle of the rat was recorded. The authors reported a side-to-side variability 
of less than 4%[73]. Subsequently this method was developed and validated in the rabbit 
model as well[74]. The strength of this method is that it describes the functional recovery of 
the target organ, the muscle, after reinnervation. When compared to the above mentioned 
muscle mass it can be observed that a decrease in isometric tetanic force is less than the 
decrease in muscle weight. That can be explained by the fact that the cross-sectional area 
of the muscle is closely related to the daily muscle contractions[75]. Isometric tetanic force is 
therefore a more true parameter to describe motor function than muscle weight.
Histomorphometry
Histology of cross sections of the nerve segments is a frequently used method to quantify 
nerve recovery. Axon and fiber diameter, axon and fiber count, myelin thickness and myelin 
area are obtained parameters. It has been shown that obtaining these values on the distal 
segment is more useful than looking at the mid-segment of the nerve grafts. Semi-automatic 
computer models have been introduced to reduce the labor intensity of the histological tests.
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6. GeNeRAL Aim ANd OuTLiNe OF The Thesis
The aim of this thesis is to optimize peripheral nerve reconstruction for large, segmental nerve 
defects. In order to do so, this thesis was divided in four parts. In Part I, the clinical problem was 
investigated by studying prognostic factors influencing the outcome after nerve reconstruc-
tion (chapter 2). Specific attention was paid to one of the few factors that can be potentially 
influenced after nerve trauma; early posttraumatic stress (chapter 3). After investigating the 
clinical problem of nerve reconstruction, the evaluation of nerve regeneration after nerve 
reconstruction was studied. In Part II of this thesis a non-invasive method is introduced, ul-
trasound, for the analysis of nerve recovery after trauma. First, we introduced ultrasound for 
the analysis of recovery of intrinsic hand muscles in humans after nerve trauma (chapter 4). 
Secondly, the method was established in an experimental setting in rabbits (chapter 5) as 
well as in rats (chapter 6) for the longitudinal follow up of recovery after nerve injury.
The third aim of this thesis was to improve nerve reconstruction by engineering an opti-
mized nerve allograft (Part III). In chapter 7, the optimization of nerve allografts are studied 
in vitro in rat nerves. Subsequently, decellularization and preservation protocols were tested 
on human nerves in chapter 8, where the difference between motor and sensory nerves 
was made. After optimization of the nerve allograft in vitro, the allograft was tested in vivo. 
The optimized nerve allograft was implemented in a rat model to test the functional motor 
outcome after reconstruction of a 1 cm nerve defect. The allograft was challenged to the gold 
standard, the nerve autograft (chapter 9).
In the final part (Part IV) an improvement on nerve bridging is studied. The effect of stem 
cells on the regeneration of nerves was investigated with a meta-analysis (chapter 10). Finally, 
in the last chapter of this thesis a general discussion (chapter 11) is summarized and future 
perspectives are mentioned.
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ABsTRAcT
Background A major problem in surgery of peripheral nerve injuries of the upper ex-
tremities is the unpredictable final outcome. More insight and understanding of the prognos-
tic factors is necessary to improve functional outcome after repair of peripheral nerves. The 
objective of this study is to identify prognostic factors for functional recovery of peripheral 
nerve injury of the forearm and their independent contribution in the outcome in the first 
year after reconstruction.
methods A multicentered prospective study in the Netherlands resulted in the 
inclusion of sixty-one patients with a median, ulnar or combined median-ulnar nerve injury. 
Age, level of injury, type of nerve injury, number of damaged structures, number of damaged 
arteries, education, smoking and posttraumatic stress were analyzed as prognostic factors 
for functional outcome after repair of peripheral nerves. Outcome parameters were sensory 
recovery (Semmes Weinstein monofilament test) and motor recovery (MRC, power grip, pinch 
grip) and the ability to perform daily activities.
Results  Gender, age, level of education, number of injured arteries and structures, 
damaged nerve, location of the injury, type of the nerve injury and posttraumatic stress at 
1 and 3 months after repair of the peripheral nerve injury were found to be predictors of 
functional recovery.
conclusions Our prospective analysis of prognostic factors shows several factors to be 
predictive for the functional recovery after peripheral nerve injuries of the median and/or 
ulnar nerve of the forearm. Sensibility of the hand, power grip and DASH score have proven 
to be the three best prognostic factors in this study. Of these prognostic factors only post-
traumatic stress can be influenced to optimize functional outcome.
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iNTROducTiON
The hand is the most injured body part in humans and the leading part treated in hospital 
emergency departments. In 30-40% of the injury events the upper extremity is involved[1]. 
Hand injury generally takes place in a young and economical active population[2, 3]. When 
cuts and lacerations of the fingers and hands are combined, the number of days-away-from 
work are second only to back strain and sprain frequency according to the US Bureau of Labor 
Statistics data [4]. Occupational hand injury rates varied from 0.33 to 11.0 per 100 worker-years 
according to four US and eight international industry specific studies[1]. Other studies report 
an incidence of nerve injury of 1.64% after limb trauma[5] and 5% in the ER[6].
The reconstruction of peripheral nerve injuries is imperative and crucial for successful re-
generation. However, recovery following these injuries is often disappointing. Sensibility and 
strength cannot be expected to fully recover, although improvement generally occurs[7-20]
Aside from the reconstruction, the unavailability to predict the outcome is considered 
a serious problem. Hence, more knowledge about prognostic factors is needed for further 
improvement of functional outcome during, and after repair of peripheral nerves. Early in-
tervention in patients with suboptimal sensory and motor recovery based on their individual 
profile of prognostic factors, could improve overall outcome of peripheral nerve injury. Several 
factors like age, type of injury, level of injury and delay have been described to influence 
outcome results of peripheral nerve injury.[3, 8, 10, 21-27] However, at this time, no conclusive 
agreement exists on independent predictors for functional outcome of median and ulnar 
nerve injuries.
Because of limitations of retrospective study design and the lack of prospective data on this 
subject, our aim was to identify prognostic factors that may predict prospectively functional 
recovery of peripheral nerve injuries of the forearm. In this prospective study, factors identified 
as prognostic in retrospective studies (age, level of injury, type of nerve injury, injured nerve, 
number of damaged structures and arteries, education, smoking and posttraumatic stress) 
were analyzed. Outcome parameters were motor and sensory recovery and the ability to 
perform daily activities in the first year after injury.
PATieNTs ANd meThOds
study population
Patients with a peripheral nerve injury, operated in the University Medical Center Rotterdam, 
the University Medical Center Utrecht (UMCU), the MCRZ Rotterdam, the Isala Clinics Zwolle, 
the University Medical Center Nijmegen “St.Radboud” and the University Medical Center Am-
sterdam (VU) were asked to participate in this study (inclusion 2000-2003). Inclusion criteria 
were a traumatic median and/or ulnar nerve injury between wrist and elbow crease (divided 
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in 3 sections; proximal, middle (intermediate) and distal third). Patients under the age of 12, 
patients with amputations of hand and fingers and patients with insufficient knowledge of 
the Dutch language were excluded from participation. Also, patients with known neuro-
muscular disorders or psychological diseases were excluded. According to these criteria, 82 
patients were asked to participate in this study. Three patients rejected participation. Eighteen 
patients initially included in the study were lost during follow-up (Figure 1). Finally, the data of 
61 patients was used for evaluation. The majority of the patients lost during follow-up, injured 
themselves as a consequence of aggressive behavior, or was addicted to alcohol and was 
difficult to motivate for follow-up. For the purpose of this study, patients were evaluated at 1, 
3 and 12 months after injury.
Assessments
The assessments used are presented in Table I. For examination of motor function manual 
muscle strength testing according to Medical Research Council Muscle Power Grading 0 
(no palpable contraction) -5 (normal) was used. Data was transformed to a 10 point scale to 
prevent a non-single digit outcome, since the ulnar nerve incorporates a three muscle mea-
surement. For median nerve injuries palmar abduction of digit I was examined. For ulnar nerve 
Figure 1. Study population
Table 1. Test battery
Sensory innervation Semmes-Weinstein monofilament test[31]
Motor innervation Manual muscle strength testing according to MRC[32, 33]
Power grip strength Jamar dynamometer[34]
Tip-pinch grip strength Jamar pinch gauge meter[34]
Daily living Questionnaire (DASH)[28]
Psychological functioning Questionnaire (IES)[29]
Socio-demographic charact Questionnaire (own design)
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injuries abduction of digits II and V, and adduction of digit V were examined. If a combined 
median ulnar nerve transection was present, the lowest value was analyzed. Furthermore 
power grip and tip pinch strength were used.
Assessments were done in accordance with a standardized test procedure and were per-
formed by a physician not involved in the patient’s surgery or treatment following the injury.
Questionnaires
Daily living:
To assess the functional recovery, the DASH- questionnaire (Disabilities of Arm, Shoulder and 
Hand) was used after translation according to the criteria of the institute for Work& Health and 
the American Academy of Orthopedic Surgeons[28]. In this questionnaire patients were asked 
to score 30 items (each item scores 1-5 Likert scale) related to functional activities and injury 
related symptoms.
Psychological functioning:
To measure the current degree of subjective impact of peripheral nerve trauma experienced 
by a person, the Impact of Event Scale (IES) was used at 1 and 3 months after injury. The IES, 
designed by Horowitz in 1979, includes 15 items that refer to “the past seven days,” across the 
subscales of avoidance and intrusion and taps dimensions that are similar to the defining 
symptoms of PTSD[29]. Each item has a scoring range of 0-5 on a 4-point scale where: 0=not 
at all, 1=rarely, 3=sometimes and 5=often. Total IES scores range from 0-75 (worst score). As 
a general rule one has the indication for psychological treatment with a score above 30 [30].
Sociodemographic characteristic:
Patients were asked to answer questions about their occupation, education level ranging 
from one (did not finish primary school) to seven (university degree) and whether they did 
return to work.
statistical analysis
Predictive factors to be investigated were gender, age, injured nerve, number of damaged 
structures, number of damaged arteries, location of injury (proximal, intermediate and distal), 
type of injury (sharp or crush), smoking, education level and posttraumatic psychological 
stress. For statistical analysis of post-traumatic stress, 1 and 3 months IES scores were analyzed. 
For evaluation of functional outcome 12 months measurements were used. The association 
between each predictor and recovery was first studied by correlation analysis. An association 
was found to be significant at a p-level <0.05. All variables which showed a univariate associa-
tion with a significance level <0.10 where entered in a multivariate regression analysis. The 
stepwise backward multivariate regression model evaluates the independent contribution 
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of predicting factors for sensory and motor recovery (powergrip, pinchgrip and MRC-score) 
and daily activities (DASH). This analysis could not be performed with all cases due to missing 
values. To include all valid cases in the final model, the multivariate analysis was re-executed 
with the selected variables for the stepwise backward regression analysis. SPSS software ver-
sion 17.0 was used[35].
ResuLTs
study population
For this study purpose 61 patients with median (n=28), ulnar (n=27) and combined nerve 
injuries (n=6) that were surgically repaired in the participating hospitals were prospectively 
examined at 1, 3, and 12 months after injury. Study population characteristics are demon-
strated in Table II. Eighty-five percent of the study population was blue collar worker and 15% 
was white collar worker. After one year, seven patients (15.6%) had not yet returned to work, 
which involved 18% of all patients performing a job that specifically required hand function. 
Thirty-four patients were smokers with an average smoking of 12 cigarettes per day (range 
2-30). The median education score of the study population was 4, i.e. finished high school.
Table 2. Characteristics of study population
characteristics of study population
Age child <16 5 (8,2%)
adolescent 16-25 18 (29,5%)
young adult 26-40 20 (32,8%)
adult >40 18 (29,5%)
Sex Male 51 (84 %)
Female 10 (16 %)
Injured nerve Median 28 (44,3%)
Ulnar 27 (45,9%)
Combined 6 (9,8%)
Outcome and predictive factors
First, the relation was determined between functional outcome and factors reflecting char-
acteristics of lesions as well as other patient characteristics that, according to literature, were 
found to have prognostic importance. Table III indicates which factors were associated with 
the outcome measurement at 12 months after surgery, using correlation analysis for con-
tinuous variables and analysis of variance for categorized prognostic factors. Subsequently, 
variables that were found to be associated with the outcome measurements were analyzed to 
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evaluate the most important factors. Of this final model, the percentage explained variability 
is reported which is the percentage variability of the outcome, which can be explained by the 
different factors within that model.
More detailed data can be found in the Appendix. Mean percentages of the different 
outcome parameters subdivided for location of injury, injured nerve and type of injury are 
depicted.
median sensibility
Univariate analysis showed that women had better median sensibility (r=.391,p=0.022) and 
when more structures were involved in the lesion median sensibility was less (r=-.363,p=0.038).
ulnar sensibility
Male gender (r=.430,p=0.013), higher age group (r=-.473,p=0.005), and proximal lesions (r=-
.387,p=0.026) were significantly related with worse ulnar sensibility.
sensibility of the hand
Univariate analysis showed that gender (r=.308,p=0.016), age group (r=-.408,p=0.001), com-
bined nerve injury (r=-.339,p=0.008), distal nerve lesions (r=.272,p=0.034) and proximal nerve 
lesions (r=-.308,p=0.016) were significantly correlated with sensibility of the hand. Multivariate 
Table 3. Univariate analysis using correlation analysis.
sens 
med
sens 
uln
sens 
hand
Power 
grip
Pinch 
grip
mRc 
med
mRc 
uln
mRc 
hand
dAsh 
score
Gender ✓ ✓ ✓
Age group ✓ ✓ ✓ ✓
education ✓
smoking
Nr. of structures ✓ ✓ ✓ ✓ ✓ ✓ ✓
Nr. of arteries ✓ ✓ ✓ ✓ ✓
damaged nerve Ulnar ✗ ✗
Medial ✗ ✗ ✓
Combined ✓ ✓ ✓ ✓ ✓
Location Distal ✓ ✓
Intermediate
Proximal ✓ ✓
Type of injury Sharp/Crush ✓
Posttraumatic 
stress
IES 1 month ✓ ✓ ✓
IES 3 months ✓
✓ = factors univariately significantly correlated with the outcome, ✗ = not applicable
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regression analysis showed a significant model [F(4,60),16.158 p<0.001], that explained 54% 
of the variance. Male gender, higher age group, combined nerve injury and proximal nerve 
lesion were found to be negatively correlated with the sensory recovery of the hand, see Table 
IV.
Power grip
Univariate correlation analysis showed that age group (r=-.431,p=0.007), number of structures 
involved (r=-.365,p=0.004), number of arteries involved (r=-.310,p=0.015), combined nerve 
lesions (r=-.372,p=0.003) and posttraumatic stress at 1 month (IES1) (r=-.394,p=0.002) were 
significantly correlated with power grip. Lower age group and a lower number of structures 
and arteries involved were significantly associated with higher power grip. Combined 
nerve lesions and a higher degree of posttraumatic stress at 1 month were associated with 
lower power grip. Multivariate regression analysis resulted in a significant model [F(4,53),8.141, 
p<0.001] that explained 40% of the variance. This model showed that higher power grip was 
correlated with a lower age group, less arteries involved, a higher level of education and a 
lower degree of post-traumatic stress at 1 month. Beta coefficients of the multivariate regres-
sion analysis are depicted in Table IV.
Table 4. Beta coëfficients related to outcome in multiple regression analysis
sens
hand
Power
grip
Pinch
grip
mRc
hand
dAsh
score
Gender 20.659
Age group -6.516 -6.280 3.914
education 1.749 3.541
smoking
Nr. of structures -2.241
Nr. of arteries -11.992 -1.934
damaged
nerve
Ulnar
Medial
Combined -25.798 -2.759
Location
Distal
Intermediate
Proximal -17.505 -16.410
Type of injury Sharp/crush -2.226
Posttraum. 
stress
IES 1 month -.352 .617
IES 3 months -.368
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Pinch grip
Number of structures involved (r=-.346,p=0.007), number of arteries involved (r=-.320,p=0.012), 
combined nerve lesions (r=-.256,p=0.046), distal nerve lesions (r=.372,p=0.003), posttraumatic 
stress at 1 month (r=-.257,p=0.046) and education (r=.306,p=0.025) were found to significantly 
correlate with pinch grip. A lower number of structures and arteries injured, combined nerve 
injuries, proximal nerve lesions, a higher degree of posttraumatic stress at 1 month, and higher 
educational level significantly correlated with less pinch grip. Multivariate analysis showed a 
significant model [F(3,51),7.960 p<0.001] that explained 33% of the variance. A proximal nerve 
lesion, lower educational level and more structures involved were associated with a lower 
pinch grip, see Table IV.
median motor recovery
Fewer structures (r=-.437,p=0.011) and fewer arteries (r=-.344,p=0.046) involved in the lesion 
were univariate significantly related with a better median motor recovery measured by MRC.
ulnar motor recovery
More injured structures (r=-.412,p=0.019) and crush nerve injuries (r=-.352,p=0.045) were 
univariate found to significantly correlated with worse ulnar motor recovery.
motor recovery of the whole hand
Number of structures involved (r=-.411,p=0.001), number of arteries involved (r=-.387,p=.002), 
medial nerve injury (r=.362,p=0.004) and combined nerve injuries (r=-.289,p=0.024) were 
univariate significantly correlated to better motor recovery. Multivariate regression analysis 
showed a significant model [F(3,60),5.658 p=0.002] with explained 23% of the variance. The 
number of arteries involved, combined nerve lesions and crush injuries were related to lower 
motor recovery of the hand.
dAsh
Age group (r=.478,p<0.001), number of structures (r=.326,p=0.012) and arteries 
(r=.262,p=0.040) involved, combined nerve injuries (r=.277,p=0.031) and the degree of 
posttraumatic stress at 1 (r=.446, p<0.001) and 3 months (r=.423, p=0.001) were significantly 
correlated to the DASH results analyzed with univariate analysis. Multivariate analysis showed 
a significant model [F(3,59),7.782 p<0.001] explaining 29% of the variance. Age group and 
posttraumatic stress at 1 and 3 months were included in this model, see Table IV.
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discussiON
Our prospective study revealed that (1) gender, (2) age, (3) education, (4) number of structures 
involved, (5) number of arteries involved, (6) damaged nerve, (7) location of injury, (8) type of 
nerve injury and (9) posttraumatic stress at 1 and 3 months after repair of a peripheral nerve 
injury were all significant predictors for different aspects of functional outcome 12 months 
after injury. Of all possible prognostic factors only smoking was not found to be significantly 
correlated to functional outcome in this study.
sensibility of the hand
Fifty-four percent of the variability of the sensibility of the hand can be explained using this 
prognostic model. Negative prognostic factors are male gender, higher age group, combined 
nerve injury and proximal nerve lesions. Interpretation of these results show that females 
have a 20% higher sensibility compared to men, a higher age group lowers the sensibility 
with 6.5%. As we defined 4 age groups the difference in hand sensibility between the oldest 
and youngest age group is 19.5%. Combined nerve injuries have a 25.8% lower sensibility 
compared to the ulnar and medial injuries and a proximal lesion lowers the sensibility with 
17.5% compared to the other locations.
Power grip
The difference in return of power grip after peripheral nerve injury in our study population can 
be explained for 40%. This prognostic model included age group, educational level, number 
of arteries involved and amount of posttraumatic stress at 1 month. The power grip was 6.3% 
less in each higher age group. The difference between the oldest and youngest group is 
18.85%. Education gives a 1.7% increased power grip per level. When we compare the highest 
education level with the lowest we found a difference of 10.5% in return of power grip.
Pinch grip
Thirty-three percent of the differences in the return of pinch grip following peripheral nerve 
trauma can be explained with our model. Prognostic factors are educational level, number 
of structures involved and proximal location of the injury. Education level gives an increase 
in pinch grip of 3.5%. Comparing the highest with the lowest educational level we find a 
difference of 21.2%. A higher number of structures involved give a 2.3% decrease in pinch 
grip. Proximal nerve lesions decrease the return of pinch grip with 16.4% when compared 
with other locations.
motor recovery of the whole hand
The difference in motor recovery of the hand can be explained for 23% with this prognostic 
model. Factors included in this model are number of arteries involved, type of injury, com-
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bined nerve injuries. On a zero to 10 scale the MRC score will be 1.9 points less for each 
involved artery. Combined nerve injuries will lower the MRC score with 2.8 points compared 
to single nerve injuries. Crush injuries decrease the MRC score of the hand with 2.2 points 
compared to sharp nerve injuries.
dAsh
The outcome of the DASH score can be explained for 29% with the age group and amount 
of posttraumatic stress at 1 and 3 months postoperatively. A higher age group results in a 3.9 
point higher DASH score. The older age group -thus- has an 11.7 point higher DASH score. 
Interestingly, our model showed a discrepancy between the 1 and 3 month posttraumatic 
stress assessment and the DASH. This is in contrast to our univariate analysis where both time 
points of posttraumatic stress level show a negative correlation with the DASH score.
Factors which showed to be important in predicting outcome of peripheral nerve injury 
can be subdivided in general characteristics and injury-specific characteristics. The general 
characteristics, age, gender, educational level and amount of posttraumatic stress at 1 and 
3 months will be discussed first. It is commonly known that age has an important influence 
throughout all subjects in regenerative medicine[8, 27, 36]. Not unsurprisingly this is also the 
case in our study.
Gender clearly influences recovery of sensibility after nerve injury. The results of the uni- & 
multivariate analysis show that gender is only related as a prognostic factor to sensory recov-
ery and not motor function recovery. Be that as it may, we can’t find a logic explanation in our 
data set regarding this prognostic factor. Nevertheless, the results demonstrate women in 
general will have a better sensory recovery after a peripheral nerve injury.
Educational level proofs to be of strong predictive value for sensibility, power grip and DASH 
outcome. People in the lower educational level group are more likely to perform (heavy) labor 
work. And thus, it is likely that their chances to be involved in a more severe hand trauma are 
higher compared to the white-collar population. Evidently this will influence the functional 
outcome after recovery. Secondly, it is our experience that educated patients are more willing 
to train intensively with their hand therapists, which has been reported to affect function, 
both for sensory and motor recovery[7]. The aid of hand therapy is of paramount importance 
in the rehabilitation of patients. In this study, all patients were assigned the same postopera-
tive rehabilitation program. Amount of visits per participants were not recorded in this study.
Posttraumatic stress level at one and three months postoperatively has significant influ-
ence on the recovery of power grip and DASH outcome[37].
Despite the obvious, no relation between smoking and one of the functional outcome 
factors was found in both the uni- and multivariate analysis. In two retrospective studies 
healing after nerve transection appeared to be affected adversely by cigarette smoke[12, 38]. 
However in an experimental study regarding the effects of tobacco smoke on nerve healing 
after crush injury in a rat model, no significant association between tobacco smoke exposure 
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and delayed nerve recovery was found[39]. An experimental study in 2011 showed that expo-
sure to cigarette smoke was associated with a slower functional recovery following ischemia/
reperfusion injury of a peripheral nerve in the rat[40].
The injury-specific characteristics, number of structures and arteries involved, location, 
type of damaged nerve and the type of nerve trauma are all influencing functional recovery. 
Obviously, we found that the number of structures and arteries involved were predictors of 
outcome. Interestingly, studying the multivariate models, the relation was only found for 
motor recovery (e.g. power grip and MRC), and not for sensory recovery and DASH outcome.
cONcLusiON ANd FuTuRe PeRsPecTiVes
Gender, age, educational level, number of injured structures and arteries, damaged nerve, 
location of injury, type of nerve injury and posttraumatic stress at 1 and 3 months are strong 
predictors for functional recovery after peripheral injuries of the median and/or ulnar nerve 
of the forearm. Sensibility of the hand, powergrip and DASH score have proven to be the best 
three prognostic factors in our study. Our results may help us to inform patients about their 
expected recovery during the first year after injury. The information also assists clinicians in un-
derstanding the outcome of patients with peripheral nerve injuries of the forearm. However, 
at this time, posttraumatic stress is probably the only factor which can be influenced in an 
early phase to optimize functional outcome results. To what extent the latter really improves 
outcome should be subject of further study.
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APPeNdiX
Appendix Table 5. Location of injury in relation to outcome at 12 months
Mean values (M) of the different outcome parameters subdivided for location of injury with standard deviation (SD). 
Values are mean percentages of recovery in comparison with normalized data.
Sens 
med
Sens 
uln
Sens 
hand
Power 
grip
Pinch 
grip
MRC
med
MRC 
uln
MRC 
hand
DASH 
score
M (SD) M (SD) M (SD) M (SD) M (SD) M (SD) M (SD) M (SD) M (SD)
distal
48.9% 
(29.4)
63.5% 
(28.9)
76.6% 
(17.5)
67.6% 
(20.5)
65.3% 
(23.0)
7.2 
(3.4)
4.0 
(3.0)
5.9 
(3.6)
16.0% 
(17.2)
intermediate
40.0% 
(56.6)
52.5% 
(32.0)
72.6% 
(16.6)
62.8% 
(14.5)
46.4% 
(14.7)
4.0 
(5.6)
4.6 
(2.9)
4.1
(3.1)
21.0% 
(21.1)
Proximate
38.6% 
(35.8)
30.0% 
(16.2)
58.7% 
(21.2)
59.9% 
(29.5)
41.4% 
(33.0)
4.0
(3.7)
4.0 
(3.3)
4.0
(3.5)
10.9% 
(10.1)
Appendix Table 6. Injured nerve in relation to outcome at 12 months
Mean values (M) of the different outcome parameters subdivided for injured nerve with standard deviation (SD). 
Values are mean percentages of recovery in comparison with normalized data.
Sens
med
Sens
uln
Sens 
hand
Power 
grip
Pinch 
grip
MRC 
med
MRC 
uln
MRC 
hand
DASH 
score
M (SD) M (SD) M (SD) M (SD) M (SD) M (SD) M (SD) M (SD) M (SD)
median
48.4% 
(32.0)
X
74.1% 
(16.0)
71.0% 
(19.5)
63.3% 
(24.4)
6.6 
(3.9)
X X
14.9% 
(18.4)
ulnar X
57.3% 
(30.4)
77.0% 
(17.9)
65.0% 
(22.1)
58.6% 
(24.9)
X
4.6 
(3.0)
X
13.6% 
(12.4)
combined
40.0% 
(25.7)
43.5% 
(27.4)
50.0% 
(21.8)
42.7% 
(8.9)
36.5% 
(26.8)
6.0
(3.4)
2.3 
(1.9)
2.3 
(1.9)
30.3% 
(22.5)
Appendix Table 7. Type of injury in relation to outcome at 12 months
Mean values (M) of the different outcome parameters subdivided for type of injury with standard deviation (SD). 
Values are mean percentages of recovery in comparison with normalized data.
Sens
med
Sens
uln
Sens 
hand
Power 
grip
Pinch 
grip
MRC
med
MRC
uln
MRC 
hand
DASH 
score
M (SD) M (SD) M (SD) M (SD) M (SD) M (SD) M (SD) M (SD) M (SD)
sharp
49.7% 
(30.5)
55.7% 
(30.2)
73.8% 
(19.3)
66.4% 
(20.0)
60.3% 
(25.9)
6.9
(3.7)
4.4 
(2.8)
5.6
(3.5)
16.1% 
(17.5)
crush
30.6% 
(30.4)
40.0% 
(28.3)
67.1% 
(14.4)
59.4% 
(31.0)
45.9% 
(20.1)
4.0
(3.6)
0.0 
(0.0)
3.1
(3.6)
14.3% 
(11.4)
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ABsTRAcT
Background Psychological symptoms frequently accompany severe injuries of upper 
extremities and are described to influence functional outcome. As yet little knowledge is 
available about occurrence of posttraumatic psychological stress and the predictive charac-
teristics of peripheral nerve injuries of the upper extremity for such psychological symptoms. 
In this prospective study the incidence of different aspects of early posttraumatic stress in 
patients with peripheral nerve injury of the forearm is studied as well as the risk factors for the 
occurrence of early psychological stress.
methods In a prospective study design patients with a median, ulnar or combined 
median-ulnar nerve injury were monitored for posttraumatic psychological stress symptoms 
with the Impact of Event Scale questionnaire (IES) up to three months post-operative.
Results  Psychological stress within the first month after surgery occurred in 
91.8% of the population (IES mean=22.0, SD=17.3). Three months post-operative, 83.3% (IES 
mean=13.3, SD=14.1) experienced psychological stress. One month postoperative 24.6 % and 
three months postoperative 13.3% of the patients had IES scores indicating for the need for 
psychological treatment. Female gender, adult age and combined nerve injuries were related 
to occurrence of psychological stress symptoms one month post-operative.
conclusions In the majority of these patients, peripheral nerve injury of the forearm is 
accompanied by early posttraumatic psychological stress, especially in female adults who 
suffered from combined nerve injuries.
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iNTROducTiON
Severe injuries of the upper extremity are frequently accompanied by psychological symp-
toms like persistent, distressing recollection of trauma as flashbacks and nightmares, disturbed 
affect and anxiety, conditioned arousal to reminders of the trauma, and avoidance of stimuli 
reminiscent of the accident [1] [2]. When such symptoms last for more than one month, these 
are representative of posttraumatic stress disorder (PTSD). Posttraumatic stress disorder is a 
strongly disabling condition, impairing functionality and physical health of sufferers. PTSD is 
also associated with a high level of suicidal behavior (19%)[3]. Epidemiological studies indicate 
that posttraumatic stress disorder is becoming a major health concern; approximately one 
third of the population will be exposed to severe trauma during their lifetime and in 10-20% 
of these individuals posttraumatic stress disorder will develop. The incidence of posttraumatic 
stress disorder in injured adults admitted to a hospital is ranging between 14-46%[4]. It has 
been estimated that the prevalence of posttraumatic stress disorder in the general population 
ranges from 3-6%[5-7]. The symptoms of posttraumatic stress disorder reflect a psychological 
disturbance that often requires medication or psychotherapy. Cognitive-behavioral therapy, 
relaxation training, imagery techniques and systematic desensitization are all helpful treat-
ment strategies to help the patient return to a productive everyday life [3, 5, 8-10]. Although 
early post-traumatic stress disorder is related to functional outcome after peripheral nerve 
injury, still little is known about the incidence and predictive factors for posttraumatic stress 
symptoms [1, 8, 9, 11, 12], how to assess incidence and intensity of post-traumatic psycho-
logical stress symptoms and to identify risk factors for early psychological stress. Hence this 
study was designed to evaluate not only this prevalence after severe nerve injury of the up-
per extremity, but also to possibly identify specific risk factors for the development of early 
psychological stress after a nerve injury.
PATieNTs eN meThOds
study population
Between 2000 and 2003, patients with a peripheral nerve injury, operated in the University 
Medical Centre Rotterdam, the University Medical Centre Utrecht (UMCU), the MCRZ Rotter-
dam, the Isala Clinics Zwolle, the University Medical Centre Nijmegen “St.Radboud”, the Univer-
sity Medical Center Amsterdam “VU” were asked to participate in this study. Exclusion criteria 
were age under 12 years old, amputations of hand and fingers and insufficient knowledge of 
the Dutch language. By including amputation victims, not only the diversity of our patient 
trauma severity would increase but also objectively measuring recovery of the hand function 
would be a problem. According to these criteria 82 patients were asked to participate in the 
study. Three patients rejected participation and 16 patients who initially participated were lost 
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during follow up. Finally, data of 61 patients was used for evaluation. A flowchart of the study 
population is presented in figure 1. Informed consent was provided by all participants. The 
psychological evaluation was assessed at one and three months post-operative. The Medical 
Ethical Committee of the University Medical Center Rotterdam approved this study.
Assessments
To measure the current degree of subjective impact of peripheral nerve trauma experienced 
by a person, the Impact of Event Scale (IES) was used at 1 and 3 months after injury. The IES, 
designed by Horowitz in 1979, includes 15 items that refer to the “the past seven days,” across 
the subscales of avoidance and intrusion and taps dimensions that are similar to defining 
symptoms of PTSD[3, 13]. The patients were invited to rate several questions as: “I have been 
avoiding things that could remind me of the accident”, “I had trouble falling asleep of stay-
ing asleep because of pictures of thoughts of the accident reappeared” and “Each time I was 
reminded to the accident, I had recurrent feelings about it”. Each item is scored on a 4-point 
scale. These scores were reduced, weighed and labeled as follows: 0 points = not at all, 1 point 
= rarely, 3 points = sometimes, 5 points = often. Total IES scores ranges from 0-75 (75= worst 
score). As a general rule patients displaying scores above 30, have symptoms serious enough 
to be in need for psychological treatment [14].
Statistical analysis:
The relation between type of injury, number of damaged structures, presence of arterial dam-
age, age, gender, education level and posttraumatic psychological stress, 1 and 3 months 
after injury (measured with the IES), was studied with one-way analyses of variance or Pearson 
product moment correlation analyses. Variables that were found to be associated with early 
posttraumatic stress were then included in a multivariate regression model to evaluate their 
independent contribution in the prediction of posttraumatic psychological stress.
Figure 1. Flowchart of study population
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ResuLTs
study population
For this study 61 patients with median (n=30; 49%), ulnar (n=24; 39%) and combined nerve 
injuries (n=7; 12%) that were reconstructed in the participating hospitals, were prospectively 
examined at 1 and 3 months. The study group consisted of 23 children and adolescents (38% 
≤ 25 years) and 38 adults (62% ≥ 26 years). Most patients, 84% (n=51), were male and 16% 
(n=10) were female.
Psychological impact
Incidence of psychological posttraumatic stress symptoms:
The results from the IES revealed that 91.8% (mean = 22.0, SD = 17.3) of the study population 
experienced psychological stress within the first month after surgery (Table 1). Three months 
post operatively psychological stress was experienced by 83.3% (mean = 13.3, SD = 14.1). A 
score greater than 30, which indicates the need for psychological treatment, was found in 24.6 
% of the patients at one month and in 13.3% at three months postoperative. Scores above 
40, which is the threshold for severe psychological stress, were found in 14.8% of the patients 
when measured one month after surgery. At 3 months, 8,3% of the patients still scored above 
40. A minor assessment score (<18) was reported by 44.3% (1 month) and 73.3% (3 months). 
A moderate score was found (18-39) in 36.1% (1 month) and 13.3% (3 months) of the patients. 
Psychological stress symptoms at one month and three months showed a strong correlation 
(r=.75, p<0.001).
Table 1. Psychological stress symptoms by gender, age and injury
ies 1 month ies 3 months
Mean SD N Mean SD N
Gender*
males 19,8 14,91 51 12,1 12,98 50
Females 33,3 24,41 10 19,1 18,38 10
Age*a
Adolescents 15,0 13,85 23 7,1 8,88 23
Adults 26,2 18,00 38 17,1 15,43 37
Injury
median 19,5 17,8 28 14,4 16,0 27
ulnar 21,2 15,9 27 11,8 12,4 27
combined*b 37.5 16,2 6 15,5 13,4 6
Total 22,0 17,3 61 13,3 14,1 60
IES, Impact of Event Score;*p<0.05
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Predictors for early post-traumatic psychological stress:
Significant independent predictors of early post-traumatic psychological stress, one month 
post operative were gender (F(1,59) 5.45, p=.023) and age (F(1,59) 6.53, p=.013). At three 
months post operative only age was a predicting factor for psychological stress (F(1,58) 
7.68, p=.007). Females had significantly more psychological stress symptoms at one month 
compared to males. Adults had more symptoms than adolescents, both at one and three 
months post operative. The one-way analysis of variance for stress symptoms according to 
type of nerve injury showed a non significant difference (F(1,59) 1.05 p=0.310), but post hoc 
comparisons indicated that combined nerve injuries differed from median nerve lesions 
(mean difference=18.0, SE=7.56, p=.021) and that they differed from ulnar nerve lesion (mean 
difference=16.3, SE=7.58, p=.036). On the other hand, these relationships were not found for 
the measurements three months postoperative. The mean scores for the psychological stress 
symptoms in relation to these predictors are presented in Table 1. The predictor education 
(range 1-7) showed an average of 4.1. The number of damaged structures was averaged with 
5.5. 57% of the patients had arterial damage and the location of the injury was in 69% of 
the patients distally orientated. All of these factors were not associated with the amount of 
psychological stress symptoms at one and three months post-operatively.
Next, a multivariate backward regression analysis was executed, using psychological stress 
symptom score at one month postoperative as dependent variable and age, gender and 
type of nerve injury as predictors. This resulted in a significant model (F(2,58) 5.47 p=.007) 
that explained 40% of the variance. Both age (β=.28, p=0.028) and gender (β=.25, p=0.048) 
contributed significantly, whereas type of injury (specifically median nerve injury that was 
least associated with psychological stress symptoms of the different kinds of injury) did not 
contribute significantly (β=-.034, 0.780).
discussiON
This study showed that psychological stress symptoms occur in most patients after peripheral 
nerve injuries of the upper extremities within the first month after surgery. Our prospective 
study showed that almost all patients (92%) experienced psychological stress symptoms 
and 83% still experienced psychological stress three months post operatively. Psychological 
treatment was indicated in 25% one month postoperative and still in 13% at three months 
postoperative, according to the IES.
In medical practice attention following hand trauma is primarily focused on functional 
recovery. However, posttraumatic stress disorder has been found to contribute more to 
patient’s perceived general health than the degree of physical functioning or the severity 
of injury[15]. Psychological results of hand injuries are immediately apparent; there is fear of 
potential further injury and the injured hand acts as a constant reminder. An example of a 
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hand injury with serious functional consequences and often a disappointing recovery is a 
peripheral nerve injury of the forearm. Earlier studies demonstrated a mean time of returning 
to work of 31.9 weeks and 41% of patients did not return to work at all in the first year after 
peripheral nerve injury[16, 17]. A study that investigated even more severe trauma of the 
forearm showed that as much as 45,2% of patients did not return to work within a year after 
injury[18].
In the current prospective study the majority of the patients with peripheral nerve injuries 
of the upper extremities experienced psychological stress symptoms within the first three 
months after surgery. One month postoperative a quarter of all patients displayed psycho-
logical stress with the severity that was indicative for psychological treatment. Three months 
postoperative 13% of the patients suffered from severe psychological stress. These findings 
are in agreement with earlier study results. In a retrospective study of Jaquet et al. 94% of 
patients with peripheral nerve lesions demonstrated additional posttraumatic psychological 
stress. In that retrospective study, psychological morbidity, measured with the impact of event 
scale, was found in 36% of the patients[19].
One should not only be aware of the importance of this high prevalence of posttraumatic 
psychological stress after peripheral nerve injury. Also, data as part of a bigger prospective 
study also indicated early psychological stress after peripheral nerve injury as a predictive 
factor for power grip and daily activities -measured with the daily activity of shoulder and 
hand questionnaire (DASH)- twelve months after injury[19]. Consequently, a more severe 
posttraumatic stress one month after injury was associated with greater motor disability.
Early identification of patients with psychological stress symptoms and evidently ap-
propriate treatment could improve functional outcome and facilitate earlier return to work 
in patients with severe hand trauma. Grunert et al. already demonstrated (1991) that early 
intervention reduced the effects of litigation on stress symptoms[11]. Van der Kolk et al (1994) 
suggests that patients with more recently detected stress symptoms have better response 
to treatment[20]. Besides, early detection, support and treatment of people with emotional 
problems, costs less than the long-term costs associated with failure to provide early and 
effective treatment for the society[7]. Once actual PTSD has developed, it is often a chronic 
and recurring condition [3]15. Although effects of therapy in patients with PTSD and peripheral 
nerve injuries need further study, our results indicate that early support and intervention 
could optimize surgical treatment results. Earlier research has demonstrated effectiveness of 
cognitive-behavior therapy, group therapy, and exposure therapy (i.e. the patients repeatedly 
relive the frightening experience under controlled conditions to help him or her to think 
through the trauma)[8]. In 80% of people with PTSD, depression, or anxiety disorders, alcohol 
or other substance abuse occurs[3, 21]. The likelihood of treatment success of peripheral nerve 
injuries of the upper extremities is therefore increased when these other –psychological- 
conditions are appropriately diagnosed and treated accordingly. Nevertheless, psychological 
stress symptoms will not affect all patients suffering from a similar injury. Hence, identification 
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of risk factors that may lead to psychological stress symptoms is needed for optimal selection 
and consequently treatment of the specific patient population that suffers from PTSD. Previ-
ous exposure to trauma and a personal or family history of psychiatric disorders, particularly 
depressive disorders were found to be predictors of PTSD.
In our study, significant independent predictors of early post-traumatic psychological 
stress were female gender, adult age and a combined nerve injury. Education, concomitant 
arterial bleeding, number of damaged structures and location of injury were not significantly 
associated with the amount of psychological stress at one and three months postoperatively.
Consequently, female gender was found to be predictive for early posttraumatic stress. 
Multiple research studies have demonstrated that, in general, women have higher rates of 
PTSD compared to men[4, 22-27] however the results are mixed regarding the prevalence 
of PTSD in males or females among individuals who have experienced an injury or disability. 
Perry et al (1987) [28] found that individuals who had severe burns, the PTSD was more likely 
to emerge in males. Roca et al (1992) [29] found that gender did not significantly predict 
posttraumatic stress levels among individuals with burn injuries.
Another factor predictive for early posttraumatic stress in our study was age; Adult age (≥ 
26 years) was associated with a higher degree of early post-traumatic psychological stress, 
one month post-operative. In contrast, several studies on other diseases, the younger age 
-actually- was indicated as a predictor of PTSD. In a recent study where the role of physi-
cal, psychosocial and compensation-related factors in the development of 129 patients of 
an adult population with PTSD following major trauma were examined, it was found that 
PTSD was significantly associated with younger age (P < 0.0001)[12]. However, note that in 
our study children above 12 years and adolescents were included, whereas the other studies 
concerned adults.
Combined nerve injuries were associated with a higher degree of early psychological stress 
one month post-operative than median nerve injury. However, the relatively small number of 
patients that was diagnosed with this type of injury could explain the relatively low correlation. 
As such, further research on the type of injury in relation to psychological stress symptoms 
seems indicated. Severity of injury does not appear to be a strong predictor for PTSD. Feinstein 
in 1991[30] and Michaels in 1999[4] were unable to find a relation between severity of injury 
and PTSD. The major risk is conveyed by the experience of the fear, horror and helplessness 
and the ongoing pain and uncertainty caused by the injury[31]. In peripheral nerve injury 
patients and especially patients with combined nerve injuries helplessness and uncertainty 
caused by the injury is substantial.
A meta-analysis of 77 studies by Brewin et al., in 2000 showed that both female gender, 
younger age and severity of injury is associated with a higher risk of developing PTSD[32].
The remaining question is what mechanism is responsible for impaired functional outcome 
in peripheral nerve patients with psychological stress symptoms. Research has demonstrated 
that PTSD clearly alters a number of fundamental brain mechanisms[5]. Neurobiological stud-
51
Posttraumatic psychological stress outcome nerve injury
3
ies indicate that three structures in the brain are involved with this disorder: the amygdala, 
medial prefrontal cortex and hippocampus. Neuroimaging research showed hyperrespon-
sivity within the amygdala, reduced neuronal responsivity and cortical volumes in medial 
prefrontal structures and reduced hippocampal volume[33]. Besides glucocorticoid hyper-
sensitivity three neurohormone systems (noradrenegic system, serotonergic system and the 
hypothalamic-pituitary-adrenal [HPA] axis) are dysregulated in PTSD patients, which represent 
possible neurochemical substrates for an unbalanced modulation of the limbic circuit[5, 33-
35]. Abnormalities or dysfunctional processes in brain chemicals may result in problems with 
coping, behavior, learning and memory. These skills are particularly important in patients with 
peripheral nerve injuries, who have to adapt to alterations in recognition of objects and touch 
perception, due to abnormal innervation and misdirection of nerves.
In a review by Yehuda et al in 2011 little evidence is found for specific genes associated 
with increased risk of the developing PTSD[36]. Twin studies suggest that PTSD symptoms 
are moderately heritable[37]. Further research in the field of genetics is recommended to 
determine the role of genes in psychological stress after trauma.
The accompanying symptoms of PTSD like depression, sleeping disorders and loss of 
motivation could also be responsible for impaired functional recovery and a late return to 
work. Furthermore there is evidence that psychological stress adversely affects the immune 
system and could influence and delay wound healing [5]. When striving for optimal recovery, 
aside from surgery, psychological stress in particular could be one of the few factors which 
we can try to influence in order to improve their functional outcome. Hence, early detection 
of posttraumatic psychological stress symptoms and subsequent support and intervention in 
this patient group might improve their functional outcome.
cONcLusiONs
In conclusion this study demonstrates a high prevalence of early posttraumatic psychologi-
cal stress following peripheral nerve injury of the forearm. In the majority of these patients, 
peripheral nerve injury of the forearm is accompanied by early posttraumatic psychological 
stress, especially in female adults who suffered from combined nerve injuries.
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ABsTRAcT
Background To investigate whether ultrasonographic measurement of the cross-
sectional area (CSA) of the intrinsic hand muscles can be used to predict muscle strength in 
a valid and reliable manner, and to determine if this method can be used for follow-up of pa-
tients with peripheral nerve injury between the wrist and elbow. Design: Repeated-measures 
cross-sectional study.
methods Healthy adults (n=31) and patients with ulnar and median nerve injuries 
(nZ16) between the wrist and elbow who were visiting the Erasmus Medical Center or Maas-
stad Hospital were included in the study (N=47). Correlation between measured muscle 
CSA and strength and assessment of inter- and intrarater reliability. Ultrasound and strength 
measurements of the intrinsic hand muscles were conducted bilaterally. To establish validity, 
the CSA of 4 muscles (abductor digiti minimi, first dorsal interosseus, abductor pollicis brevis, 
opponens pollicis) was compared with strength measurements of the same muscles con-
ducted with the Rotterdam Intrinsic Hand Myometer. Repeated measures were conducted to 
assess inter- and intrarater reliability.
Results  The assessed CSA strongly correlated with strength measurements, with 
correlations ranging from 0.82 to 0.93 in healthy volunteers and from 0.63 to 0.94 in patients. 
Test-retest reliability showed excellent intrarater reliability (intraclass correlation coefficient 
range, 0.99-1.00) in patients and volunteers and good interrater reliability (intraclass correla-
tion coefficient range, 0.88-0.95) in healthy volunteers.
conclusions We found that ultrasound is a valid and reliable method to assess the CSA 
of specific muscles in the hand. Therefore, this technique could be useful to monitor muscle 
reinnervation in patients suffering from peripheral nerve injury as a valuable addition to 
strength dynamometers.
59
Ultrasound nerve injury clinical
4
iNTROducTiON
Peripheral nerve injury is disabling and has a prevalence of approximately 3% in trauma pa-
tients.1 As a direct result of median or ulnar nerve injury, muscles are denervated and atrophy 
consequently occurs in the weeks after injury. This can result in severe loss of hand function. 
The outcome with or without surgery is often unpredictable and disappointing. Most patients 
suffer considerable posttraumatic psychological stress because of the daily confrontation 
with their inability to use the injured hand and the uncertainty concerning the functional 
outcome. This psychological stress is believed to adversely affect functional recovery.2,3 To 
provide patients and surgeons with more information concerning the outcome of surgery 
and therapy, muscle strength measurement has become an integral part of the physical 
examination and longitudinal followup after nerve injury.4-7
The methods most frequently used to evaluate outcome of motor function of the hand 
are manual muscle testing introduced by the British Medical Research Council (MRC) and 
grip and pinch strength dynamometers.8,9 In addition, more recently, the Rotterdam Intrinsic 
Hand Myometer (RIHM) has been developed to measure individual finger or thumb strength, 
allowing more direct assessment of intrinsic muscle strength.10
However, manual muscle testing and dynamometers have a number of limitations. First, 
the MRC scale used for manual muscle testing is an ordinal scale with disproportional dis-
tances between grades and provides little information on recovery in the 4 to 5 segment.11 
Second, strength measurements generally assess several muscles at the same time and do 
not allow the examiner to measure individual muscles. Because the assessed muscles are 
rarely innervated by the same nerve, strength measured is not a direct representation of 
regeneration of one specific nerve. Third, strength measurement is often influenced by other 
factors than muscle strength alone (eg, injuries of associated soft tissues and tendons, pain 
inhibition, patient motivation, malingering). Another limitation specific to dynamometers is 
that they cannot be used by patients who score <3 on the MRC scale. Hence, dynamometers 
do not allow detection of early muscle recovery.10,12,13 Therefore, new methods that can 
tackle these limitations are necessary to provide patients and clinicians with more detailed 
and specific information.
Clinical studies have shown ultrasounds to be highly reliable for measurement of muscle 
cross-sectional area (CSA) and to have a strong correlation with magnetic resonance imaging 
findings.14,15 Ultrasonography has also been described as a useful tool in the diagnosis of 
neuromuscular disorders and for the documentation of the course of muscle atrophy and 
mesenchymal. abnormalities in neurogenic muscle lesions in a rabbit model.16,17 Addition-
ally, a previous study conducted by our research group showed high correlations between 
the gastrocnemius muscle index and muscle thickness measured with ultrasound in a rat 
sciatic nerve transection model.18 Muscle atrophy and regeneration, objectified by repeated 
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measurements of the muscle CSA in time, may therefore serve as a monitoring tool to evalu-
ate muscle reinnervation, even in the early stages of recovery.
The purpose of this study was to determine whether ultrasonographic measurement of 
the CSA of the intrinsic hand muscles can be used as a valid and reliable method to predict 
muscle strength and whether it can be used to monitor muscle reinnervation in patients 
suffering from nerve injury.
meThOds
Participants
Ethical approval for this study was obtained in the Erasmus Medical Center and Maasstad Hos-
pital. Subjects visiting either hospital were approached for inclusion. After signing informed 
consent, 47 subjects participated in this study. A short questionnaire was used to determine 
hand dominance and the presence of known upper-extremity problems or factors that could 
influence hand strength. We excluded all subjects with preexisting deformities or myopathies 
of the hand. Subjects unable to use the RIHMa because of insufficient strength or pain and 
subjects aged <18 years were also excluded. Subjects were divided into 2 groups: a group of 
healthy volunteers and a group of patients with nerve injuries of the ulnar or median nerve or 
both nerves combined (Table 1).
Thirty-one healthy volunteers (15 men, 16 women; mean age, 27.5y; age range, 21-54y) 
were included for normative reference. Sixteen patients (12 men, 4 women; mean age, 35.9y; 
age range, 19-61y) had a laceration of the ulnar nerve (n=8), median nerve (n=6), or both 
nerves (n=2) in the forearm between the elbow and wrist. The patients were operated on 
by hand surgeons and received hand therapy at the rehabilitation department of one of the 
participating hospitals. All patients had combined nerve and tendon injuries, except for 1 
patient who only had an isolated ulnar nerve injury. The average time period after injury was 
15 months (range, 6-39mo). Most injuries were caused by sharp objects causing injury to the 
forearm between the elbow and wrist.
Table 1. Group characteristics
Characteristic Healthy Volunteers Patients
Sex 15 male 16 female 12 male 4 female
Hand dominance 26 right 5 left 14 right 2 left
Damaged nerve NA 8 median nerve 10 ulnar nerve
Meange age (range) (y) 27.5 (21-54) 35.9 (19-61)
Abbreviation: NA, not applicable
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ultrasound measurements
The ultrasonographic evaluation was conducted using a SonoSite TITAN ultrasound system,b 
with a 5- to 10-MHz broadband linear array probe. We used 2 examiners who were blinded to 
each other’s measurements. The first examiner also performed a second measurement with a 
pause of at least 15 minutes to minimize the recall bias. The examiner and patient were seated 
at opposite sides of a table. The patient was asked to rest the arms on the table in a relaxed 
position, with the dorsal aspect of the hand and forearm in contact with the examination 
table. The thumb was held at a 45degree angle to the midline of the hand. The array probe 
was placed directly onto the skin using sufficient transmission gel.c All scans were made from 
the palmar surface of the hand.
We assessed the CSA of 2 intrinsic hand muscles, abductor digiti minimi (ADM) and first 
dorsal interosseus (DI), which are innervated by the ulnar nerve, and 2 muscles innervated 
by the median nerve, abductor pollicis brevis (APB) and opponens pollicis (OP). The positions 
used to measure the CSA of the muscles were standardized to find the most reproducible 
measure of the intrinsic hand muscles at, or close to, their thickest point (Fig. 1). The scan 
planes were determined before the start of the study by pilot ultrasound evaluation of the 
intrinsic hand muscles in healthy volunteers, and the positions were validated using cadaver 
models.
All ultrasound measurements were conducted bilaterally followed by strength measure-
ments using the RIHM. In the patients, only the muscles innervated by the injured nerve 
were measured. To assess interrater reliability, a second examiner also conducted ultrasound 
measurements bilaterally in 10 healthy volunteers and 15 patients. Then all healthy volunteers 
and 13 patients underwent a second ultrasound measurement by the first examiner to assess 
interrater reliability. Some patients were unwilling to undergo a second and/or third ultra-
sound examination.
Processing and analysis of the ultrasound images
Scans of the CSA of the muscles for each subject were saved as bitmap image files and trans-
ferred to a personal computer using SiteLink Image Manager 2.2.1.b The analysis of the images 
was conducted in Adobe Photoshop CS6 Extended.d The lasso tool was used to precisely 
select the CSA of the muscle in question. The hyperechoic fasciae surrounding the muscles 
were excluded from the selection in all measurements. The correct measurement scale was 
set using the depth scale depicted on the right edge of the ultrasound images and the ruler 
tool to determine the pixel/ distance ratio. Finally, the CSA was computed using the analysis 
option. The muscles were then outlined using the stroke option, and the images were saved 
for future reference (Fig. 2).
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strength measurements
Strength measurements were conducted with the RIHM. The intra- and interrater reliability 
and validity of the RIHM has been proven in, among others, patients with median and ulnar 
nerve injuries and patients with Charcot-Marie-Tooth disease.10,19 We used the protocol 
previously described by Schreuders et al.10 In short, the patient was shown how to position 
the fingers and thumb and was instructed to keep the finger or thumb in that position with 
maximum strength. Force was applied to the same anatomic reference points as used for 
Figure 1. Schematic representation of the 3 different scanning planes indicated with the letters A, B, 
and C. The letters correlate with the inserts on the right, indicated with the same letters, depicting the 
probe positions during measurement of the assessed muscles. (A) The thenar muscles were measured 
at the proximal third of the first metacarpal bone, with the probe positioned on the lateral side of the 
thenar eminence, moving the muscles to the palmar surface. The flexor pollicis longus tendon was used 
as an anatomic landmark, placing the probe as perpendicular as possible to the tendon. (B) The first DI 
muscle was measured at the proximal third of the second metacarpal bone, with the scanning plane as 
perpendicular as possible to its muscle fibers. (C) The ADM was measured at the proximal third of the 
fifth metacarpal. The probe was placed on the ulnar side of the hand, moving the hypothenar muscles 
to the palmar surface of the hand. The scanning plane was as perpendicular as possible to the muscle 
fibers of the ADM.
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Figure 2. Ultrasound images 
after analysis; the 4 assessed 
muscles are outlined.
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the manual muscle testing and described by Brandsma et al.4,20 The force applied with the 
RIHM was slowly increased while the patient was verbally encouraged to hold the finger or 
thumb in place. Four movements were used to assess the strength of the 4 intrinsic hand 
muscles also used for the ultrasonography measurements: the muscles innervated by the 
ulnar nerve were assessed by measuring ulnar abduction of the little finger (mainly the ADM) 
and by measuring radial abduction of the index finger (mainly the DI). Muscles innervated by 
the median nerve were assessed by the anteposition of the thumb (mainly the APB) and the 
opposition of the thumb (mainly the OP). All movements were tested 3 times, and the mean 
was calculated.
statistical analysis
For all statistical analyses, IBM SPSS Statistics 20e was used. The correlation between the CSAs 
measured with the ultrasound scans and the strength measurements obtained with the RIHM 
was determined for each of the assessed muscles separately using the Pearson correlation 
coefficient. The test-retest reliability of the CSA measurements was determined with the intra-
class correlation coefficient (ICC) (2- way mixed model, absolute agreement, single measures), 
standard error of measurement, smallest detectable difference (SDD), and normalized small-
est detectable difference. Bland-Altman plots were used to visualize the reliability.21
The ICC is the ratio of the between-subjects variability over the between-subjects variabil-
ity plus the within-subject variability. 22 The SDD is the amount of change needed between 
repeated tests to detect a real difference. For a 95% confidence level, the SDD is calculated 
as 1.96 x √2 x standard error of measurement. The standard error of measurement is the 
square root of the error variance. When 2 repeated measurements differ more than the SDD, 
the change represents a real change in CSA. The normalized SDD is the SDD expressed as a 
percentage of the mean CSA, which makes it easier to interpret in clinical use.
In clinical practice, the contralateral side is often used as an internal control, and often the 
10% rule is used for side-to-side comparison. This rule indicates that the grip strength is ap-
proximately 10% greater in the dominant hand than the nondominant hand.23 A relative low 
intrasubject side-to-side variability is important when the healthy contralateral side is used 
as the internal control.24 To see whether the CSAs of the muscles in the uninjured hand can 
provide a normative reference value for that person, we compared the data collected from 
the dominant hands with the data collected from the nondominant hands in the healthy 
volunteers for each muscle separately by using the paired-samples t tests. Also, the differ-
ences in muscle CSA between the dominant and nondominant hands were calculated using 
1 - (nondominant hand/dominant hand) and were expressed as percentages. For comparison, 
the same calculations were also conducted for the strength measurements.
65
Ultrasound nerve injury clinical
4
ResuLTs
The assessed muscles could all be identified clearly after a short learning curve. Execution of 
ultrasound measurements of both hands took an average of 10 minutes. Strength measure-
ments took an average of 15 to 20 minutes to complete per subject.
correlation between csA and strength measurement
There was an overall high correlation between the CSA and strength measurements in the 
healthy volunteers (r=0.82-0.93, P<.01). High correlations were also found between the CSA 
and strength measurements of the DI and OP muscles in the patients (r=0.94 and r=0.85, 
P<.01) (table 2). The correlations for both groups are visualized with scatter plots (Fig. 3).
Subanalyses of the dominant (r=0.80-0.93, P<.01) and nondominant (r=0.81-0.93, P<.01) 
hand showed similar values in the healthy volunteers.
intrarater reliability
The reliability between the 2 sessions, expressed as an ICC, was excellent for all 4 assessed 
muscles. The standard error of measurement was approximately the same for all muscles in 
the healthy volunteers and ranged between 0.02 and 0.03 in the patients. The normalized 
SDDs were between 4% and 8% in the healthy volunteers and between 4% and 13% in the 
patients (table 3).
The Bland-Altman plots clearly show that all data are evenly distributed around the zero 
line in the healthy volunteers and patients (figs 4 and 5).
Table 2. Correlations between CSAs and strength measurements
Muscle Pearson correlation (r) R2 Significance (2 tailed)
Healthy volunteers
ADM (n=62) 0.87 0.75 <.01
DI (n=62) 0.83 0.70 <.01
OP (n=62) 0.93 0.86 <.01
APB (n=62) 0.82 0.67 <.01
Patients
ADM (n=9) 0.74 0.55 <.05
DI (n=10) 0.94 0.88 <.01
OP (n=8) 0.85 0.71 <.01
APB (n=7) 0.63 0.39 .13
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interrater reliability
The reliability between the 2 examiners, expressed as an ICC, was good (ICCs range, 0.88-
0.95; P<.01) for all 4 assessed muscles in the healthy volunteers. The normalized SDDs were 
between 15% and 25%.
Among the patients, reliability was acceptable in patients with median nerve injury. The 
ICC was 0.54 (P=.052) for the ADM, 0.27 (P=.17) for the DI, 0.75 (P<.01) for the OP, and 0.58 
(P=.04) for the APB. The normalized SDDs ranged between 51% and 74% (table 4).
Table 3. Intrarater reliability
Muscle Mean CSA ± SD (cm3) ICC SEM (cm3) SDD (cm3) %SDD (cm3)
Healthy volunteers
ADM (n=62) 1.27 ± 0.34 1.00 0.03 0.07 5.5
DI (n=62) 1.85 ± 0.42 1.00 0.03 0.08 4.3
OP (n=62) 1.32 ± 0.34 0.99 0.03 0.09 6.6
APB (n=62) 1.14 ± 0.27 0.99 0.03 0.09 8.3
Patients
ADM (n=9) 0.94 ± 0.05 0.99 0.02 0.07 7.3
DI (n=10) 1.21 ± 0.42 1.00 0.02 0.05 4.4
OP (n=8) 0.81 ± 0.47 1.00 0.02 0.07 8.5
APB (n=7) 0.71 ± 0.35 0.99 0.03 0.09 12.7
Abbreviations: %SDD, normalized SDD; SEM, standard error of measurement.
Figure 3. Scatter plots showing the correlation between the CSA and strength measurement for all 
muscles in healthy volunteers (left) and patients (right).
An overall high correlation between the CSA and strength measurements is seen in the healthy volunteers. High 
correlations were also found between the CSA and strength measurements of the DI and OP muscles in patients.
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Figure 4. Bland-Altman plots of the mean CSA of the ADM (top left), DI (top right), OP (bottom left), 
and APB (bottom right) muscles versus the difference between the CSA in test and retest for the patient 
group. All data are evenly distributed around the zero line.
Figure 5. Bland-Altman plots of the mean CSA of the ADM (top left), DI (top right), OP (bottom left), and 
APB (bottom right) muscles versus the difference between the CSA in test and retest for the healthy 
volunteers group. All data are evenly distributed around the zero line.
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Between-limb comparisons
There was a significant difference (all P values <.05) in the CSA and strength measurements 
between the dominant and nondominant hand in a paired-samples t test analyses for all the 
assessed muscles. Further analyses of the side-to-side variability in muscle CSA and muscle 
strength showed a mean difference in the CSA between the dominant and nondominant 
hand ranging from 3% to 5% and a mean difference in strength between the dominant and 
nondominant hand ranging from 5% to 10% (table 5).
Table 4. Strength and CSA scores of dominant and nondominant hands in healthy volunteers
Muscle Hand
Strength CSA
Mean Strength (N) Mean Differences (%)* Mean CSA (cm2) Mean Difference (%)*
ADM ND 27.82 9.57 1.23 5.45
D 30.91 1.30
DI ND 46.61 4.73 1.80 4.33
D 49.46 1.89
OP ND 129.48 4.54 1.30 2.57
D 135.24 1.34
APB ND 59.33 9.27 1.11 4.00
D 65.25 1.16
Abbreviations: D, dominant; ND, nondominant.
* These scores were calculated with individual data for each of the group; the mean scores were not used.
Table 5. Interrater reliability
Muscle Mean CSA ± SD (cm3) ICC SEM (cm3) SDD (cm3) %SDD (cm3)
Healthy volunteers
ADM (n=62) 1.24 ± 0.37 0.94 0.10 0.27 21.9
DI (n=62) 1.89 ± 0.47 0.95 0.10 0.28 14.8
OP (n=62) 1.35 ± 0.34 0.88 0.12 0.33 24.9
APB (n=62) 1.14 ± 0.32 0.95 0.07 0.19 16.6
Patients
ADM (n=9) 1.01 ± 0.24 0.54 0.19 0.51 51.1
DI (n=10) 1.32 ± 0.34 0.27 0.34 0.95 71.5
OP (n=8) 0.83 ± 0.43 0.75 0.21 0.59 71.9
APB (n=7) 0.68 ± 0.28 0.58 0.18 0.50 73.7
Abbreviations: %SDD, normalized SDD; SEM, standard error of measurement.
69
Ultrasound nerve injury clinical
4
discussiON
The aim of this study was to assess the validity and reliability of ultrasound as a noninvasive 
method to monitor muscle reinnervation in patients suffering from nerve injury by quantifying 
the CSA of the atrophied intrinsic hand muscles. Values for the CSA of the assessed muscles 
showed a strong correlation with values found by strength measurements with the RIHM, 
proving the validity of our ultrasound method for predicting muscle strength. In addition, 
we found excellent intrarater reliability in both patients and healthy volunteers and a good 
interrater reliability in the healthy volunteers. The ultrasound even proved to be more reliable 
than the RIHM. The normalized SDDs ranged between 4% and 8% in the healthy volunteers 
and between 4% and 13% in patients when measurements were conducted by the same 
examiner. These values are much lower than the 18% to 27% mentioned for the RIHM in previ-
ous studies.25
The measured side-to-side variability in strength between the dominant and nondominant 
hand using the RIHM is in line with previous studies. However, to our knowledge, no reference 
values for between-hand comparisons are available for the CSA of the intrinsic hand muscles. 
Our measured mean difference of 3% to 5% for the CSAs does seem to be in line with the 
mean difference in strength measured with the RIHM. This study confirmed that ultrasound 
is an efficient and fast dynamic method to evaluate the CSA of specific muscles in the hand. 
As such, it could be a useful tool to monitor muscle reinnervation. This method proved to be 
especially valuable in the evaluation of patients with little strength because of the trouble 
positioning the fingers for the RIHM measurements.
study limitations
Future research should include larger patient groups because we believe the small number of 
patients included in our study was the reason why we did not have significant correlations for 
all analyses conducted on the patient group.
Some considerations are important when using this method. To perform the ultrasound 
measurements, knowledge of the anatomic structures of the hand and technical experience 
with ultrasound is necessary. The use of a standardized protocol with a predetermined set 
of anatomic landmarks is crucial for the validity and reliability of this method because dif-
ferent scan positions will result in different CSA measurements. Furthermore, the ultrasound 
technique is highly operator dependent, as shown by the analysis for the interrater reliability. 
This is especially true in the patient group where the muscle outlines are less clear and more 
subject to interpretation by the examiner. This suggests that follow-up of a patient should be 
conducted by the same examiner to achieve the most accurate results.
Future research should focus on long-term (ie, longitudinal) follow-up of patients with dif-
ferent periods of muscle denervation and different sites of nerve injury to prove the additional 
benefit of this proposed ultrasound method in a clinical setting. It would be interesting to see 
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whether the correlations found in this study can be verified in patients with longstanding 
muscle denervation (eg, patients with Charcot-Marie-Tooth disease) because longstanding 
muscle denervation causes permanent muscle damage, changing the correlation between 
the CSA and strength. It could also be an opportunity to increase the number of patients 
included in the study because we believe that the nonsignificant results for some of the 
analyses can be explained by the limited patient group size.
cONcLusiONs
We have demonstrated that ultrasound is a valid and reliable method to evaluate the CSA of 
specific muscles in the hand. As such, ultrasound could allow the observation of muscle rein-
nervation in patients suffering from nerve injury noninvasively. The healthy contralateral side 
can be used as an internal control when consideration is given for between-limb variability. 
This method is particularly interesting for patients who are incapable of using a dynamom-
eter, providing an opportunity to evaluate muscle reinnervation, even in the early stages of 
recovery and in patients with extended tendon injuries.
suppliers
a. The Rotterdam Intrinsic Hand Myometer (RIHM); med.engineers.
b. SonoSite Inc.
c. Parker Laboratories Inc.
d. Adobe Systems Inc.
e. IBM Corp.
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ABsTRAcT
Purpose Currently established outcome measurements to evaluate functional 
recovery after peripheral nerve reconstruction in animal models are invasive and require ani-
mals to be sacrificed. The aim of this study was to develop and validate a novel, non-invasive 
ultrasound technique for the longitudinal analysis of functional recovery after segmental 
peroneal nerve reconstruction in a rabbit model.
methods Twelve male New Zealand White rabbits underwent a 1 cm peroneal 
nerve autograft reconstruction. Ultrasound measurements were performed prior to surgery 
and at 1, 2, 4, 8, 12 and 16 weeks post-operatively. All rabbits were able to undergo manual 
restraint for the ultrasound procedure, avoiding the risks of anesthetics. At 12 and 16 weeks, 
functional recovery was evaluated using Compound Muscle Action Potential (CMAP), iso-
metric tetanic force measurements (ITF), wet muscle weight and nerve histomorphometry. 
Data were compared to the ultrasound measurements by calculating the Pearson correlation 
coefficient. Additionally, intra- and inter-rater reliability of the ultrasound measurements was 
determined.
Results Ultrasound demonstrated very good correlations with ITF and wet 
muscle weight. Good correlations with nerve histomorphometry and a moderate correlation 
with CMAP were observed. Both intra- and inter-rater reliability of this ultrasound technique 
were excellent.
conclusions Ultrasound analysis of the tibialis anterior muscle in the rabbit provides 
a reliable and valid method for analysis of functional recovery in the rabbit peroneal nerve 
reconstruction model. The non-invasive nature allows for longitudinal follow-up within the 
same animal and measurement of early recovery without the use of anesthesia.
clinical relevance Application of this non-invasive technique can reduce the variability 
and sample size necessary in peripheral nerve reconstruction studies and will provide an ideal 
tool for comparative studies in larger animal models.
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iNTROducTiON
The treatment of peripheral nerve injury still represents a clinical challenge.[1] To study 
alternative treatment strategies for peripheral nerve repair, animal models are used.[2] Rats 
are frequently used and especially useful as a first in vivo step to study short-term nerve 
regeneration due to their fast neuroregenerative capacity. However, important disadvantages 
impairing its clinical relevance, include the much faster nerve regeneration compared to 
humans and limited length of nerve gaps that can be created in rats.[3] Those limitations can 
be overcome using a larger animal model, the rabbit, where larger nerve gaps up to 8 cm are 
feasible.[4] Furthermore, the rabbit’s neuroregenerative and immunological properties more 
closely mimic the human situation, providing an important step prior to research in clinical 
setting.[5-6]
To evaluate motor nerve recovery after nerve reconstruction in both rat and rabbit, the easily 
obtainable wet muscle weight is frequently used. Other commonly used and established 
outcome measurements include isometric tetanic force measurement (ITF), a more accurate 
measurement of functional recovery, electrophysiological testing and nerve histomorphom-
etry.[7-8,10] However, all those techniques require the animal to be euthanized following 
assessment, restricting longitudinal analysis of outcome over time. A commonly used non-
invasive test is the sciatic function index. Unfortunately, this technique correlates poorly with 
other functional outcome measurement and is only feasible in the rat model.[9]
The use of ultrasound in a rat model has shown to be both reliable and valid.[7, 10] Allow-
ing for multiple measurements over time within the same animal, ultrasound can reduce the 
variability within the studied groups. This would ultimately reduce the required sample size 
and costs of these studies. We hypothesize that a similar technique could be used in the rabbit 
model as a non-invasive method for analysis of nerve reconstruction results. Therefore, the 
aim of this study is to investigate the reproducibility, reliability and validity of a non-invasive 
ultrasound technique to measure the tibialis anterior muscle cross-sectional area for analysis 
of the functional recovery in a rabbit peroneal nerve injury model.
mATeRiALs ANd meThOds
After approval by the Institutional Animal Care and Use Committee, 12 male New Zealand 
White rabbits (Harlan Laboratories Inc., Indianapolis, IN) (weighing 3 to 4 kg) underwent a 
1-cm peroneal nerve autograft reconstruction on the left side. Animals were housed individu-
ally with a twelve-hour light-dark cycle. Food and water were provided ad libitum.
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ultrasound measurements
The optimal ultrasound protocol was determined in a pilot study. Based on previous studies, 
different probe positions to obtain the muscle cross-sectional area using ultrasound were 
compared using cadaveric rabbit legs (data not shown).[7, 10, 11] The protocol that both ob-
servers rated as most easily obtainable showed a standard deviation of less than 5% evaluating 
measurements within and between observers and this protocol was chosen. All rabbits were 
able to undergo the ultrasound procedure under manual restraint using a “Bunny Snuggle” 
(Lomir Biomedical Inc., Malone, NY), avoiding the risks of anesthetics. Ultrasound measure-
ments were obtained prior to surgery and 1, 2, 4, 8 weeks after surgery and at the sacrifice 
procedure, 12 and 16 weeks postoperatively. The lower legs were shaved and remaining hair 
removed using hair removal cream (SURGI-PREP™, Miltex, York, PA). The experimental set-up of 
the ultrasound measurements of the tibialis anterior muscle in the rabbit is depicted in Figure 
1. An instructional video of the ultrasound protocol is available as online supplement on the 
Journal’s Web site (www.jhandsurg.org). With the ankle joint of the rabbit in a 90° angle, the 
patella and lateral malleolus were identified. The ultrasound probe was placed perpendicular 
to the muscle at 1/3 of the distance between those landmarks and cross-sectional images 
of the muscle obtained using the Philips CX50 ultrasound system with a 12 to 3 MHz linear 
transducer (Philips Healthcare, Eindhoven, the Netherlands) and ultrasound gel (Aquasonic 
100, Parker Laboratories, Fairfield, NJ). Following the ACLAM and IACUC guidelines, animals 
were monitored for signs of discomfort.[12] At all time points multiple measurements were 
Figure 1. experimental set-up. The experimental set-up of the ultrasound recording. The position of 
the probe and lower leg of the rabbit are depicted.
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obtained by two similarly trained observers, independent from each other. The cross-sectional 
area of the tibialis anterior muscle was analyzed in Adobe Photoshop CS5 Extended (Adobe 
Systems Incorporated, San Jose, CA).
surgical procedure
Anesthesia was induced using 35 mg/kg Ketamine (Ketaset®, Fort Dodge Animal Health, 
Fort Dodge, IA) and 5 mg/kg Xylazine (Vettek, Bluesprings, MO) administered intramuscular 
(IM). After a subcutaneous (SC) injection of 0.18 mg/kg Buprenorphine (Buprinex®, Reckitt 
Benckiser Pharmaceuticals Inc., Richmond, VA), animals were intubated and maintained at 
spontaneous ventilation with the Bain ventilation system (Harvard Apparatus, Holliston, MA) 
under 1-2% isoflurane. Animals received intravenous (IV) lactated Ringer’s solution and animal 
temperature was maintained at 37°C. All surgical procedures were performed under standard 
aseptic conditions. Through a longitudinal incision on the posterolateral aspect of the left 
thigh, the sciatic nerve and its peroneal branch were exposed by a muscle splitting approach. 
Under a surgical microscope (Zeiss OpMi 6; Carl Zeiss Surgical, Oberkochen, Germany), 
a 1 cm segment of the peroneal nerve was dissected at a level 4 cm distal to the border 
of external obturator muscle. The autograft was reversed and sutured using six 10-0 nylon 
epineural sutures (Ethicon Inc., Johnson&Johnson, NJ) on each side. All nerves had a similar 
diameter. Wounds were closed in layers using 4-0 Vicryl rapid bioabsorbable sutures (Ethicon 
Inc., Johnson&Johnson, NJ). Postoperatively, animals received 5 mg/kg Enrofloxacin (Baytril®, 
Bayer Animal Health, Shawnee Mission, KS) and 4 mg/kg Carprofen (Rimadyl, Pfizer animal 
health, NY) SC once daily for 5 days. Elizabethan collars were worn for two weeks after surgery. 
Rabbits were observed daily until the end of the study.
sacrifice procedure
At 12 and 16 weeks, 6 animals per time point underwent a non-survival procedure. All measure-
ments were conducted bilaterally. Similar to the surgical procedure, anesthesia was induced 
and animals intubated. Anesthesia was maintained using 0.6 mg/kg/min Propofol (Fresenius 
Kabi, Lake Zurich, IL) IV. Infusion rate was adjusted based on corneal reflex, respiration- and 
heart-rate. Propofol was used in lieu of isoflurane, which has been shown to interfere with 
skeletal muscle contraction.[4, 13] Dextrose 5% was administered IV to prevent muscle fatigue.
Electrophysiology
On an anesthetized rabbit, a miniature bipolar electrode (Harvard Apparatus, Holliston, MA) 
was clamped around the exposed sciatic nerve proximal to the autograft and a ground 
electrode was placed in the surrounding musculature. Two recording electrodes were placed 
on the tibialis anterior muscle surface, one proximally near the motor endplates and the 
other distally.[14] Using a VikingQuest Portable EMG (Nicolet Biomedical, Madison, WI) the 
Compound Muscle Action Potential (CMAP) was measured. Stimulation duration of 0.02 ms 
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and the minimum intensity to elicit a maximum CMAP signal was used. The responses were 
analyzed for CMAP amplitude.
Isometric tetanic force measurement
Isometric tetanic force (ITF) measurement was performed as previously described by Giusti et 
al.[4] Briefly, the tibialis anterior tendon was connected to a force transducer (MDB-50, Trans-
ducer Techniques, Temecula, CA) using a custom clamp. Using Kirschner wires (DePuy Synthes 
Vet, West Chester, PA), the knee and ankle joints were secured on a custom made platform. 
A bipolar stimulator (Grass SD9, Grass Instrument Co., Quincy, MA) was used to stimulate the 
peroneal nerve distally to the graft and the signal acquired from the force transducer was 
processed using LabVIEW (National Instruments, Austin, TX). After determining the optimal 
initial muscle tension, the isometric tetanic muscle force was measured at 100, 125 and 150Hz.
Histomorphometry
Animals were euthanized with an overdose of Fatal-Plus® (Vortech pharmaceuticals, Dearborn, 
MI) IV and the lower body perfused with 10% formalin through the exposed aorta. A 2.5 mm 
segment of the peroneal nerve distal from the graft was harvested 2 cm proximal to where 
the nerve enters the tibial muscle and fixed in Trump’s fixative solution. Samples were cut into 
1 μm sections, stained with toluidine blue (Fisher Scientific, Pittsburgh, PA) and analyzed using 
Image-Pro software (Image-Pro Plus 7.0; Media Cybernetics, Bethesda, MD). The N-ratio was 
calculated as the total myelinated fiber area divided by the total tissue cable area.[15]
Wet Muscle Weight
The tibialis anterior muscles on both sides were carefully dissected and the tendons were 
removed. Muscles were directly weighed to determine the wet muscle weight.
statistical analysis
The sample size of this study was based on data from the pilot study showing the highest 
standard deviation of the ultrasound recordings being 5%. The variability of the other out-
come measurements was based on previous studies.[15],[4] Assuming the same variability 
would occur in this study, the number of animals needed for 80% power to reliably detect a 
correlation of at least 0.65 was calculated to be 12.
To determine the validity, reliability and reproducibility of the ultrasound technique, the 
inter- and intra-rater reliability (ICC) (two-way mixed model, absolute agreement, single 
measure) were calculated. SPSS (SPSS version 17, IBM, Chicago, IL) was used for analysis.[16] 
Additionally, Pearson correlation coefficients between ultrasound recordings and CMAP, ITF, 
muscle weight and histomorphometry were calculated. To this end, data were expressed as 
percentage recovery by dividing the data of the injured side by the data of the healthy side 
of the same animal. For further confirmation of the correlation between ultrasound and wet 
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muscle weight of the tibial muscle, a Bland Altman plot was created. P-values <0.05 were 
considered statistically significant.
ResuLTs
All rabbits survived during surgery and follow-up and no major complications occurred. 
Minor complications that were observed were superficial licking wounds on the dorsum of 
the foot of the operated leg (n=4) and a superficial skin inflammation on the lower leg (n=1). 
Topical silver sulfadiazine cream 1% (Thermazene, Ascend Laboratories LLC, Montvale, NJ) 
was applied until complete wound healing.
The procedure was well tolerated by all animals. Using ultrasound imaging showed the 
smallest muscle cross-sectional area index at 8 weeks (51% ± 6% (Standard Deviation, SD)) 
increasing to a mean recovery rate of 60% ± 8% at 12 weeks and 91% ± 10% at 16 weeks. 
Images of the ultrasound recordings are depicted in Figure 2. To evaluate the reliability and 
reproducibility of the ultrasound technique, the mean recovery rates as found by both observ-
ers at each time point are depicted in Figure 3. Both the intra-rater and inter-rater reliability 
were found to be excellent as shown in Table 1.
Figure 2. ultrasound recordings of the same animal over time. In the bottom row, the tibialis an-
terior muscle is delineated with a white line. The number in each picture indicates the follow-up time 
point in weeks.
Table 1. Validity and reliability of ultrasound recordings of the tibial muscle.
icc (95% ci) p
intra-rater reliability 0.994 (0.992 – 0.996) < 0.0001*
inter-rater reliability 0.989 (0.984 – 0.992) < 0.0001*
The intra- and inter-rater reliability of the ultrasound technique and the 95% Confidence Intervals. * indicates a statis-
tically significant correlation (p<0.05)
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Functional outcome measurements
Using CMAP measurements, a mean recovery rate of 44% ± 8% (SD) at 12 weeks and 67% 
± 9% at 16 weeks was found. In three animals (n=1 at 12 weeks and n=2 in the 16 week 
group) CMAP could not be obtained reliably. In one animal (week 16) the ITF test could not be 
performed due to mechanical failure of the force transducer. ITF showed 39% ± 24% recovery 
at 12 weeks recovering up to 104% ± 37% at 16 weeks. The wet muscle weight of the tibial 
muscle showed a mean recovery rate of 45% ± 8% at 12 weeks, which improved up to 86% 
± 13% at 16 weeks. Finally, calculation of the N-ratio revealed a mean recovery at 12 weeks of 
61% ± 14% and 83% ± 10% at 16 weeks.
correlations with ultrasound measurements
The correlations between ultrasound measurements and other outcome measurements at 12 
and 16 weeks are shown in Table 2. All correlations were found to be moderate to excellent 
and are statistically significant (p<0.01). For significance, the Pearson correlation tests the cor-
relation that was found against the null hypothesis: ρ = 0 (no correlation). A significant result 
(p <0.05) means that the correlation is significantly different from 0 (e.g. there is a significant 
correlation).
A Bland Altman plot of ultrasound measurements and wet muscle weight is shown in 
Figure 4. The narrow 95% limits of agreement indicate statistical equivalence of the methods.
Figure 4. Bland Altman plot of the ultrasound 
and muscle Weight measurements. To visualize 
the difference between the recovery rates calculat-
ed using ultrasound (US) measurement and muscle 
weight (MW), a Bland Altman plot was created. The 
average of the two measurements is plotted on the 
x-axis and the difference on the y-axis. The dotted 
lines indicate the 95% limits of agreement.
Figure 3. muscle cross-sectional area recovery 
rate over time after nerve reconstruction. The 
muscle cross-sectional area of the operated leg 
expressed as percentage of the non-operated side 
as measured by the two independent observers 
(Obs 1 and Obs 2) at the different time points.
83
Ultrasound nerve injury rabbit
5discussiON
Ultrasound provides a promising non-invasive tool for functional evaluation of motor recovery 
after peripheral nerve reconstruction in the rabbit model. The non-invasive nature allows to 
use animals as their own control over time. This minimizes inter-animal variability, yielding 
higher power with the same number of animals. Both ultrasound and the conventional wet 
muscle weight share the same rationale for the measurement of motor nerve regeneration. 
Denervation will lead to atrophy in the target muscle causing a decrease in muscle mass as well 
as muscle cross-sectional area. Both will increase again when reinnervation is established.[17]
Ultrasound measurements were obtained at several time points after surgery to investigate 
the reliability and reproducibility of the technique for muscles in different stages of recovery. 
Results are depicted in Figure 2 and 3 and furthermore show that early onset of muscle recov-
ery can be detected using ultrasound.
This study found a very high inter- and intra-rater reliability (r= 0.989 and 0.994), indicating 
both high reliability and reproducibility of this method, in line with previous research.[7, 10]
The excellent correlation between ultrasound and MRI to measure muscle cross-sectional 
area has been extensively reported in literature and was therefore not repeated in this study.
[18-21] Furthermore, since this study shows a very strong correlation between a novel non-
invasive technique and the current gold standard muscle weight, additional correlation to 
more invasive techniques such as MRI is obsolete.
Two different endpoints, 12 and 16 weeks, were chosen to study the validity of the tech-
nique in a model with varying stages of muscle reinnervation. The validity of this technique 
to quantify functional recovery was shown by the strong correlations between ultrasound 
and both ITF and muscle weight (r=0.83 and 0.97 respectively) and good and moderate cor-
relations with histomorphometry (r=0.69) and CMAP (r=0.59). The lower correlation between 
ultrasound and CMAP could be explained by the higher variability in CMAP values. This is in 
line with previous studies that used CMAP in rabbits.[4, 15]
Previous studies validated muscle cross-sectional area measurement by ultrasound for both 
the gastrocnemius and tibial muscle in rats.[7, 10] In the rabbit typically only the peroneal 
Table 2. Correlations between ultrasound and four established outcome measurements
ultrasound
correlation (95% ci) p
compound muscle Action Potential (cmAP) 0.59 (0.18 – 0.83) <0.01*
isometric Tetanic Force 0.83 (0.62 – 0.93) < 0.0001*
muscle Weight 0.97 (0.94 – 0.99) < 0.0001*
histomorphometry 0.69 (0.41 – 0.86) 0.0001*
* indicates a statistically significant correlation (p<0.05)
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branch, innervating the tibialis anterior muscle, instead of the entire sciatic nerve is grafted.
[15] Therefor measurement of the gastrocnemius muscle like Nijhuis et al.[7] proposed would 
not be suitable. In both rat ultrasound studies the animals were sacrificed at each interim time 
point. In this study, ultrasound images were obtained within the same animal at multiple time 
points, showing that this model is useful to obtain longitudinal data within the same animal. 
In addition to the previous studies, this study also shows the correlation between ultrasound 
measurements and CMAP and nerve histomorphometry.
A review of the literature for non-invasive evaluation of functional recovery after nerve 
reconstruction in the rabbit peroneal nerve model yield few techniques, all with clear limita-
tions. The toe spread reflex described by Schmitz et al.[22] indicates onset of motor recovery 
but does not discriminate in the quality of the muscle function. Meffert et al.[23] described 
a transcutaneous muscle strength quantification that requires deep sedation. With an over 
7% reported risk of death in rabbits due to anesthetics, techniques that can avoid anesthesia 
are highly favorable.[24] Our ultrasound procedure can be performed without any form of 
anesthesia and we were able to complete the ultrasound measurements in no longer than 15 
minutes per animal, limiting the risks for the animals.
When implementing this technique, a well-defined protocol will allow repeated measure-
ments of the same muscle section. In this study, the learning curve of both observers was 
diminished due to the pilot study that was executed previously. Practice of the technique 
prior to implementation will yield the best reliability and smallest variability among observers. 
Although not scientifically proven, after 2 weeks we obtained very good correlations between 
similarly trained observers, indicating that two weeks provide accurate practice. This is in ac-
cordance with previous studies.[7, 10]
The fact that ultrasound measurement of the muscle cross-sectional area is an indirect 
measure of motor nerve recovery could be considered a limitation of this study. However, this 
is similar for the muscle weight index that is commonly used and accepted. Furthermore, we 
found a very good correlation between ultrasound measurements and ITF measurements, a 
direct measurement for functional motor recovery.[4, 15]
Recovery rates of more than 100% measured using isometric tetanic force are in line with 
previously reported data and may be explained by a side preference in the rabbit.10,[15],[4, 25]
These limitations notwithstanding, this study demonstrates that this ultrasound technique 
provides a reliable and valid method for analysis of functional motor nerve recovery in the 
rabbit peroneal nerve reconstruction model. Naturally, this method can be used for other 
nerves and innervated muscles as well, such as brachial plexus injury models. The non-invasive 
nature allows for longitudinal follow-up within the same animal and measurement of early 
recovery, providing an ideal tool for comparative studies of nerve reconstruction strategies.
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ABsTRAcT
Background Today’s golden standard to measure functional recovery after nerve trauma 
in experimental studies is the muscle mass ratio and the isometric tetanic force, both of which 
are invasive and require a sacrificial procedure. We propose ultrasound as a non-invasive 
method to obtain the amount of muscle atrophy and determine its validity and reliability by 
comparing it to muscle mass ratio, isometric tetanic force and histology.
methods Fifty rats sustained a 10 mm autograft sciatic nerve reconstruction. With a 
two-week interval, 5 animals were tested with a total follow-up of 20 weeks. The functional 
recovery of the hindlimb muscles were measured with ultrasound, muscle mass ratio and 
isometric tetanic force. Additionally, neuromuscular junctions were histologically analysed. 
The different evaluation techniques were compared and the reliability of the ultrasound was 
determined.
Results  Four weeks after denervation extensive muscle atrophy resulted in a de-
crease of muscle mass up to 30%. Ultrasound showed good correlations with muscle mass 
ratio for both tibial (r=0.85) and gastrocnemic muscles (r=0.89). The intra- and inter-rater 
reliability of the ultrasound were high (r=0.97 and 0.88). The correlation with force was lower 
(0.62), although still statistically significant.
conclusions Ultrasound measurement of muscle atrophy was highly correlated with the 
golden standard muscle mass ratio and was also significantly correlated with isometric tetanic 
force. Histology confirmed the regeneration pattern observed with ultrasound. We propose 
that ultrasound can be used as a valid alternative to muscle mass ratio to study muscle atro-
phy after nerve injury in a less-invasive and more animal-friendly manner.
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iNTROducTiON
To study peripheral nerve injury, experimental studies are required that are valid and reli-
able in measuring successful restoration of nerve function. A wide variety of tests assess the 
peripheral motor nerve outcome after nerve reconstruction: Electrophysiology, muscle mass 
ratio, ankle angle, histomorphometry and functional tests as the walking-track analysis and 
isometric tetanic force[1-4]. Walking track analysis is only used in rats and was previously com-
monly used as a measure of motor outcome. It is reported to be fraught with inaccuracies 
stemming from autotomy of the feet and contractures of the ankle.[5]. The most commonly-
used test is presently the post-sacrifice muscle mass ratio. The main reason for the popularity 
of this test is its simplicity. However, the isometric tetanic force measurement may be the 
most valid assessment of muscle strength, as it directly evaluates the actual strength capacity 
and not the indirect muscle mass measure[2]. Several studies already confirmed the lack of 
association between the different tests available[5-8].
Recently we introduced the use of ultrasound as a valid, non-invasive, and repeatable tool 
to measure the gastrocnemic muscle thickness and thus quantify muscle atrophy following 
nerve injury[9]. While we found a high correlation with muscle mass, a number of questions 
still remained. For example, it is unclear how the ultrasound measurement would compare 
to a measure of true muscle force, such as the isometric tetanic force measurement. In ad-
dition, the method was only validated for a single muscle, the gastrocnemius muscle; the 
reliability and validity of the visualization and measurements of the tibial muscle has not yet 
been described. Since many nerve regeneration studies use the tibial muscle, a much smaller 
muscle, as a reference, an ultrasound protocol to allow assessment of this muscle would be 
very valuable[2, 10, 11].
The aim of this study is to determine if ultrasound is a valid tool to visualize muscle atrophy 
in the tibial muscle by comparing the ultrasound assessment to muscle weight and to a more 
true measure of muscle force, i.e. isometric tetanic force testing. The ultrasound recordings and 
muscle measurements were also obtained of the bigger, gastrocnemic muscle. In addition, 
the neuromuscular junction (NMJ) in the muscle was histologically examined by visualizing 
the denervation and re-innervation of the motor endplates of the tibial and gastrocnemic 
muscle, and were related to the other outcome assessments. We hypothesize that the early 
reinnervation, before return of strength can be visualized with this method. The overall goal 
of this study is thus to create a valid, repeatable, and, most importantly, non-invasive method 
to analyze functional outcome after nerve injury over time using ultrasound.
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meThOds
Animals
The experimental protocol was approved by the institutional animal care and use committee. 
Fifty adult female Lewis rats were used, weighing 175-200 grams (Charles River Laboratories 
Inc.). Animals were pair-housed in hooded cages on a 12-hour light/dark schedule at room 
temperature. The rats were given food and water ad libitum. Surgical and sacrificial procedures 
were performed under general anaesthesia (Isoflurane, 1-2 % in a mixture of O2/N2O).
surgical Technique
For this experiment, a reversed nerve autograft reconstruction was made. The surgical pro-
cedure was performed by one surgeon and assistant using standard aseptic microsurgical 
techniques under the operating microscope (Zeiss OP-MI 6-SD; Carl Zeiss, Goettingen, Ger-
many) on sciatic nerves of the hind limbs. The operated leg (left or right side) was randomly 
chosen. The sciatic nerve was exposed by an oblique skin incision. A 10 mm segment of the 
sciatic nerve was dissected, reversed and sutured back using 10/0 Ethilon sutures (Ethicon, 
Johnson & Johnson, Amersfoort, the Netherlands). The muscle was approximated using 2 6/0 
Vicryl Rapide sutures after which the skin was closed with the same sutures (Ethicon, Johnson 
& Johnson, Amersfoort, the Netherlands). Buprenorphine (0.5 mL/kg BW) was injected sub-
muscular as an analgesic.
evaluation of muscle atrophy
Every other week, functional measurements were performed on both legs on a total of five 
animals per time period. The total follow-up duration was 20 weeks with a total of 100 legs 
examined.
ultrasound
After initial isoflurane anesthesia, ultrasound images of the muscles were recorded. At first, for 
better conduction of ultrasound waves, hair of the leg was removed by shaving and applica-
tion of depilation cream. For analysis of the tibial muscle, the knee and ankle joint where held 
in a 90° angle. Transducer gel was applied and the probe was placed in a 45° angle without 
applying pressure on the muscle. The sagittal plane of the tibial muscle was visualized. The 
experimental ultrasound set-up is depicted in Figure 1. To perform the ultrasound measure-
ments of the gastrocnemic muscle, the rat hind paw was placed in a water basin, as previously 
described by our group[9]. In this position, images of the sagittal plane of the gastrocnemic 
muscle were recorded. All measurements were conducted bilaterally. The ultrasound record-
ings were performed with the use of the SonoSite Titan Ultrasound (SonoSite Inc., Bothell, 
USA), with a 5-10 MHz linear array probe. In order to obtain an inter- and intrarater reliability 
of the ultrasound measurements of the tibial muscle, two independent and blinded inves-
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tigators performed each evaluation twice. Images were analyzed to determine the muscle 
thickness for the gastrocnemic- and the cross-sectional area of the tibial muscle using Adobe 
Photoshop CS6 Extended (Adobe Systems Incorporated, USA).
isometric tetanic force measurement
The isometric tetanic force measurement was determined for the tibial anterior muscles of 
both legs as described by Shin et al.[2] The sciatic nerve was exposed by an oblique skin inci-
sion. The tendon of the tibial muscle was exposed via a second skin incision and released at 
its insertion. The leg was fixed to a platform with Kirschner wires, which prevents the leg from 
moving during muscle stimulation. The Kirschner wires were placed through the knee- and 
ankle joint. The tendon of the tibial muscle was connected to the force transducer (MDB-50, 
Transducer Techniques, Temecula, CA) and placed in a horizontal position. A miniature bipolar 
stimulating electrode (Harvard Apparatus) was placed around the exposed sciatic nerve. A 
bipolar stimulator (Medtronic, NL) was used to generate the stimulus and the signal acquired 
from the force transducer was processed on a PC using WinTest (Testometric, Hartech, NL). 
During testing, body temperature was maintained with a heating pad and the muscles 
were kept wet and warm with a constant warm saline drip (37˚C). Prior to the maximum 
muscle force measurements, the optimal values of initial muscle tension (pre load) needed 
to be determined. This is the muscle tension in which the muscle can generate its maximum 
muscle force. With this optimal preload, the isometric muscle contraction force was measured 
with the predetermined frequencies of 100, 120 and 140 Hz. Stimulation was applied for a 
maximum of 2 seconds or until a force peak was clearly observed.
Figure 1. experimental set-up of the ultrasound recording of the tibial muscle
(Published with permission of the Mayo Foundation for Medical Education and Research. All rights reserved, copy-
right 2015.)
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muscle mass
After the muscle testing, the animal was euthanized using an overdose pentobarbital (1 mL/
kg BW) that was injected intracardially. The tibial and gastrocnemic muscles of both the oper-
ated and control leg were carefully dissected. The muscle weight was obtained directly after 
dissection to obtain the wet muscle weight.
histology
For histological analysis, tibial and gastrocnemic muscles where fast frozen at -40 °C and serial 
50-µm frozen sections were cut using a cryostat. A combination stain for the demonstration of 
motor nerve terminals and cholinesterase at the neuromuscular junctions was used as previ-
ously described by Pestronk et al.[12]. This method uses bromoindoxyl acetate staining for cho-
linesterase and silver-gold impregnation for nerve terminals. The silver stain reveals individual 
myelinated axons as black filaments, while the acetylcholinesterase stain labels motor endplates 
containing the enzyme acetylcholinesterase as well-demarcated transparent blue zones. Unlike 
acetylcholine receptors, acetylcholinesterase stays permanently after denervation.
statistical Analysis
All collected data was expressed as a ratio of the operated leg divided by the healthy leg to 
allow comparison of the percentage of recovery between techniques. Obtained values were 
compared between the different evaluation techniques. Two comparisons were made: the 
isometric tetanic force method with the ultrasound and the muscle weight with the ultra-
sound. A Pearson correlation coefficient was calculated between the different measurements 
of the same muscles and the associated confidence intervals were determined. A Bland Alt-
man plot was used to visualize the difference between the ultrasound and muscle mass ratio 
of the tibial muscle. To assess the validity and reliability of these measurements, the inter-rater 
and intra-rater reliability of this method was calculated using the inter-observer correlation 
(ICC). A p-value < 0.05 was considered statistically significant.
ResuLTs
After a short learning curve of approximately two weeks, tibial muscle images could easily 
be obtained using ultrasound by both examiners. The procedure did not take more than 10 
minutes per animal. Images of the ultrasound recordings are depicted in Figure 2.
Tibial muscle
Muscle atrophy obtained with the golden standard, muscle mass ratio, showed a steep de-
crease in the fourth week (32 ± 9% (SD)), followed by an increase of muscle mass with a ratio 
of 72 ± 6% in the 14th week and 78 ± 5% in the last follow-up week (Fig.3) The recovery of the 
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muscle force, depicted in Figure 4, showed recovery rates of 40 ± 4% in week 10, reaching up 
to 76 ± 8% in the 20th follow-up week. As the force was not powerful enough to produce mea-
sures in the first three follow-up weeks, no recovery rates of these weeks could be obtained. 
When relating ultrasound to muscle weight and muscle force, we found that ultrasound 
images from the tibial muscle showed the same pattern of atrophy followed by recovery of 
the muscle. Similar to muscle mass ratio, with ultrasound most atrophy was observed at week 
4 (44% ± 9%), followed by recovery reaching 76 ± 2 percent in the last follow-up week. The 
correlations between the ultrasound and the muscle mass and muscle force are depicted in 
Table 1. Ultrasound showed strong significant correlations with muscle weight for the tibial 
muscle (0.854 ± 0.06). The correlation between ultrasound and muscle force was lower (0.624 
± 0.17) but still highly significant (p<0.001).
Figure 2. ultrasonographic images of the tibial muscle.
The dotted line indicates the area of the muscle used to calculate the area of the tibial muscle of the healthy (Above, 
left) and operated leg (Above, right). The operated legs show a smaller surface area of the muscle than the healthy leg. 
The tibial muscle was measured 6 weeks postoperatively. At the bottom, the solid line indicates the muscle thickness 
measured in the gastrocnemic muscle at the healthy (Below, left) and operated side (Below, right).
Figure 3. The recovery of the tibial muscle mea-
sured with muscle mass ratio and ultrasound.
The recovery of the muscle shows the same trend in 
both evaluation methods, error bars = SEM.
Figure 4. The recovery of the tibial muscle 
measured with ultrasound and force.
The correlation between ultrasound and force was lower 
than ultrasound and weight. However, their significant 
correlation is 0.624, error bars = SEM.
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Gastrocnemic muscle
The recovery rates of the gastrocnemic muscle measured with ultrasound and muscle weight are 
displayed in Figure 5. Ultrasound recordings of the gastrocnemic muscle showed slightly lower 
values than for muscle weight. The lowest recovery rate was 40 ± 2% in week 4 with the ultrasound 
and a muscle mass ratio of 28 ±4 percent. The correlation between the ultrasound and muscle 
weight measurements of the muscle atrophy was high (0.893 ± 0.04), as depicted in Table 1.
Neuromuscular junctions
Staining of the motor endplates and myelinated axons visualized the denervation and re-
innervation of the muscles, as shown in Figure 6. Where the ultrasound and muscle mass 
ratio still shows high values in the second post-operative week, histology shows few axons 
and free endplates. Also, clubbing was observed, that is axonal sprouting which occurs first 
as an outgrowth of fine-beaded fibers ending as an axonal dilatation. This is a sign of nerve 
regrowth. This phenomenon was seen up till week 8. Free endplates were visible up till week 
4, in accordance with ultrasound where we observed an increase in the muscle mass starting 
in week 4. Motor endings formed by several motor arborizations were observed in week 6 and 
week 8 after nerve injury with reconstruction. Sprouting of the axons and poly-innervated 
motor endplates could be seen between the 6th and 16th week. Starting from week 14, the 
innervation of the muscle showed a more normalized pattern. This is also in accordance with 
our ultrasound finding where we saw a stabilization starting at the 16th week. Up till 20 weeks, 
poly-innervated motor endplates were observed. The muscle of the control side was also 
examined end showed no pathological changes in the innervation pattern.
Reliability
The reliability of the ultrasound recordings of the tibial muscle are depicted in Table 2. Both 
the inter-rater and intra-rater reliability were high. The Bland Altman plot (Figure 7) was cre-
ated to visualize the comparison between the two methods i.e. the ultrasound and muscle 
weight. The two techniques generally did not differ more than 10%, which shows a good 
overall reliability of these measurements.
Table 1. Correlation between Ultrasound, Muscle Weight and Isometric Tetanic Force for both muscles
Tibial muscle
Ultrasound
Correlation (95% CI) p
Muscle weight 0.854 (0.789-0.899) < 0.001*
Isometric Tetanic Force 0.624 (0.428-0.759) < 0.001*
Gastrocnemic muscle
Muscle weight 0.893 (0.844-0.927) < 0.001*
*Statistically significant correlation (p<0.05)
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Table 2. Validity and reliability of ultrasound re-
cordings of the tibial muscle
ICC (95% CI) p
intrarater reliability 0.974 (0.961-0.983) < 0.001*
interrater reliability 0.882 (0.825-0.921) < 0.001*
*Statistically significant correlation (p<0.05)
Figure 5. The recovery of the gastrocnemic mus-
cle measured with ultrasound and weight.
The recovery of the muscle shows the same trend in both 
evaluation methods, error bars = SEM.
Figure 6. Acetylcholinesterase staining to visualize the neuromuscular junctions.
(Left) Overview; a wholemount acetylcholinesterase stained rat tibial muscle, showing that this muscle is composed 
of one belly (original magnification x1.25). Note that the muscle has a single motor endplate band which is located 
in the middle portion of the muscle. (Center) Clubbing; re-innervated tibial muscle (week 8), showing two endplates 
on atrophic muscle fibers (original magnification x40) and two growing nerve fibers ending as growth clubs (arrow). 
(Right) Sprouting; re-innervated tibial muscle (week 14), showing a branching axon forming a double motor arboriza-
tion, assumed to supply one muscle fiber (original magnification x40). The thickness of the sections (50μm) causes 
part of the material to be out of the plane of focus at high magnification.
Figure 7. A Bland Altman plot of the two methods, muscle mass ratio and ultrasound.
The average value of the methods is displayed on the x-axis where the difference between the two methods is 
displayed on the y-axis. The plot shows a good overall reliability of the measurements and reasonably small limits of 
agreement. SD=standard deviation.
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discussiON
New applications for the use of ultrasound are studied and introduced in different research 
fields for various indications and implications[13, 14] as ultrasound is a non-invasive and an 
easy to use method. This study investigated the relation between muscle force, muscle weight 
and muscle diameter obtained with ultrasound to assess the functional motor nerve recovery 
in a rodent model after nerve injury with reconstruction. Ultrasonographic recordings in this 
study showed similar recovery of the muscle as shown by the muscle weight; the correlation 
between both measurements was 0.854 and 0.893, indicating strong relations between the 
ultrasound and muscle mass. A Bland Altman plot further confirmed that ultrasound and 
muscle weight have small limits of agreement. The muscle force and ultrasound findings 
showed lower but still highly-significant correlations (r=0.624). One possible explanation is 
that force does not relate as directly with ultrasound as muscle weight (i.e. more fibers, more 
force). This theory is further strengthened by the fact that during the first weeks of recovery 
the muscle weight gradually increased with delayed response intensity with the isometric te-
tanic force evaluation. Staining of the neuromuscular junctions shows the same denervation 
and re-innervation patterns of the muscles as observed with ultrasound, weight and force. 
Sprouting of the axons and poly-innervated motor endplates were visible until the sixteenth 
post-operative week, after which the pattern was normalized.
A systematic review of Wood et al[5] in 2011 explicitly stated the importance of the 
comparison of different outcome measures of peripheral nerve regeneration. They found an 
extensive battery of tests but poor correlations between most of them. Today, muscle mass 
ratio is generally accepted as the golden standard for the evaluation of nerve regeneration 
in experimental animal studies. Although the assessment is easy, we would like to emphasize 
that muscle force is closer to the real functional recovery. Shin et al. found that the sciatic 
foot index (SFI) as a non-invasive assessment did not significantly correlate with the isometric 
tetanic force or muscle weight[7]. These findings were also confirmed by Urbancheck et al[8]. 
Several other authors confirmed the lack of specificity of the SFI[4-6]. To our knowledge, no 
other methods than ultrasound have proven to be non-invasive, making it possible to obtain 
serial measurements and significantly correlate with other valid outcome measurements.
There are various ways to analyze the functional recovery after nerve trauma in animal 
experiments, which all have their advantages and disadvantages. This new non-invasive ul-
trasound method allows analysing functional motor recovery after nerve trauma in the same 
animal over time. The assessment is easy and could be performed in less than ten minutes. In 
future studies, ultrasound assessment can be executed without sacrificing the animal, leading 
to a reduction in the number of animals required for an experiment. Since the regeneration 
will be evaluated in the same animal, variation within a group will decrease. This will further 
reduce the number of animals needed in experimental studies on nerve reconstruction and 
simultaneously increase the power of the study. A combination can be made with other non-
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invasive measurements as the sensory pinprick test, to obtain an overall indication of nerve 
recovery.
A limitation of this present study is that animals where not measured over time to prove 
that this can also be reliable. In striving to achieve not only a reduction in the required number 
of animals needed, but also a reduction in variation, animal tests in nerve regeneration studies 
should preferably be non-invasive. These limitations notwithstanding, this study is the next 
step in creating non-invasive tests for the total analysis of the animal after nerve trauma with 
or without reconstruction.
cONcLusiONs
In conclusion, this study illustrates the purpose of the new, non-invasive method to analyze 
the functional recovery of the muscle after nerve reconstruction. This method proves to be a 
valid and reliable method to obtain the muscle atrophy and recovery of both the gastrocne-
mic and tibial muscles. Non-invasive evaluation techniques will reduce the required number 
of animals for experiments and will also reduce the variation within the study groups.
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ABsTRAcT
Purpose Commercially available processed nerve allografts have shown to be inferior 
to autografts in previous animal studies. We hypothesized that combining different process-
ing and storage techniques will result in improved nerve ultrastructure preservation, lower 
immunogenicity and minimize cellular debris. Different processing protocols were evaluated 
which included chemical detergents, enzymes and irradiation, with the addition the enzyme 
Elastase and cold or frozen storage was used. The goal of this study was to create an optimized 
nerve allograft.
methods Fifty rat nerves were decellularized with modifications of previous protocols 
and the addition of Elastase. Subsequently, the nerve segments were stored at either 4 or 80°C. 
Both processed and fresh control nerves were analyzed with confocal microscopy using im-
munohistochemical stainings on the basal lamina (laminin γ-1), Schwann cells (S100-protein) 
and immunogenicity (MHCI). Morphology of the ultrastructure and amount of cellular debris 
was analyzed on cross sections of the nerves stained using toluidine blue staining, H&E stain-
ing and electron microscopy.
Results  Nerve ultrastructure was preserved with all decellularization protocols. 
Storage at -80°C severely altered nerve ultrastructure after any decellularization method. 
Elastase was found to significantly reduce the immunogenicity and amount of Schwann cells, 
while maintaining good structural properties.
conclusion Reduced immunogenicity, diminished cellular debris and the elimination 
of Schwann cells was observed when Elastase was added to the nerve processing while main-
taining ultrastructure. Storage at -80°C after the decellularization process heavily damaged 
the nerve ultrastructure as compared to cold storage. Further in vivo studies need to prove 
the nerve regenerative capacity of these optimized allografts.
107
Decellularization nerve allograft rat - in vitro
7
iNTROducTiON
Segmental peripheral nerve injures are devastating, life altering injuries [1]. Injuries with 
extensive damage require excision of the damaged nerve and a bridging segment (i.e. nerve 
graft) to provide a tension-free nerve reconstruction [2, 3]. To date, the nerve autograft rep-
resents the gold standard for reconstruction of extensive nerve damage [2]. Nerve autografts 
are accompanied by significant donor side morbidity. Limitations in cross-sectional area, 
length and supply preclude optimal reconstructive options and often require prioritization 
of reconstructive goals[4, 5]. As such, throughout decades of research, alternatives have been 
proposed, developed and implemented. Within the arsenal available, the surgeon can now 
choose between synthetic biocompatible conduits, autologous non-nerve tissues (i.e. vein, 
muscle), processed allografts and autologous nerves [2, 6].
One of the alternatives to bridge nerve gaps is with allografts. Allograft reconstruction has 
the advantage of mitigating donor side morbidity as well as having an unlimited supply and 
length of graft. A processed nerve allograft should not induce an immune reaction. Reduction 
of graft immunogenicity can be accomplished by eliminating cellular constituents, resulting 
in a little to absent immune reaction (13,14). Remaining debris will also reduce or inhibit nerve 
regenerative capacity since debris may result in a fibrotic intra-luminal occlusive blockade. 
Further enhancement of the regenerative capacity of the graft can be accomplished by the 
preservation of native extracellular matrix. The overall goal of nerve decellularization is to 
remove all cellular elements except the basal lamina – thus removing any immunogenicity 
of the tissue, as illustrated in Figure 1. Aggressive processing will diminish immunogenicity 
but will also alter the structural properties. The optimal balance between removing cellular 
remnants while maintaining structural properties needs to be determined.
Figure 1. Nerve graft and hypothesized nerve allograft.
The ultimate goal of processing a nerve allograft is to remove all cells and cellular debris, which are targeted in an 
immune response while preserving the extracellular matrix
Chapter 7
108
The current available processing protocols have been studied extensively and a standard 
processing protocol is available. Regularly used protocols comprise a complex algorithm of 
steps including chemical detergents, irradiation and cryopreservation [7]. The basics of this 
protocol are the essentially the foundation of decellularization of nerves and have only been 
slightly modified by numerous investigators [8]. Given the fact that current processed allograft 
studies (both experimental as clinical) demonstrate inferior results to autografts, we sought 
to determine if the addition of Elastase to the processing would improve decellularization 
[9]. Elastase is an enzyme, which destructs proteins by deconnecting peptide junctions and 
breaking down elastin. It has been successfully used in the decellularization of other tissues 
than nerves; for instance in heart valve and cartilage decellularization [10, 11]. Currently all the 
clinical available allograft conduits are frozen upon use. In addition to optimizing the decel-
lularizing process, the effect of frozen storage versus cold storage on the effect of processed 
nerve grafts has not been adequately evaluated.
The purpose of this in vitro study was twofold. First, to study the effect of Elastase on the 
decellularization of rat nerve tissue, and second to evaluate the effect of storage, either frozen 
or cold. We hypothesized that the addition of Elastase will allow the extracellular matrix to be 
preserved with a minimal amount of debris. Determination of the optimal storage technique 
(e.g. cold or frozen) in addition to optimization of the decellularization process would allow for 
the optimal nerve allograft for the reconstruction of large peripheral nerve defects.
meThOds
After approval by our institutions the Institutional Animal Care and Use Committee (IACUC), 
twenty-five Sprague-Dawley rats, weighing 250-350 grams (Harlan, Indianapolis, IN), were 
used. After initial Isoflurane induction, all animals were sacrificed with an overdose of pen-
tobarbital. Bilateral, 15 mm nerve segments of the sciatic nerve were aseptically harvested. A 
total of 50 nerve segments were collected.
experimental design
A total of 5 groups were compared in this study. All groups consisted of 10 nerves. The first 
group was processed following the standard protocol based on previous studies[7-9]. The 
second and third group underwent the same processing only with the addition of the en-
zyme Elastase in two different time periods (i.e. 8 and 16 hours) (group2 & 3). The effect of 
freeze storage (-80°C) was also studied in group 4. A native unprocessed nerve (group 5) was 
analyzed as a negative control. An overview of the studied groups is depicted in Table 1.
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Nerve allograft processing
Briefly, nerves segments were immediately after harvest placed in RPMI 1640 solution at 4 
°C over night. The next day the nerve tissues were placed in deionized distilled water. After 8 
hours, the water was replaced by a solution containing 125 mM sulfobetaine-10 (SB-10), 10 
mM phosphate, and 50 mM sodium. The nerves were agitated for 15 h and rinsed for 15 min 
in a washing solution of 10 mM phosphate and 50 mM sodium. Next the washing solution 
was replaced by a solution containing 0.14% Triton X-200, 0.6 mM sulfobetaine-16 (SB-16), 
10 mM phosphate, and 50 mM sodium and agitated for 24 h. Next the tissues were rinsed 
with the washing solution 50 mM phosphate and 100 mM sodium. The washing solution was 
replaced by SB-10 solution and the nerves agitated for 8 h. Next they were washed once using 
the washing solution and put into a solution of SB-16/Triton X-200. The nerves were agitated 
for 15 h and then washed in a solution containing 10 mM phosphate and 50 mM sodium. 
Subsequently, nerves were incubated in a solution containing 2 U/ml Chondroitinase ABC 
for 16 h at room temperature and then washed in a solution containing 10 mM phosphate 
and 50 mM sodium. In the Groups 2 – 4 nerves, which underwent Elastase treatment, were 
incubated in a solution containing 0.05 U/mL Elastase at 37 °C for 8 (group 2) or 16 hours 
(group 3 and 4). After that, the nerves were sterilized with gamma radiation of 2.5 kGray.
storage
As previously described and successful in other fields, tissue was freeze-stored [9]. Nerve seg-
ments were stored in Ringers solution at -80°C for the freeze storage (group 4) for a duration 
of two weeks before final analysis. The other storage method was cold storage (4°C) where 
nerves were placed in PBS solution.
Outcome analysis
Structure
A 5 mm section of each nerve segment was fixed in 2% Trump’s solution (37% formaldehyde 
and 25% glutaraldehyde). 1 µm thin sections were transversally cut and stained with 1% 
toluidine blue. Another 5 mm section of each nerve segment was suspended in OCT, fast 
frozen and 5 µm transverse sections were cut. Nerve sections were stained with hematoxylin 
Table 1. Experimental design
Group Treatment storage
I Standard Cold (4 °C)
II Standard + Elastase (short) Cold (4 °C)
III Standard + Elastase (long) Cold (4 °C)
IV Standard + Elastase (long) Freeze (-80 °C)
V Un-processed/native nerve No
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and eosin (H&E). Digital images of each sample were taken using a microscope digital camera 
(Nikon microscopy digital color camera 4.0 mega pixels, Melville, New York). The organization 
of the basal lamina was visualized with a laminin staining as described below. For electron 
microscopy, ultra-thin section were cut (500 A), placed on copper grids (200 mesh, EMS, 
Philadelphia, PA) and stained with uranyl acetate (EMS) and lead citrate (EMS). Sections were 
examined under a JEOL 1400 transmission electron microscope (JEOL Ltd, Peabody, Mas-
sachusetts, USA). All sections were scored for their structural properties on a 1-5 scale with 
1 being worst and 5 being optimal. Three independent and blinded investigators performed 
the analysis. Validity and reliability of the objective analysis was determined with an intra-class 
correlation of 0.83 (95% CI; 0.71-0.90).
Remnants (Axons and immunogenicity)
Intraluminal remnants were examined with immunohistochemical (IHC) stainings on different 
components of the nerve allograft. Nerve segments were pre-fixed with 4% cold paraformal-
dehyde and fast frozen. Transverse frozen sections (5 µm thickness) were cut. To identify the 
remnant axons left in the graft, a S100 staining was performed. To study the immunogenicity 
of the graft after processing, MHC-I was stained. Additionally, laminin was stained to identify 
the basal laminae. The IHC staining procedure was performed using the Leica Bond III Stainer 
(Leica, Buffalo, IL). The sections were post fixed in 4% paraformaldehyde and retrieved on-
line using Epitope Retrieval 1 (Leica, Buffalo, IL) for 5 minutes. The primary antibodies used 
are as follows: polyclonal S100 anti-rabbit (Dako) was used at 1:5000, polyclonal laminin y1 
anti-rabbit (Sigma) was used at 1:200, mouse anti-MHCI (Clone OX18, Novus Biological) was 
used at 1:100. All antibodies were incubated for 60 minutes. The detection system used was 
Research detection (Leica DS9455). This system includes the Protein Block (Dako X0909) and 
secondary antibody AlexFluor488. All sections were nuclear stained with Hoechst33342 
(Invitrogen H1399). Once completed, slides were removed from stainer and rinsed for 5 
minutes in distilled water. Slides were coverslipped using ProLong Gold antifade media (In-
vitrogen). Nerve slides were examined under a fluorescence laser confocal microscope (LSM 
780, Zeiss, Germany) and pictures were captured with a camera. The intensity of stainings in 
the cross section of the nerve was measured with Image J software (NIH, Bethesda, USA) to 
quantify the different stainings.
statistical Analysis
Data were expressed as mean ± SEM. For structural analysis, the results of the three different 
observers and the three different stainings were averaged to score the structural properties. 
Statistical analysis of the differences between the groups was performed with one-way analy-
sis of variance (ANOVA) followed by Bonferroni post hoc test with GraphPad Prism 5 software 
(GraphPad Software, CA, USA). P-values < 0.05 were considered to be significant.
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ResuLTs
An overview of the different stainings is depicted in Figure 2 and a summary of the results in 
Table 2.
1. enzymatic decellularization
Structure: score
The structure of the nerve graft was not significantly influenced by the addition of Elastase to 
the decellularization protocol. Group I, the standard protocol, showed a score of 3.9 ± 0.2 and 
group II, with the addition of Elastase, 3.5 ± 0.1. There was no significant difference between 
the groups. A longer exposure of the enzyme, group III, did not influence the structure of the 
nerve graft (3.2 ± 0.1). There was no statistical difference between the groups (Fig. 3).
Table 2. Summary of results of the effect of Elastase and freeze storage on different components of the 
nerve segments
elastase Freeze storage
sT
Ru
cT
u
Re structure = ↓
Laminin = =
Re
m
N
A
N
Ts Axons ↓ ↑
immunogenicity ↓ ↑
Figure 2. Overview of different staining for group iii, iV and V.
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Structure: Laminin
The same was observed when the intensity of the laminin was determined. The enzyme did 
not significantly reduce the presence of laminin in the nerve. Group I (standard protocol) had 
a laminin intensity of 65.7 ± 8.6, group II (with Elastase) 53.22 ± 6.2 and the group with a longer 
exposure to Elastase, group III had a score of 51.5 ± 3.3. No significant difference between 
those three groups was observed (p=0.20).
Remnants: Axons
Axons were significantly reduced by the addition of the extra enzymatic step (group I; 9.5 ± 
1.0, group II; 5.0 ± 0.5). Prolonged exposure to Elastase (group III) showed an even lower score 
of axons (3.2 ± 0.4). The difference between the groups was statistically significant (p<0.0001) 
(Fig. 4).
Remnants: Immunogenicity
Elastase had a similar significant effect of reduction of the remnants when evaluating im-
munogenicity. The standard protocol without the enzyme (group I) had an MHCI score of 18.2 
± 1.8, the addition of Elastase reduced the MHCI score to 9.3 ± 1.0. The observed differences 
were significant, p<0.0001 (Fig. 5).
2. storage
Structure: score
The effect of cold or freeze storage at either 4°C or -80°C showed a tremendous effect on the 
structure of the graft. When frozen, the total score for the structure significantly decreased 
from 3.2 ± 0.1 (Group III) to 1.6 ± 0.2 in Group IV for the rat nerves. The effect of storage was 
visualized with electron microscopy in Figure 6.
Figure 3. staining Axons. The axons, visualized 
with the S100 staining, show a decrease in Group 
III and IV when treated with elastase.
Figure 4. staining immunogenicity. The im-
munogenicity of the nerve grafts, visualized with 
MHCI staining, show a decrease with addition of 
Elastase.
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Structure: Laminin
Storage had no significant effect on the laminin intensity staining. The score of group III (51.49 
± 3.31) was not significantly different compared to the frozen group (IV) 63.67 ± 2.4, p=0.20.
Remnants: Axons
When looking at the effect of storage on the intraluminal remnants, it was demonstrated 
that the cold storage nerves contained a significantly lower amount of axons, stained with 
S100 compared to the frozen nerves. The effect of storage was statistically significant different. 
(Group III 3.2 ± 0.3, were the freeze storage (group IV) was higher 5.7 ± 0.3 (Fig. 4).
Remnants: Immunogenicity
The effect of cold or freeze storage at either 4°C or -80°C showed a severe effect on the struc-
ture of the graft. The immunogenicity in the rat nerves of the cold storage group (III), stained 
with MHCI, were statistically significant different (9.3 ± 1.0) from the frozen storage (group IV 
20.8 ± 1.2) as depicted in Figure 5).
Figure 5. staining structure. The structure score 
of the nerve grafts was not significantly influenced 
by the enzyme. Frozen storage of the grafts signifi-
cantly reduced the score.
Figure 6. scanning electron microscopical images of the nerve graft. Native nerve (left), cold pre-
served nerve allograft: group II (middle), frozen nerve allograft: group III (right)
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discussiON
This study demonstrated that the enzyme Elastase reduced immunogenicity, diminished cel-
lular debris and cleared Schwann cells better while maintaining the ultrastructure compared 
to standard decellularization protocols. Storage at -80°C after the decellularization process 
heavily damaged the nerve ultrastructure compared to cold storage. Currently available 
nerve allograft processing techniques are not sufficient enough to create nerve allografts that 
can truly challenge the nerve autograft in the clinical setting. Creating a nerve allograft has 
therefore been the subject of multiple studies[12] [7] [8] [13].
Knowledge of the ultrastructural anatomy of a peripheral nerve is key to the understanding 
the concept of nerve allograft transplantation. There are two domains in the ultrastructure: 
an internal basal lamina (BL), and an external fibrillar matrix. The BL faces, and is linked to 
,cellular membranes and its components typically include laminin heterotrimers, collagens, 
nidogen or entactin and poreoglycans. The exact molecular assortment of the BL is cell-
specific[14]. Schwann cells, undoubtedly, are essential for myelination and are responsible 
for the fast conducting signaling. It has been shown that preservation of the basal lamina 
is necessary to support the host Schwann cells and direct new axon sprouts [15]. Without 
laminin, Schwann cells cannot differentiate into a myelinating phenotype [16]. Their relation 
is essential for a structured conducting pattern. Previous studies showed that in mice lacking 
the laminin γ-1 gene, axon sorting and myelination is derailed, affecting the capacity of axons 
to regenerate [16]. In addition to its presence, the organization of the basal membrane is of 
paramount importance in supporting regeneration. Fragmentation of the basal lamina has 
been demonstrated using electron microscopy after chronic denervation. The progressive 
fragmentation of the basal membrane is negatively correlated with the re-innervation [17]. 
Therefore, evaluating the integrity of the basal membrane is fundamental to determine the 
ideal processing technique to create a nerve allograft.
This study demonstrates the effect of modifications to the standard processing techniques 
in a rat model. Modifications to the processing protocol should not disrupt the presence and 
organization of the basal lamina, but should reduce the remnant debris and axons. The stan-
dard processing technique was modified by addition of an extra enzymatic step. The enzyme 
Elastase was hypothesized to remove more of the remnants cells and debris by disrupting 
the tight junctions[11]. In this study both the organization and the presence of laminin was 
studied. When evaluating the amount of axons remaining in the nerve graft, the addition of 
Elastase showed a significant reduction of S100 expression. Longer exposure to the enzyme 
did not significantly further reduce the cellular remnants in the rat nerves. The immunoge-
nicity of the grafts was also reduced by the addition of the enzyme. The elastase processed 
nerves provided a nerve allograft with reduced cellular remnants resulting and preservation 
of the ultrastructure.
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The addition of Elastase reduced the amount of axons in the nerve allograft by 66.3%. The 
immunogenicity was reduced by 48.9% when the enzyme was added to the decellularization 
process. By freeze storage of the nerve allograft the structural score was reduced by 50.0% 
when compared to the cold stored allograft. The effect of both the Elastase and storage on 
the allograft was significantly different.
Previously produced nerve allografts were preserved at -80°C[10]. In other research fields 
(bone allograft studies), the allograft structure is less fragile than the nerve tissues and toler-
ates freezing preservation better than nerve tissue[10]. The destructive effect of freezing of 
nerve tissues was found in our study. The freeze stored processed nerve allograft proved to 
have significant worse structure compared to the cold stored preservation. In Figure 3 the 
difference between the two studies storage methods is demonstrated. It can be appreciated 
that the ultrastructure of the nerve, still visible in the cold stored nerve, is severely destructed 
in the frozen stored nerve. The structure can almost no longer be observed.
We recognize the limitations of this study, in particular that the effect of the processing is 
only investigated in vitro. The neuroregenerative effect of our proposed processing and stor-
age of the allograft still needs to be studied in an in-vivo animal model. Furthermore, it could 
be argued that more groups need to be investigated. For instance different temperatures 
could be incorporated in this study. We choose to use two temperatures 4 and -80°C as these 
are the most commonly used temperatures in clinical setting. To maintain power for this study 
we only used five different groups.
These limitations notwithstanding, we have clearly demonstrated that the addition of the 
enzyme Elastase to nerve processing resulted in maintenance of the nerve ultrastructure 
while significantly reducing immunogenicity, diminished cellular debris and Schwann cells 
compared to standard decellularization protocols. Additionally, we demonstrated that stor-
age at -80°C after the decellularization process heavily damaged the nerve ultrastructure as 
compared to cold storage at 4°C. We have been able to improve the ultrastructure while re-
ducing further the immunogenic capacity of the nerve allografts in this study by the addition 
of the enzyme Elastase and modification of storage after nerve processing. Further research 
should focus on the neuroregenerative effect of by this means optimized nerve allografts in 
an in vivo study.
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ABsTRAcT
Background Nerve allograft reconstruction has been extensively studied but clinical 
results remain inferior to the gold standard of the nerve autograft. Previous studies focused 
on optimization of nerve allograft processing but were limited to rat nerve tissue, prior to 
use on human nerve tissue. The purpose of this study was twofold: first, to determine the 
optimal processing technique using elastase in the both motor and sensory human nerve 
and second, to determine the effect of storage temperature on the elastase processed human 
nerves.
methods Seventy human nerve segments were used in this in vitro study. The enzyme 
elastase was added to the standard decellularization protocol. Additionally, the effect of either 
cold or frozen storage was tested. All nerve segments were immunohistochemically stained 
on basal lamina (laminin γ-1), Schwann cells (S100 protein) and immunogenicity (major his-
tocompatibility complex class I) and analyzed with confocal microscopy. The preservation of 
the ultrastructure of the nerve segments was analyzed with toluidine blue, H&E staining and 
electron microscopy.
Results  The addition of the enzyme had a positive effect on the decellularization 
process of the nerve allograft. The immunogenicity and remnants of the nerve grafts were 
significantly reduced. Increased concentration of the detergents did not show a beneficial 
effect on the human nerve allografts. Storage of the nerve segments at minus 80 degrees 
Celsius resulted in a lower structural score when compared to cold storage. Motor nerve had 
better structural properties after processing when compared to the sensory nerve allografts.
conclusion This study investigated the effect of elastase on the processing of a human 
nerve allograft and tested different storage temperatures. The addition of an extra enzymatic 
step to the processing of the allograft reduced immunogenicity and remnants in the nerve 
allograft with preservation of the ultrastructure. Frozen storage of the nerve allograft severely 
altered the structure. These conclusions are in line with the findings of processing in rat tissue. 
Human motor nerves were better preserved when compared to sensory nerves. We recom-
mend a new processing technique, with the addition of elastase, cold storage and use of 
motor nerves to engineer a human nerve allograft.
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iNTROducTiON
The segmental loss of peripheral nerve may result from open or closed extremity trauma, 
resection of benign or malignant primary nerve tumors, or limb-sparing tumor surgery. 
Currently available reconstructive options include vascularized and conventional (non-
vascularized) nerve autografts, nerve conduits from a variety of materials, nerve allografts 
and nerve transfers[1, 2]. Of these, autografting remains the gold standard. However, available 
autogenous nerves are limited in length, diameter and number limiting their ability to recon-
struct segmental loss of major peripheral nerves. In addition, their harvest results in significant 
donor site morbidity as well[3]. Among the possible options for reconstruction, processed 
nerve allograft is a promising alternative to nerve autografting[1].
A nerve allograft more closely mimics the structural properties of a nerve without the need 
to sacrifice healthy nerve tissue with the consequent donor site morbidity. Furthermore, the 
allograft is theoretically unlimited in both supply and length. During the early introduction of 
the use of unprocessed nerve allografts the use of immunosuppressive drugs was required[4, 
5]. With advances in processing techniques, cellular components have been minimized 
resulting in substantially decreased immunogenicity of the nerve grafts[6]. This has allowed 
the use of decellularized allografts without immunosuppression. However, current results of 
commercially available nerve allografts remain unsatisfactory[1, 7, 8]. The balance between 
eliminating cellular remnants while maintaining structure is key in the optimization of nerve 
allograft processing. Our group significantly improved this technique for allograft processing 
in rodents, stressing this balance. It was found that the addition of an enzyme resulted in 
a decrease in cellular remnant (i.e. both axons and immunogenicity) while preserving the 
ultrastructural components of the nerve. The effect of cold storage was compared to freeze 
storage as commercially available allografts are all frozen upon use. A striking difference with 
regard to the extracellular matrix was found when freeze stored.
Previous studies evaluating motor nerve reconstruction have demonstrated inferior out-
comes with sensory or mixed nerves compared to motor nerves when reconstructing a mo-
tor nerve defect[9]. This phenomenon is referred to as modality-specific regeneration[9-11]. 
Although different researchers addressed this difference, this hasn’t been translated to the 
production of nerve allografts, and in fact a majority of commercially available nerve allografts 
are sensory in origin. Additionally, previous studies have focused solely on rodent nerve tis-
sues and the processes optimized for the rodent nerves were then applied to human nerves. 
The purpose of this study was twofold: first, to determine the optimal processing technique 
using elastase in the human nerve (motor and sensory) and second, to determine the effect 
of storage temperature on the elastase processed human nerves.
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meThOds
The Institutional Review Board of our institution approved this study. For obtaining the hu-
man nerve segments, motor and sensory nerves were harvested from recently deceased 
donors. Exclusion criteria for the donors were diabetes, peripheral neuropathies and previous 
surgeries or irradiation at the donor site. Also, nerves needed to be harvested within 4 hours 
post mortem. The sural (sensory), thoracodorsal (motor) and long thoracic (motor) nerves were 
aseptically harvested and cut into 15 mm segments. A total of 70 human nerve segments 
were obtained.
experimental design
A total of seven groups were compared, each consisting 10 nerves. Within each group 5 nerve 
segments of a sensory nerve and 5 segments of a motor nerve were included. The first group 
was processed following the standard protocol based on previous studies[12-15]. Each group 
has an additive compared to the previous group. Group 2 and 3 underwent the similar pro-
cessing with the addition of the enzyme Elastase in two different exposure times (i.e. 8 and 16 
hours). The effect of freeze storage (-80°C) was studied in group 4. Group 5 and 6 were treated 
with a higher concentration of the detergents with either cold (group 5) or freeze (group 6) 
storage. In group 7 an unprocessed, native nerve was analyzed (negative control). In Table 1 
an overview of the experimental groups is depicted.
Nerve allograft processing
After sterile, aseptic harvest, nerve segments were directly placed in RPMI 1640 solution at 4°C. 
The following day nerve segments were put in deionized distilled water. After 8 hours, nerves 
were placed in a solution containing 125 mM sulfobetaine-10 (SB-10), 10 mM phosphate, and 
50 mM sodium. Nerves were agitated for 15 hours and rinsed in a washing solution (10 mM 
Table 1. experimental design. A total of 7 experimental groups were studied with a different process-
ing treatment and cold of frozen storage. Each group contained a total of 10 nerve segments (5 sensory 
and 5 motor nerve segments).
Group Treatment storage
I Standard Cold (4 °C)
II Standard + Elastase (short) Cold (4 °C)
III Standard + Elastase (long) Cold (4 °C)
IV Standard + Elastase (long) Freeze (-80 °C)
V Standard (high) + Elastase (long) Cold (4 °C)
VI Standard (high) + Elastase (long) Freeze (-80 °C)
VII Un-processed/native nerve No
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phosphate and 50 mM sodium) for 15 min. Next, nerves were placed in a different solution 
(0.14% Triton X-200, 0.6 mM sulfobetaine-16 (SB-16), 10 mM phosphate, and 50 mM sodium) 
and agitated for 24 hours. Subsequently tissues were rinsed with the washing solution (50 mM 
phosphate and 100 mM sodium) after which the nerves were agitated in the SB-10 solution 
for 8 hours. The nerves were washed with the washing solution again and agitated in the 
SB-16/Triton X-200 solution for 15 hours and then washed in a solution (10 mM phosphate 
and 50 mM sodium). For groups 6 and 7 a higher concentration of the detergents was used 
(250 mM SB-10, 1.2 mM SB-16 and 0.14% Triton X-20). For the first enzymatic step segments 
were incubated in a solution with 2 U/ml Chondroitinase ABC for 16 hours after which they 
were washed in a solution (10 mM phosphate and 50 mM sodium). In the groups II – VI, with 
the enzyme Elastase, nerves were incubated in a solution containing 0.05 U/mL Elastase for 8 
(group II and V) or 16 hours (group III and VI) at 37°C. After processing, nerves segments were 
sterilized with 2.5 kGray gammaradiation.
storage
After processing nerve segments were either cold (4°C) of freeze (-80°C) stored. For the freeze 
storage nerve segments were stored in Ringers solution at -80°C (group IV and VI). For the 
other groups, nerves were placed in PBS solution and cold stored (4°C). Nerves were stored 
for the duration of two weeks before the analysis.
Outcome analysis
Structure
Nerves were cut in 5 mm segments fixed in 2% Trump’s solution (37% formaldehyde, 25% 
gluteraldehyde). After embedding, 1 µm thin sections were transversally cut and stained with 
1% toluidine blue. Another 5 mm of the nerve segment was suspended in OCT, fast frozen and 
transverse sections were cut (5 µm). The sections were stained with hematoxylin and eosin (H&E). 
Digital images of each sample were made using a microscope (Nikon microscopy digital camera, 
Melville, New York). A laminin staining, described below, was used to visualize the organization 
of the basal lamina. Electron microscopy was performed on ultra-thin section (500 A) stained 
with uranyl acetate and lead citrate. Sections were visualized with a JEOL 1400 transmission 
electron microscope (JEOL Ltd, Peabody, Massachusetts, USA). The structural properties of all 
sections were scored on a 5-point scale ranging for 1 (worst) to 5 (optimal). Three independent 
and blinded investigators performed the analysis. Validity and reliability of the objective analysis 
was determined with an intra-class correlation of 0.74 (95% CI; 0.59-0.83).
Remnants (Axons and immunogenicity)
Intraluminal remnants, axons and immunogenicity, were examined with immunohistochemical 
stainings (IHC) on different elements of the nerve allografts. Pre-fixation with 4% cold parafor-
maldehyde was used after which nerve segments were fast frozen and cut in transverse sections 
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of 5 µm. A S100 staining was performed to identify remnant axons in the nerve segment. A 
MHC-1 staining was used to analyze the immunogenicity of the nerve after processing. Ad-
ditionally, to identify the basal laminae a laminin staining was performed. All IHC stainings were 
performed with a Leica Bond III Stainer (Leica, Buffalo, IL). Nerve sections were post fixed with 
4% paraformaldehyde and retrieved on-line using Epitope Retrieval 1 (Leica, Buffalo, IL) for 5 
minutes. The primary antibodies used are: polyclonal S100 anti-rabbit (Dako) was used at 1:5000, 
polyclonal laminin y1 anti-rabbit (Sigma) at 1:200 and mouse anti-MHCI (Clone EP1395Y, Novus 
Biological) were used at 1:200. The antibodies were incubated for 1 hour. The Research detection 
system (Leica DS9455) was used which included the Protein Block (Dako X0909) and second-
ary antibody AlexFluor488. A Hoechst33342 nuclear stain was used on all sections (Invitrogen 
H1399). Slides were coverslipped with ProLong Gold antifade media (Invitrogen). All nerve slides 
were analyzed with a fluorescence confocal microscope (LSM 780, Zeiss, Germany) and images 
were captured with a digital camera. The intensity of stainings on the cross section of the nerves 
were analyzed with Image J software (NIH, Bethesda, USA).
statistical analysis
All data were presented as mean ± SEM. To score the structural properties, the results of the 
three different observers and the three different stainings were averaged. Statistical analysis 
of the differences between the groups was performed with one-way analysis of variance 
(ANOVA) followed by Bonferroni post hoc test. For difference between nerve types additionally 
a two-way ANOVA analysis was performed. GraphPad Prism 5 software (GraphPad Software, 
CA, USA) was used. A p-value < 0.05 was considered statistically significant.
ResuLTs
An overview of the results is depicted in Table 2.
1. enzymatic decellularization
The effect of Elastase on the decellularization process was analyzed by comparing group I 
(standard protocol) with group II (standard protocol with Elastase). A longer exposure to the 
enzyme was studied with group III.
Structure: score
The structure of the nerve grafts was not significantly reduced by the addition of the extra 
enzymatic step (p=0.09). In group I, standard protocol, the score was 3.2 ± 0.2 whereas in 
group II, with Elastase, the score was 3.1 ± 0.3. Longer exposure to the enzyme, group III, 
did also not significantly influence the structural score (3.2 ± 0.3). The unprocessed nerve 
segments scored 4.9 ± 0.1 (Fig. 2).
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Structure: Laminin
Laminin in the processed nerve grafts in the standard protocol group I had a score of 63.0 ± 
6.1. Addition of Elastase (group II) had a score of 58.6 ± 4.7. Longer exposure to the enzyme 
(group III) resulted in a score of 43.17 ± 3.6. These differences were not statistically significant 
(p=0.02) (Fig. 3).
Remnants: Axons
The axons in the nerve grafts, identified with the S100 staining had a score of 6.3 ± 0.9 in 
standard protocol group I (Fig. 4). In group II this was 6.8 ± 1.2 and for group III 5.9 ± 0.7. In 
comparison, the S100 expression in the native nerve was found to be 44.6 ± 3.0. There were 
no statistical significant differences between group I-III (p=0.80).
Table 2. effect of processing on different components of the nerve allograft.
The effect of Elastase, freeze storage and higher concentration of detergents is visualized for the different outcome 
measurements structure (i.e. structural score and laminin staining) and remnants (axons stained with S100 and im-
munogenicity with MHCI).
elastase Freeze storage high conc. detergents
sT
Ru
cT
u
Re structure
= ↓* =
Laminin
= = ↓*
Re
m
N
A
N
Ts Axons
↓ = =
immunogenicity
↓ = =
* for statistical significant differences
Figure 2. structural scoring. The structural proper-
ties were scored for the different groups. In group IV 
and VI a significant lower score was observed.
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Remnants: Immunogenicity
The immunogenicity of the nerve graft processed with the standard protocol (group I) was 
6.3 ± 0.5. With addition of the enzyme (group II) this was 6.3 ± 0.7. Longer exposure to the 
enzyme (group III) resulted in a score of 4.5 ± 0.5. The differences showed a trend with a p 
value of 0.055 (Fig. 5).
Figure 3. Laminin staining of all nerve segments.
The laminin was scored and showed a significantly lower 
score in the frozen allograft group C/IV (and F/VII).
Figure 4. staining of axons with s100.
The amount of axons in the processed allograft were as-
sessed with the S100 staining.
Figure 5. staining of immunogenicity on mhci.
The immunogenicity of the processed allograft was inves-
tigated with the MHCI staining. In the group with a longer 
exposure to the enzyme Elastase a reduction of the MHCI 
was observed.
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2. higher concentration detergents
To evaluate the effect of the higher concentration of detergents group III and V will be com-
pared (cold storage with low and high concentration of detergents) and group IV will be 
compared with group VI (freeze storage with low and high concentration of detergents).
Structure: score
The structural score of the processing with a higher concentration of detergents, group V, 
was lower (2.8 ± 0.2) compared to group III (3.2 ± 0.3). This comparison could also be made in 
the freeze storage group with high concentration of detergents (group VI) which scored 1.5 
± 0.1 compared to group IV with a score of 1.6 ± 0.2. Both comparisons were not significant 
different (Fig. 2).
Structure: Laminin
Laminin was significantly lower in the high concentration detergents group VI (39.1 ± 4.5) 
compared to group IV (63.7 ± 3.7) (p=0.01). In the two cold storage groups, the high concen-
tration group V scored 60.7 ± 5.3 and the lower concentration (group III) scored 43.2 ± 3.6, this 
comparison was not significant (p=0.17) (Fig. 3).
Remnants: Axons
The axons in group III scored 5.9 ± 0.7 compared to the higher concentration detergents in 
group V (4.9 ± 1.1). In the freeze storage group VI the score was 2.8 ± 0.2 compared to Group 
IV 5.7 ± 1.0. Both comparisons showed no statistical differences between the groups (p=0.9 
and 0.13 respectively) (Fig. 4).
Remnants: Immunogenicity
A higher concentration of detergents had no significant influence on the immunogenicity of 
the nerve grafts (p=0.9). Group III, V, IV and VI scored respectively 4.5 ± 0.5, 4.7 ± 0.8, 4.7 ± 0.5 
and 4.5 ± 0.8 (Fig. 5).
3. storage
To evaluate the effect to structure on the nerve grafts group III (cold storage) will be compared 
with group IV (freeze storage).
Structure: score
The effect of cold (4°C) or freeze storage at -80°C showed a tremendous effect on the structure 
of the graft. The freeze storage (group IV; 1.6 ± 0.2) was lower than group III (3.2 ± 0.3). This 
difference was statistically significant (p=0.01) (Fig. X). In comparison, an unprocessed, native 
nerve, had a score of 4.9 ± 0.1 (Fig. 2).
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Structure: Laminin
Laminin scores in the cold storage group III were 43.2 ± 3.6 compared to the freeze group IV 
with a score of 63.7 ± 3.7. This difference was significant (p<0.01) (Fig. 3).
Remnants: Axons
The axons in group III were 5.9 ± 0.7 which was not significant different from group IV (5.7 ± 
1.0). No significant difference between the groups was observed (p=0.89) (Fig. 4).
Remnants: Immunogenicity
Storage had no significant influence on the immunogenicity, visualized with MHCI (p=0.81). 
Group III had a score of 4.5 ± 0.5 and group IV showed a score of 4.7 ± 0.5 (Fig. 5).
4. difference motor and sensory nerves
Each group consisted 5 sensory and 5 motor nerve segments. The difference between motor 
and sensory nerves was analyzed with a two-way ANOVA. Regarding the structural proper-
ties of the nerve segments a statistically significant difference was found (p=0.03) between 
the motor and sensory nerve favoring the motor nerve segments. The laminin scores were 
not statistically different (p=0.71). The axons were also statistically different (p=0.01). The 
immunogenicity of the nerve segments, stained with MHCI, was also different between the 
two different nerve types (p<0.001). A greater reduction in immunogenicity was seen in the 
processed motor nerve segments.
discussiON
This study was conducted to optimize the decellularization protocol to create a human nerve 
allograft. The effect of the enzyme Elastase and type of storage was investigated. Additionally 
the differences of processing with motor and sensory nerves were studied. In conclusion, the 
addition of the enzyme shows a beneficial effect on the decellularization of the human nerve 
allograft. Longer exposure to the enzyme showed significantly better results. The immuno-
genicity of the nerve allograft was significantly reduced as well as the amount of axons, the 
remnants. The addition of Elastase showed no negative effect of the structure of the allograft.
The storage technique of the allograft was either cold storage, at 4 degrees Celsius or 
frozen storage, at -80 degrees Celsius. This had no significant influence on either the amount 
of axons or immunogenicity of the nerve allografts. However, a striking difference was found 
between the two storage techniques with regard to structure. The cold storage, at 4 degrees 
Celsius, scored significantly higher whereas the frozen storage, at -80 degrees Celsius, severely 
altered the ultrastructure of the nerve and is therefore preferable over the cold allograft. After 
decellularization of a nerve allograft the grafts should be cold stored instead of frozen.
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The addition of Elastase to the decellularization protocol and the investigation of the effect 
of storage was previously studied in rat nerves. In this study and the in vitro study on rat 
nerves, the positive effect of the addition of the elastase and the effect of cold storage was 
found. This shows that the optimization of decellularization of the tissues is similar in both 
tissues. Previous studies have been focused on rat tissue[7, 14-16]. We sought to test different 
decellularization protocols on human nerve tissue and determine the optimal protocol.
As rat nerve tissue is different from human nerve tissue (i.e. bigger diameter), different 
protocols were used. The effect of a higher concentration of the detergents was investigated. 
It was hypothesized that this would decrease the amount of cellular debris in the grafts after 
processing. However, the higher concentration of detergents did not significantly reduce the 
amount of axons stained with S100. The same was observed with regard to immunogenicity. 
The higher concentration of the detergents did not significantly reduce the MHCI positive 
cells in the human nerves. No significant effect of the higher concentration was seen on the 
structure of the grafts.
Next to the addition of an extra enzymatic step to the decellularization process, the ef-
fect of storage was investigated as well. Clinically available nerve allografts are stored at -80 
degrees Celsius. In clinical practice this makes it difficult as not all operation theaters have a 
place to store nerve allografts at -80 degrees. More importantly, the effect of storage on nerve 
allografts has never been studied. Previous allografts were analyzed after the decellulariza-
tion process, but not after the storage of the grafts. In this study we found that cold storage 
showed no negative influence on the axons and immunogenicity. Furthermore, with cold 
storage the ultrastructure of the allograft was maintained significantly better then compared 
to frozen storage.
This study strived to elucidate the difference between sensory and motor nerves. Motor 
nerves were better preserved compared to the sensory nerves. The basal lamina of the motor 
nerve is thicker and the endoneural tubes are larger in motor nerves as compared to sensory 
nerves[9]. Also, the specific way of signaling through motor nerves is different from signaling 
in sensory nerves. Studies have shown that motor nerves have four times higher regenera-
tion capacity through motor nerves grafts as compared to sensory nerve grafts[9]. This is an 
important factor when determining the optimal processing technique for nerve allograft for 
the reconstruction of motor nerves. Possibly the thicker basal lamina in motor nerves explains 
why the motor nerves are better preserved when compared to the sensory nerves.
It can be stated that the nerve allograft still does not score better then the gold standard, 
the autograft. The clinically used decellularized nerve allograft is used for both sensory and 
motor nerve reconstruction. The results of these nerve allograft on motor nerve regeneration 
are still not satisfactory[8]. The currently available nerve allograft seems only effective for the 
reconstruction of short digital, sensory nerve gaps. This study, focusing on optimization of the 
nerve allograft can improve nerve allograft reconstruction.
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One of the limitations of this study is the relatively small sample size and the in vitro nature 
of this study. Although statistically significant differences between the studied groups were 
found those could be type II errors due to the relatively low power of this study. Despite this 
small sample size, this study is the first experimental study to compare different techniques in 
the optimization of the human nerve allograft. Further studies should be executed to deter-
mine the effect of the optimized nerve allograft in an in vivo, animal model.
These limitations notwithstanding, we can conclude that the decellularization of the hu-
man nerve allograft can be enhanced by the addition of the enzyme Elastase. Cold storage 
shows better results with regard to maintaining the ultrastructure of the nerves when com-
pared to freeze storage. Using higher concentration of detergents on human nerve tissue did 
not show a beneficial effect. Motor nerves seem to be better preserved after processing when 
compared to sensory nerves. The conclusions of this study are in line with the optimization 
of nerve allograft found in rat tissue. The next step should be to test the optimized nerve 
allograft in vivo.
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ABsTRAcT
Background For segmental nerve injuries that cannot be directly repaired, a bridging 
nerve graft is required. Although the nerve autograft remains the gold standard, limited avail-
ability and donorsite morbidity remain major disadvantages. Previously, our group evaluated 
the role of elastase in the decellularization process of nerve allografts and demonstrated 
improved maintenance of the basement membrane and diminished immunogenicity com-
pared to traditional decellularization protocols. The purpose of this study was two fold: 1) 
to compare the elastase processed nerve allografts and nerve autografts and 2) to compare 
the type of storage (cold vs frozen) with respect to functional motor outcome in a rat sciatic 
segmental nerve defect model
methods Sixty-six Lewis rats underwent a 10-mm sciatic nerve reconstruction using 
either a cold or frozen stored decellularized nerve allograft or a nerve autograft. Sprague-
Dawley rats served as full MHC-mismatch donors. The functional motor outcome was evalu-
ated after 12 and 16 weeks. Ankle angle, compound muscle action potential (CMAP), isometric 
tetanic force, wet muscle weight and histomorphometry were tested bilaterally.
Results  For CMAP and isometric tetanic force, no statistically significant difference 
was found between groups at both time points. For ankle angle, histomorphometry and 
muscle weight, the cold stored allograft was equivalent to the autograft while the autograft 
showed significantly better results compared to the frozen allograft at both time points. Over-
all the frozen stored allograft showed inferior results while the cold stored allograft showed 
results comparable with the autograft.
conclusions For all outcome measurements, the elastase processed, cold preserved 
allograft showed no statistically significant differences with the gold standard, the nerve au-
tograft, for both early and late regeneration. In three out of the five outcome measurements, 
cold storage of the processed allograft showed better results than the frozen stored allograft.
clinical Relevance Although further studies in a larger animal are desired, the cold 
stored nerve allograft decellularized with elastase shows promising results with respect to 
motor outcome when compared to the gold standard, the nerve autograft.
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iNTROducTiON
Traumatic injuries to the peripheral nerves can cause considerable disability and economic 
burden[1]. Although highly prevalent in military conflicts, peacetime injuries commonly result 
from trauma secondary to motor vehicle accidents, penetrating trauma, industrial injuries and 
falls. 5% of the patients admitted to Level I trauma centers have a peripheral nerve injury[2-4]. 
The majority of peripheral nerve injuries require surgical reconstruction to restore sensation 
and function[5]. The gold standard for nerve injuries that cannot be directly repaired is the 
nerve autograft[6]. Typically, the sural nerve is harvested and sectioned into cables to fit the 
diameter and length of the defect[7]. However, the autograft is limited by supply, diameter, 
and length, and is accompanied by donor site morbidity[8]. This has constrained the ability 
to optimally reconstruct nerves of patients with multiple segmental defects where length of 
nerve graft needed far exceeds the availability and results in the need to prioritize the nerves 
to be reconstructed. In the last several decades, different alternatives have been proposed 
to replace the autograft, each with advantages and disadvantage[9-14]. Currently available 
reconstruction options comprise of nerve grafts (auto- and allograft), biological conduits (e.g. 
arterial and venous) and synthetic conduits (collagen, polyglycolic acid and caprolactone)[14].
One of the proposed reconstruction alternatives was the use of a nerve allograft. Theoreti-
cally, a nerve allograft will more closely mimic the structure of the autograft than an empty 
conduit. The first allografts introduced required the use of immunosupressants[15]. Although 
progress has been made, further development is required prior to using the allograft instead 
of an autograft, especially in longer nerve gaps. The results of clinically available processed 
allografts, especially for motor reconstruction have not been optimal or adequately studied. 
While sensory nerve recovery has shown similar results to autograft, motor recovery remains 
inferior to the autograft[16, 17]. Previous research by our group has shown that, in a rat model, 
the allograft nerve processed by AxoGen (AxoGen, Alachua, Florida) showed comparable 
results to the autograft at 12 weeks. However, at 16 weeks there was a statistically significant 
difference, where the allograft isometric motor strength degraded while the autograft con-
tinued to improve strength[9]. This inferior motor recovery stimulated the search for a better, 
optimized nerve allograft. The allograft process was improved by the addition of elastase, 
and demonstrated significant improvements in an in vitro study were different processing 
techniques and storage protocols were compared[18]. Based on histological outcome, the 
allograft process was improved and storage (frozen vs cold) was found to have a significant 
influence on the structure of the grafts.
The purpose of this study was to evaluate the elastase decellularized allograft nerve in a 
segmental rat sciatic nerve gap model. Specifically, a comparison of the elastase decellular-
ized allograft nerve to autograft with respect to motor nerve regeneration was evaluated in 
addition to the effect of storage of the decellularized allograft.
Chapter 9
136
meThOds
After approval by the Institutional Animal Care and Use Committee, 66 Lewis rats (weighing 
250-300 grams) were used and 22 Sprague-Dawley rats served as full major histocompatibility 
complex mismatch nerve donors. Lewis rats are used as they are known for their reduced 
tendency for autotomy[19]. Animals were randomly divided in 3 groups, each treated for a 
10mm sciatic nerve gap. Group I (n=22) served as a control using a nerve autograft. Group 
II (n=22) had a unilateral nerve gap reconstructed with a processed nerve allograft that was 
cold stored (‘Allograft Cold’). Group III (n=22) had a similar procedure except the processed 
allograft was freeze-stored (‘Allograft Frozen’). The rats were given food and water ad libitum 
and were individually housed with a 12 hour light-dark cycle.
Nerve processing
Twenty-two Sprague-Dawley rats, weighing 300-350 grams, were sacrificed with an intraperi-
toneal injection of pentobarbital after which 15 mm nerve segments were harvested asepti-
cally. Nerve allografts were prepared as previously described[18, 20]. Briefly, nerve segments 
were placed in RPMI medium, followed by subsequent steps using different detergents, two 
enzymatic steps and gamma irradiation[18]. At the end, the processed allografts were stored 
in phosphate buffered saline at 40C (‘allograft cold’) and the allografts were stored in Ringers 
Lactate at -800C (‘allograft frozen’) for 14 days.
surgical procedure
Rats were anesthetized with an intraperitoneal cocktail of ketamine (Ketaset®, 100mg/ml, 
Fort Dodge Animal Health, Fort Dodge, IA) and xylazine (VettekTM, 100mg/ml, Bluesprings, 
MO) 10:1 mixture, administering a dose of 1 ml/Kg body weight after initial induction with 
Isoflurane. Anesthesia was maintained with additional doses of ketamine only. Ringers Lactate 
was administrated subcutaneously to prevent dehydration, and body temperature was main-
tained with a heating pad. The left sciatic nerve was exposed with a mid-gluteal incision. A 
10 mm sciatic nerve segment was excised under an operating microscope (Zeiss OpMi6, Carl 
Zeiss Surgical, Oberkochen, Germany). In group I and II a 10 mm nerve allograft, respectively 
cold or frozen, was used to bridge the 10 mm nerve gap using 10-0 nylon epineural sutures. 
In the control group, group III, the nerve segment was reversed and put back. The muscle 
was approximated and the skin was closed with 5-0 Vicryl rapid sutures. Postoperatively trim-
ethoprim/sulfadiazine 30 mg/Kg (Tribrissen, Five Star Compounding Pharmacy, Clive, IA) was 
administered to prevent infection and buprenorphine (Buprinex®, 0.1 ml/kg, Reckitt Benckiser 
Pharmaceuticals Inc., Richmond, VA) served as an analgesic.
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evaluation of motor Functional Outcome
For the sacrificial procedure, at 12 and 16 weeks, the animals were anesthetized as previous 
described. The passive ankle angle, compound muscle action potential (CMAP), isometric 
tetanic force and wet muscle weight were tested bilaterally. Distal nerve segments were ana-
lyzed for histomorphometry. A detailed description of the sacrificial procedure is presented 
in the Appendix.
Ankle Angle
The maximum passive plantar flexion angle of the ankle was measured bilaterally in all animals 
to determine the ankle contracture angle as previously described[21].
Electrophysiology
The sciatic nerve was exposed as previously described. A miniature bipolar electrode (Harvard 
Apparatus, Holliston, MA) was attached proximal to the nerve graft. Recording electrodes 
were placed subcutaneous to the tibialis anterior muscle and a ground electrode was placed 
in the surrounding tissue. CMAP was measured using an EMG (VikingQuest, Nicolet Biomedi-
cal, Madison, WI). The maximal amplitude was recorded. In a similar fashion the contralateral 
side was measured.
Maximum Isometric Tetanic Force
For obtaining the maximum isometric tetanic force, the peroneal nerve, distal of the nerve 
graft was exposed. The force measurements were executed as previously described[22]. 
Briefly, the distal tendon of the tibial muscle was attached to a force transducer. The peroneal 
nerve was stimulated and the stimulus intensity was increased until maximum tetanic muscle 
force was reached.
Wet Muscle Mass
After bilateral force testing animals were sacrificed with an overdose of pentobarbital in-
traperitoneally. The tibial muscles of both hindlimbs were carefully dissected and weighed 
immediately to obtain muscle mass ratio.
Histomorphometry
Nerve segments of the peroneal nerve were excised and stored in Trumps solution (37% form-
aldehyde and 25% glutaraldehyde) and subsequently embedded in spur resin. 1µm sections 
were cut and stained with 1% Toluidine Blue. Images were acquired with a digital camera and 
analysis was performed using Image ProPlus Software (Media Cybernetics Inc, Bethesda, MD) 
where nerve area, total myelin area, number of axons and total axon area were obtained in 
semi-automatic fashion.
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statistical methods
The groups were compared with respect to ankle contracture, electrophysiology, maximum 
isometric tetanic force, muscle weight and histomorphometry. Data were expressed as a 
percentage of the contralateral (healthy) side to diminish intra-animal differences. One-way 
analysis of variance (ANOVA) followed by a Bonferroni correction for multiple testing was used 
for statistical analysis. All results are presented as mean +- standard deviation (SD). A p-value 
of 0.05 was considered significant.
ResuLTs
All animals survived the surgical procedure and no complications were observed. A summary 
of all results is presented in the Appendix Table 1.
Ankle Angle
The percentage of recovery of the ankle angle contracture of the experimental side compared 
to the contralateral side was 80.2 ± 3.1% in group I, 73.7 ± 3.9% in group II and 73.1 ± 4.2% 
in group III at 12 weeks. At 16 weeks the recovery was 88.0 ± 3.1% in group I, 77.4 ± 3.6% in 
group II and 74.1 ± 3.1% in group III. Significant difference was observed between group I and 
III (p<0.001) at both 12 and 16 weeks postoperatively (Fig. 1).
Electrophysiology
Recovery of the compound muscle action potentials (CMAP) at 12 weeks was 41.9 ± 14.4% 
in group I and 44.5 ± 15.1% and 40.8 ± 5.3% in group II and III respectively. At 16 weeks the 
recovery increased to 44.0 ± 21.9% in group I and 56.2 ± 14.0% and 53.5 ± 12.7% in group II 
Figure 1. Group comparison for ankle angle contracture and CMAP (compound muscle action poten-
tial). Results are expressed as a percentage of the contralateral, normal side and are presented as mean 
+- standard deviation. *Indicates significance (p<0.05).
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and III respectively. Group comparison showed no statistically significant difference between 
all groups at both time points (Fig. 1).
Isometric Tetanic Force
In group I, the percentage of muscle force recovery was found to be 42.3 ± 5.8%. Group II 
showed the highest recovery with 48.7 ± 7.6% and group III was 43.2 ± 10.1%. In the late 
follow-up time, at 16 weeks, the muscle force was recovered to 53.9 ± 12.0% in group I and 
55.4 ± 12.7% and 50.0 ± 11.4% in group II and III respectively. No statistical significant differ-
ence was found when the groups were compared at the early and late follow-up times (Fig. 2).
Muscle Weight
The muscle mass ratio of the tibial muscle at the 12th follow-up week was 63.7 ± 4.9%, 60.2 ± 
4.7%, 58.3 ± 4.1% in group I, II and III respectively. At 16 weeks, the muscle weight showed a 
recovery up to 71.1 ± 4.8% in the autograft group, 67.0 ± 6.6% in the cold allograft group and 
16 64.7 ± 3.7% in the frozen allograft group. At both time points, a statistically significant differ-
ence was observed between groups I and III (p<0.05 at both weeks). The autograft performed 
better than the frozen allograft. No difference was found when comparing the autograft to 
the cold allograft (Fig. 2).
Histomorphometry
Figure 3 shows the normalized results of the histomorphometry of the different groups 16 
weeks postoperatively. Total nerve area, myelin area and axon area were statistically lower in 
the frozen allograft group when compared to the autograft (p<0.05). The cold stored allograft 
did not significantly differ from the nerve autograft (Figs. 3 and 4).
Figure 2. Group comparison for isometric tetanic force and muscle weight. Results are expressed as a 
percentage of the contralateral, normal side and are presented as mean +- standard deviation. *Indi-
cates significance (p<0.05).
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Figure 3. Group comparison of histomorphometry of nerve area, myelin area, number of axons and total 
axon area at 16 weeks postoperative. Results are expressed as a percentage of the contralateral, normal 
side and are presented as mean +- standard deviation. *Indicates significance (p<0.05).
Figure 4. Histological transverse sections of the peroneal nerve at 20 X magnification. Fig 3-A: Autograft 
group at 12 weeks Fig 3-B: Cold-stored allograft at twelve weeks Fig 3-c: Freeze-stored allograft at 12 
weeks Fig 3-d: Autograft group at 16 weeks Fig 3-e: Cold-stored allograft at 16 weeks Fig 3-F: Freeze-
stored allograft at 16 weeks. Nerve size was similar between the three groups at both time point.
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discussiON
The goal of this study was to evaluate the functional outcome of the elastase processed al-
lograft in an animal segmental motor nerve defect[18]. Autograft nerve has remained the gold 
standard for segmental nerve reconstruction despite the well-known donor site morbidity 
and limited available length and diameter[8]. Therefore the surgeon is often forced to priori-
tize in the case of extensive peripheral nerve reconstruction[23]. Developing a nerve allograft 
that is unlimited in supply without the harmful donor side morbidity and with equivalent 
outcomes as the autograft would be a tremendous advance in peripheral nerve surgery. It 
is essential in the optimization of longitudinal nerve regeneration that this alternative has a 
three dimensional structure[24]. Additionally, this scaffold should cause no immunological 
reaction, thus leaving the necessity for administering immunosuppressive agents.
Previous studies were executed to evaluate the allograft’s performance, both in vitro and 
in vivo. Hudson described one of the first processing protocols for the nerve allograft[25, 26] 
which has been modified by several others. Moore et al. modified and tested the protocol 
but unfortunately, investigated only 4 animals per group and lacked power to draw any 
conclusions[27]. Whitlock et al. studied the effect of the first commercially processed allograft 
(AxoGen, Alachua, Florida) in 14- and 28 mm gaps in rats and evaluated walking track analysis, 
muscle mass and histomorphometry. They found comparable results between the allograft 
and a collagen conduit, but the allograft was not able to outperform the autograft 12 weeks 
post-operatively[28]. Interestingly the study of Whitlock was the basis for the clinical study 
with the nerve allograft (i.e. the Ranger study) without the confirmation of comparable results 
at late recovery. Giusti et al. evaluated early and late recovery at 12 and 16 weeks, using Axo-
Gen processed allograft rat nerves and compared these to autograft nerves. While both the 
allograft and the autograft had comparable results at the early recovery time of 12 weeks, 16 
weeks post-surgery the autograft outperformed the AxoGen processed rat allograft nerve[9]. 
This could be explained by the fact that the allografts still showed intraluminal remaining 
debris. This could reduce or inhibit the nerve regenerative capacity since the debris results 
in a fibrotic intra-luminal occlusive blockade. This degradation of motor function could be 
secondary to the inflammatory reaction as a consequence of the immunogenicity. As such, 
the ultimate goal is to process a nerve allograft by removing all cells and cellular debris, which 
are targeted in an immune response, while preserving the extracellular matrix. In addition to 
finding the novel processing technique, the optimal storage technique was studied. Therefore 
we challenged different processing and storage protocols in vitro and described our elastase 
processed nerve allograft.
In this in vivo study the regenerative capacity of the elastase processed nerve allograft 
was evaluated. Motor function analysis is the most reliable and important way to evaluate 
the neuroregenerative capacity of different nerve grafts[22]. Motor nerve regeneration was 
evaluated using ankle contracture, electrophysiology (CMAP), isometric tetanic force, wet 
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muscle weight and histomorphometry of the distal nerve segment at 12 and 16 weeks to 
study both early and late regeneration. An interesting observation is the superior significant 
result (i.e. 3 out of 5 assessments) of the cold stored graft compared to the frozen graft. This 
was observed in both early and late nerve regeneration. The cold preserved allograft showed 
no statistically significant difference -and thus comparable results- with the nerve autograft. 
The difference between the two storage techniques was in line with the previous in vitro 
study[18]. First, the results of this study confirm the superior effect of the cold preservation 
as found in our in-vitro study. Secondly, when comparing the results of this study to the in 
vivo study with the AxoGen processed allograft (Guisti et al), as described above, improved 
regeneration was observed at 16 weeks, favoring the elastase processed allograft, compared 
to the degradation in motor function which was observed at the 16 week time point in the 
previous in vivo study[9].
Ankle contracture, although minimal, was observed in all animals at both time points. 
Ankle contracture has shown to be correlated with muscle force and muscle weight[21],[29]. 
In our study a difference was found in ankle contracture between the autograft group and the 
frozen allograft group at both time points. No difference was observed when comparing the 
cold allograft group to the autograft.
Isometric tetanic muscle force testing is a reliable method to test motor nerve recovery[22]. 
In this study the differences between the groups were, with regard to muscle force, not sta-
tistically different. This suggests that the processed allograft can produce results similar to the 
autograft. The results of the electrophysiological testing were similar to the isometric tetanic 
force testing. Wet muscle mass showed, independent of recovery time, comparable results 
between the nerve autograft and the cold preserved allograft. On the other hand, significantly 
lower scores were found for the frozen allograft when compared to the autograft, suggest-
ing an inferior regeneration potential. Histomorphometrical analysis of the peroneal nerve, 
distal to the nerve graft, showed statistically comparable results between the cold preserved 
allograft and the autograft for all parameters investigated. The frozen allograft showed inferior 
values to the autograft, which is in line with the functional testing.
Clinically, the use of commercially available decellularized human nerves (AxoGen, Alachua, 
Florida) for motor nerve reconstruction have been reported in three case reports and recently 
in a larger multicenter study17,32,33. The case reports show results that are not compared to 
any other treatment and therefore lack the ability to show superiority of the allograft to 
the autograft. The results of the multicenter study did not provide satisfying results despite 
the positive conclusions made[16, 17]. Similar to the case reports, no control patients were 
included, and thus lack the possibility to put the results in perspective. Another study with 
this allograft was used for the evaluation of reconstruction of sensory nerve defects but also 
did not compare the nerve allograft with the nerve autograft[10]. As such, we believe that the 
introduction of a new allograft needs careful evaluation in both in vitro and in vivo studies to 
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thoroughly investigate neuroregenerative capacity. Not before non-inferiority or superiority 
has been proven, clinical testing is justified.
We recognize the limitations of this study in particular the use of the rat model. The rat has a 
rapid neuroregenerative capacity, a limited gap size and its size prohibits serial immunological 
testing. Although the regeneration is argued to be too fast, significant differences between 
groups have been demonstrated in previous studies as well as with this study. The limitation 
of the nerve gap length and the immunological testing could be overcome by using a larger 
animal.
These limitations notwithstanding, we can conclude that there is a superior regeneration 
potential of the cold stored elastase processed nerve allograft compared to the frozen stored 
allograft with respect to motor functional outcome. The elastase processed cold preserved 
allograft showed statistically similar results to the nerve autograft. Further testing in a larger 
animal model is required prior to application in the clinical setting.
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APPeNdiX
evaluation of motor Functional Outcome
Maximum Isometric Tetanic Force
For obtaining the maximum isometric tetanic force, the peroneal nerve, distal of the nerve 
graft was exposed. The force measurements were executed as previously described22. The 
tibial muscle was carefully freed from its insertion while preserving the neurovascular pedicle. 
The hindlimb was stabilized with 2 Kirschner wires (DePuy Orthopedics) in the distal femur and 
ankle joint. The distal tendon of the tibial muscle was attached to a force transducer (MDB-0.5, 
Transducer Techniques, Temecula, CA) using a custom clamp with the tendon aligned in the 
anatomical position. The force transducer signal was processed and analyzed with a computer 
using LabView software (National Instruments). A miniature bipolar electrode (Harvard Appa-
ratus) was attached to the peroneal nerve. The nerve was stimulated with a stimulator (Grass 
SD9, Grass Instrument Co., Quincy, MA). After establishing the optimal preload or muscle 
resting length, the stimulus intensity was increased until maximum tetanic muscle force was 
reached.
statistical methods
Power analysis
The sample size of the groups was based on the results of muscle force test obtained from 
previous studies showing the highest standard deviation being approximately 10%. Assum-
ing that same variability will occur (two tailed distribution, α=0.05), the number of animals to 
provide an 80% power to detect 10% difference between the groups was estimated to be 19. 
To guard against potential attrition and to overpower the study, the sample size was increased 
to 22 per group.
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Appendix Table 1. Summary of results of test for all groups
surgical intervention
Group i Group ii Group iii
Autograft Cold stored Allograft Frozen stored Allograft
No. of animals tested 11 11 11 11 11 11
sacrifice time (wk) 12 16 12 16 12 16
maximum passive plantar 
flexion ankle angle (%)
80.2 ± 1.0 88.0 ± 0.9 73.7 ± 1.2 77.4 ± 1.1 73.1 ± 1.3 74.1 ± 0.1
cmAP (%) 41.9 ± 4.6 44.0 ± 6.9 44.6 ± 4.8 56.2 ± 4.4 40.8 ± 1.7 53.5 ± 4.0
maximum isometric 
tetanic tension (%)
42.3 ± 1.8 53.9 ± 3.8 48.7 ± 2.4 55.4 ± 4.0 43.2 ± 3.2 50.0 ± 3.6
Tibialis anterior wet 
muscle weight (%)
63.7 ± 1.5 71.1 ± 1.5 60.2 ± 1.5 67.0 ± 2.1 58.3 ± 1.3 64.7 ± 1.2
h
is
to
m
or
ph
om
et
ry
of
 p
er
on
ea
l n
er
ve
 
(%
)
Nerve area 74.6 ± 4.9 92.2 ± 4.4 86.9 ± 5.9 78.7 ± 5.6 76.7 ± 3.6 71.4 ± 2.7
Myelin area 55.5 ± 4.1 72.8 ± 3.3 75.7 ± 6.9 66.1 ± 4.9 57.3 ± 3.2 53.4 ± 2.3
No. of axons 120.1 ± 11.5 130.0 ± 5.4 138.4 ± 9.5 130.3 ± 10.4 101.8 ± 4.7 101.0 ± 6.6
Axon area 29.8 ± 3.7 35.0 ± 4.0 30.7 ± 3.0 35.0 ± 3.1 18.9 ± 11.3 23.6 ± 1.5
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ABsTRAcT
Background For decades the gold standard for reconstructing a large peripheral nerve 
defect has been and still is the nerve autograft. Alternatives to the nerve autograft include 
biological conduits and vessels. Adding stem cells in the lumen of a nerve conduit has been 
the subject of multiple studies. The purpose of this meta-analysis is to summarize animal 
experimental studies on the effect of stem cells as a luminal additive when reconstructing a 
peripheral nerve defect with a nerve graft.
methods A literature search in the Medline and Embase databases was performed 
from inception to April 2012, searching for animal experiments on peripheral nerve recon-
struction models using a nerve conduit with and without the support of three different types 
of stem cells. Stem cells were analyzed according to their origin: bone marrow, adipose and 
other origins. Included studies had consistent outcome measurements: walking track analysis, 
muscle mass ratio and electrophysiology.
Results  Forty-four studies were included in the final analysis. Forest plots of the 
three outcome measurements (walking track analysis, muscle mass ratio and electrophysiol-
ogy) showed positive effects of stem cells on the regeneration of peripheral nerves at differ-
ent time points. Almost all comparisons showed significant difference for all three stem cells 
groups with a control group without stem cells.
conclusions This study systematically analyzed the different studies using stem cells as 
a luminal additive when bridging a large peripheral nerve defect. All three different stem cell 
groups showed a beneficial effect compared to reconstruction without stem cells.
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iNTROducTiON
Peripheral nerve trauma is a disabling injury with an incidence of 2,8% in trauma patients.[1] 
Reconstructing the lacerated or injured nerve stumps using a direct end-to-end technique 
without any tension results in the best recovery. If a gap between both nerve ends cannot be 
bridged without tension, a graft or guide should be used. For decades the autologous nerve 
graft has been the gold standard[2] and while this still is the case, using a donor nerve as a 
nerve graft has several limitations. The most outstanding limitation is the need for a secondary 
surgical intervention with corresponding donor site morbidity and consequently symptoms 
such as loss of sensibility (hypaesthesia), scar formation, and possible neuroma formation 
can arise. The prolonged duration of the surgery and the limited donor nerve length are also 
limitations which should not be underestimated when using a donor nerve.[3]
Due to the above-mentioned limitations of nerve grafts, experimental research has 
focussed on the use of alternative conduits. Materials used are biological- (muscle, artery, 
vein and tendon), nondegradable- (silicone tube) and biodegradable synthetic materials 
(collagen, polyglycolic acid, polyesters, copolyesters and chitosan).[4, 5] In recent years, within 
this field the introduction of supporting growth factors and other cells received increased 
interest, aiming to supply substitutes which promote nerve regeneration. A few examples of 
these additives uses are Nerve Growth factor (NGF), Schwann cells and several types of stem 
cells.[5-10] A number of different types of stem cells have been used in animal experiments 
focussing on nerve regeneration in a nerve reconstruction model. Bone marrow stromal cells 
(BMSCs), adipose-derived stromal cells (ADSCs), hair follicle stem cells, skin-derived mesen-
chymal stem cells, and amniotic fluid derived mesenchymal stem cells can all be applied.[7, 
9, 11-13] The different stem cells have different advantages and disadvantages. Stem cells, 
such as BMSCs from mesenchymal origin, can differentiate successfully into neural cells.[14] 
The BMSCs in particular can be easily harvested from bones and with their apparent plasticity 
they can transdifferentiate into a Schwann cell-like phenotype.[15] Another theory, however, 
for the beneficial effect of BMSCs is that they function as growth promoting factors.[16] ADSCs 
are less invasive to harvest as they can be derived from belly fat or other adipocyte-containing 
tissue. ADSCs have a comparable phenotypic profile as the BMSCs and some studies even 
describe that ADSCs have a more profound tendency to transdifferentiate towards a Schwann 
cell-like phenotype.[7] More recently applied stem cells, such as hair follicle pluripotent stem 
cells and skin derived stem cells, are also easily accessible and can transdifferentiate into 
Schwann Cell-like cells as well.[12]
Although most studies investigating the use of stem cell to enhance nerve regeneration 
are enthusiastic and promote further research,[11, 17] researchers have not compared their 
data to other studies nor did anyone propose an evaluation protocol which allows a correct 
comparison of the results. Therefore the purpose of this meta-analysis is to summarize the 
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effect of different types of stem cells in animal experimental studies to enhance regeneration 
after reconstructing a peripheral nerve injury.
meThOds
Following PRISMA guidelines this meta-analysis was conducted by three reviewers who as-
sessed each reference and determined study eligibility. The ARRIVE guideline was not used.
Criteria for included studies
The criteria for inclusion and exclusion of studies are depicted in Table 1.
Search method for identification of studies
A literature search in Medline and Embase (from inception to April 2012) was performed 
with assistance of a professional librarian. The following terms were applied: Nerve reconstruc-
tion, repair, injury, transection, regeneration and stem cells (different kind of stem cells) in animal 
experiments (the full search-term is presented in Figure 1). Three reviewers (C.H., T.N., B.M.) 
independently examined all articles by reading the title and, when the title seemed relevant, 
the abstract was examined. Disagreement about the inclusion or exclusion of articles was 
solved by consensus. When multiple journals published the same study, or parts of the same 
study, only one study was included and multiple reports of the same study were merged 
together.
Data collection and extraction
After examination of the included studies, data was extracted. Collected characteristics were: 
study design, sample size, animal- weight/gender/age/species and -strain, stem cell type, 
scaffold type, peripheral nerve, gap length, assessment modality, and follow-up time. The col-
lected outcome data was: sciatic functional index, muscle mass ratio and electrophysiology 
(nerve conduction velocity, amplitude and latency). If data was presented in graphs or figures 
Table 1. Inclusion and exclusion criteria.
inclusion criteria exclusion criteria
1. Peripheral nerve reconstruction
2.  Transection injury, full nerve defect with gap 
created
3. Animal and in vivo experiments
4.  Experiments comparing a nerve conduit with and 
without stem cells as luminal additive
5.  Functional tests and electrophysiology evaluation 
as outcome
1. Central nerve reconstruction
2.  End to end-coaptation, crush or traction-injury 
model, denervation or own epineurium used as 
scaffold
3. Clinical studies and reviews
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only, values were estimated using the Adobe® Photoshop CS5 measure tool. Data was entered 
in ReviewManager version 5.1[18] for further examination and analysis. Characteristics of 
included studies are shown in Table 2, data of included studies are projected in the Table 3.
Data and statistical analysis
Data analysis was performed using ReviewManager. Since the primary objective was to anal-
yse the effect of stem cells on nerve regeneration, two groups needed to be compared. In 
both groups the nerve defect should have been bridged with a conduit but only one group 
should have received the cellular therapy. Because of discrepancy and inconsistencies, not all 
outcome measurements could be used for analysis. Based on the frequency of the outcome 
measurement, three different outcome measurements were chosen for analysis, included 
were the Sciatic Functional Index (SFI), the muscle mass ratio (MM) and electrophysiology. 
These three outcome measurements were all functional whereas, for instance, histology 
differed too much to summarize the effect of different studies. The extreme heterogeneity 
makes it impossible to summarize all these varying results for a meta-analysis. From the 
included outcome measures forest plots were created (see Figures 3-5). The SFI is a measure-
ment which can be derived from the walking track analysis and is displayed in values ranging 
from 0 (good) to -100 (no function).[19] The muscle mass ratio or gastrocnemius muscle index 
is calculated by comparing the muscle mass of the operated leg with the muscle mass in the 
non-operated leg. The electrophysiology is obtained by applying electrical stimulation at the 
nerve trunk proximal of the nerve graft and at the distal part. Consequently nerve conduction 
velocity (NCV), amplitude and latency’s can be recorded.
Figure 1. Search terms in Med-
line and Embase databases (with 
number of articles identified)
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The data was categorized in three subgroups according to three different follow-up peri-
ods: less than one month, between one and three months and more than three months. The 
studies were arranged by ascending gap length. The model used for the meta-analysis was 
the random effect model. The variability of the measured effect was based on the width of the 
confidence interval and the number of animals per group. Effect sizes were expressed as stan-
dard mean differences between both groups (experimental and control) with its confidence 
interval. The variability of the overall measured effect was used as the weight for calculating 
the overall summarized effect of each subgroup. Subgroup statistics were calculated for the 
different end points.
ResuLTs
Literature search
A total of 4156 articles was found in the two databases (1401 in Medline, 2755 in Embase). 
After discarding duplicates, 3362 articles were assessed. Screening excluded 3238 records, 
leaving 124 articles for which the full text was obtained. 101 full-text articles were assessed for 
eligibility and 31 studies were excluded based on their intervention. Finally, 69 studies from 
70 reports, were included for final selection. Based on the outcome measurements set prior 
to the selection, eventually data from 44 studies from 45 reports was used for meta-analysis. 
Of these, 27 studies investigated BMSCs, 7 ADSCs and 12 other type of stem cells. The flow-
diagram of the search selection is presented in Figure 2.
Functional outcome measurements
From the forest plot (Figure 3), it can be seen that all stem cells have a significant positive effect 
on the Sciatic Functional Index (SFI) for the three different follow-up periods compared to the 
control group. More specifically, the mean difference in SFI after nerve reconstruction using 
a tube in the BMSC group compared to the control group at the three serial follow-up times 
was 16.3 (95% CI: 15.6, 16.9), 14.2 (95% CI: 13.6, 14.9) and 21.48 (95% CI: 20.4, 22.6) respectively. 
The ADSC group showed a mean difference with the control group at the different follow-up 
times of 1.4 (95% CI: 1.0, 1.8), 8.0 (95% CI: 7.7, 8.3) and 6.3 (95% CI: 6.1, 6.6) respectively. The 
mean difference with the control group found in the other stem cell group was 12.3 (95% CI: 
11.5, 13.1), 1.9 (95% CI: 1.9, 1.9) and 9.8 (95% CI: 9.2, 10.4).
The forest plots of the muscle mass ratio (MM) or gastrocnemius muscle index (GMI) for the 
two follow-up periods showed a significant positive effect of all stem cell groups compared to 
their control groups. The mean differences (%) in the BMSC’s compared to the control group 
at the two follow-up times were 5.0 (95% CI: 4.0, 6.1) and 4.0 (95% CI: 2.9, 5.1). The ADSC’s 
showed a mean difference (%) at the late follow-up time of 9.0 (95% CI: 6.8, 11.2) compared to 
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the control group. The effect of the other stem cells (SVF) was based on only one study and 
showed a mean difference (%) of 40.6 (95% CI: 23.9, 57.4) at the long follow-up time.
Regarding the electrophysiology, all stem cell groups showed significant positive effects 
compared to the control groups for the two follow-up periods except for the other stem cells 
at the long follow-up period in nerve conduction velocity. The forest plots are depicted in 
Figure 3. The mean difference in BMSC’s showed a significant positive effect on the NCV (mm/
ms) at the two follow up times of 4.7 (95% CI: 4.2, 5.3) and 1.9 (1.1, 2.7). The mean difference in 
amplitude (mV) was 1.9 (95% CI: 1.6, 2.2) and 0.3 (95% CI: 0.2, 0.4) in the two follow up times. 
The latency (ms) showed a mean difference of -0.4 (95% CI: -0.4, -0.3) and -1.3 (95% CI: -2.1, 
-0.6), compared to the control group.
The mean difference in the ADSC group was only measured at the long follow up time and 
showed a significant positive difference of 2.9 (95% CI: 2.6, 3.3) in NCV (mm/ms). The mean 
difference at the long follow up time in amplitude (mV) was 3.9 (95% CI: 3.6, 4.2). The latency 
(ms) showed a mean difference of -0.6 (95% CI: -0.6, -0.5) compared to the control group at 
the long follow up time.
The mean difference with the control group in the other stem cell group (amniotic fluid 
derived stem cells and skin-derived stem cells) showed a positive effect on the NCV (mm/
ms) at the two follow up times of 1.0 (95% CI: 0.2, 1.9) and -6.2 (95% CI: -7.2, -5.2). The mean 
Figure 2. Flowchart of study selection.
167
Meta-analysis stem cells
10
Fi
gu
re
 3
. S
ci
at
ic
 F
un
ct
io
na
l I
nd
ex
. A
bb
re
vi
at
io
ns
: S
FI
 =
 sc
ia
tic
 fu
nc
tio
na
l i
nd
ex
, B
M
SC
s =
 b
on
e 
m
ar
ro
w
 st
ro
m
al
 c
el
ls,
 A
D
SC
s =
 a
di
po
se
 d
er
iv
ed
 st
ro
m
al
 c
el
ls
Fi
gu
re
 4
. M
us
cl
e 
M
as
s R
at
io
. A
bb
re
vi
at
io
ns
: m
m
=
m
us
cl
e 
m
as
s, 
BM
SC
=
 b
on
e 
m
ar
ro
w
 st
ro
m
al
 c
el
ls,
 A
D
SC
s =
 a
di
po
se
 d
er
iv
ed
 st
ro
m
al
 c
el
ls
Chapter 10
168
Fi
gu
re
 5
. E
le
ct
ro
ph
ys
io
lo
gy
: l
at
en
cy
 (m
s)
, a
m
pl
itu
de
 (m
V)
 a
nd
 n
er
ve
 c
on
du
ct
io
n 
ve
lo
ci
ty
 (N
CV
) (
m
m
/m
s)
. A
bb
re
vi
at
io
ns
: B
M
SC
s 
=
 b
on
e 
m
ar
ro
w
 s
tr
om
al
 
ce
lls
, A
D
SC
s =
 a
di
po
se
 d
er
iv
ed
 st
ro
m
al
 c
el
ls.
169
Meta-analysis stem cells
10
difference in amplitude (mV) was 0.1 (95% CI: 0.0, 0.1) at the middle follow up time and 6.0 
(95% CI: 2.1, 9.9) at the long follow up time. The effect of the other stem cells on the latency 
was based on only one stud and showed a mean difference (ms) of -0.8 (95% CI: -1.2, -0.4) at 
the middle follow-up time.
discussiON
This meta-analysis aimed to summarize the beneficial regenerative effect of the different 
types of stem cells. Comparing animal studies investigating nerve reconstruction using a 
nerve guide with additional support of stem cells to a control group without the support 
of stem cells. Analyzing functional outcome, the contribution of stem cells is apparent and 
thus suffices an even better neuronal regeneration. The regeneration effect is summarized for 
three different functional outcome measurements.
The first outcome measurement evaluated was the SFI. The SFI showed significantly better 
results in all stem cell groups for the different follow up periods compared to a control group. 
Since the SFI is detracted from the walking track analysis, which is a valid tool for evaluating 
the regeneration of the nerve, the positive effect found in all studies using this technique is 
strong evidence for the supporting role of stem cells.[19]
The second functional outcome, the muscle mass ratio of gastrocnemius muscle index, 
also showed positive results for both the adipose and bone marrow derived stem cells. For 
the ADSCs (n=7) and BMSCs (n=27), multiple studies were used in this analysis. Like the SFI, 
the MM or GMI are also valid, well-accepted, tools for evaluation nerve regeneration. The 
standardized protocol for assessing the muscle mass allows an easy comparison between the 
different studies.
The third functional outcome measurement is electrophysiology. Using electrophysiology, 
nerve conduction latency, amplitude and velocity can be recorded. The mean differences 
showed the beneficial effect of the BMSCs and the ADSCs for all three parameters at the three 
different follow up periods. The other stem cells (amniotic fluid derived stem cells and the skin 
derived stem cells) showed a positive effect for the three different measurements for both the 
latency and amplitude at the three different follow up periods. Only with evaluation of nerve 
conduction velocity in the long follow up period in the other stem cell group, no significant 
beneficial effect of the intra luminal injection of those stem cells was found.
Interpretation of results
Regarding survival some studies investigated the survival of stem cells in the graft.[20] The 
main conclusion was that the cells survived for follow up periods up to three months[15, 
21]. The proportion of cells that survived was reported to be up to 38%.[22] Furthermore the 
transition from stem cell to Schwann cell has been encountered previously and thus indicates 
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that this could be a vital step in explaining the beneficial effect.[23-26] Schwann cells however 
not only myelinate, Hoke et al showed that the Schwann cell phenotype can be modulated, 
for example into motor or sensory Schwann cells[27]. Also the stem cells extent a more sup-
porting and productive role, producing neural growth stimulating factors.[24, 25]
Limitations
This study has a number of limitations. The first limitation is that the duration of investigation 
for the different types of stem cells varies significantly. BMSCs are subject to investigation for 
a longer period of time compared to, for example, the use of hair follicle-derived stem cells. 
As can be expected, the number of articles used for analysis for the different types of cells 
-thus- varies and possibly warrant the differences in regenerative effect.
Regarding the evaluation tools used, it should be noted that some studies evaluated nerve 
regeneration at multiple time points using the walking track analysis to determine the SFI. 
To allow a comparison between all included studies, we decided to set a maximum of three 
end points for this evaluation. For the other two outcome measurements, muscle mass and 
electrophysiology, only one end point was used. When a study compared two experimental 
groups with one control group, the data of this control group was used twice in the analysis. 
This made the actual sample size of the control group smaller than the factual one.
Implications
The studies investigated in this review are all animal related studies and do not warrant suc-
cess in clinical setting. Although multiple studies have been conducted and stimulate the 
use of stem cells for nerve reconstruction, the bridge towards clinical implementation has 
to be made yet. At this point undoubtedly strong evidence is presented for the beneficial 
effect of the stem cells. Therefore this study can help progress the translational approach for 
implementing stem cells in further clinical research. The focus of the present study was on 
the beneficial effect of stem cells on nerve regeneration. A next step could be to compare 
the overall effect of the stem cells to the regeneration after reconstructing a peripheral nerve 
defect with a nerve autograft.
cONcLusiONs
This study is the first meta-analysis executed in the field of experimental nerve reconstruction 
studies to illustrate a beneficial effect of the stem cells used as a luminal additive. Taking our 
findings into consideration, we may conclude that reconstructing a peripheral nerve gap 
using a guide with a luminal additive (i.e. cellular therapy) results in better regeneration as 
compared to using a conduit alone.
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1. PART i – investigating the clinical problem
Nerve injury may cause severe, life-altering disabilities including the loss of motor function, 
sensory loss, hyperesthesia and cold intolerance. These disabilities will have a great impact 
on a patient’s quality of life as they diminish an individual’s capacity to work and exercise 
hobbies. The outcome after surgery of peripheral nerve injuries of the upper extremities is 
often unpredictable. In part I of this thesis the clinical outcome after surgical reconstruction of 
upper extremity nerve injury was investigated. In particular we focused on prognostic factors 
for a better outcome after reconstructive surgery and the psychological stress involved with 
nerve trauma.
Several factors were shown to predict functional outcome 1 year after injury (chapter 1 and 
2). These included gender, age, education, number of structures and arteries involved, (type 
of ) damaged nerve, location of injury, type of nerve injury and posttraumatic stress at 1 and 
3 months post trauma. The factors sensibility of the hand, power grip and DASH score are the 
strongest predictors for the outcome after nerve reconstruction. Interestingly and against our 
hypothesis smoking had no significant correlation with functional outcome. We expected 
that smoking would diminish the recovery since microcirculation is significantly reduced in 
the smoking population. The low number of smoking patients in our study group could bias 
this finding.
Posttraumatic stress at 1 and 3 months are factors that can actually be influenced. Psy-
chological symptoms frequently accompany severe injuries of the upper extremities. . Post-
traumatic psychological stress was assessed with the Impact of Event Scale (IES) questionnaire, 
at month 1 and 3 following nerve repair. This questionnaire included 15 items that refer to 
‘the past seven days’, across the subscales of avoidance and intrusion and taps dimensions 
that are similar to defining symptoms of posttraumatic stress disorder In our study, 92% of 
patients experienced psychological stress 3 months post-operatively Based on IES scores, 
psychological treatment was indicated in 25% and 13% of patients, 1 and 3 months post-
operatively, respectively. Higher IES scores (i.e. more psychological stress) were negatively cor-
related with functional outcome. Early recognition of psychological stress could potentially 
improve outcome. To what extent this really will improve the outcome should be subject of 
further study. The relation between posttraumatic stress and outcome can be influenced by 
many factors. Possibly the amount of stress will decrease the person’s ability and enthusiasm 
to participate in rehabilitation programs. Fear or anxiety can also have a negative effect on the 
engagement in rehabilitation.
Although the study design was a prospective multicenter study including 7 large hospitals in 
the Netherlands, it still represents a relatively small sample size. It is known that it is difficult 
to study nerve injuries. They often have a higher percentage of loss to follow-up. A long-
term prospective study should be executed with an automated electronical inclusion of all 
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patients visiting the hospitals/national registry to include more patients. That would increase 
the power of these studies allowing for more factors to be studied.
The findings of our study were in line with the findings of other research groups[1, 2]. Bailey 
et al. highlighted the relationship between nerve injury of the upper extremity and activity 
participation,pain, depression, and perceived quality of life[2]. They reported a percentage of 
39 on the depression scale indicating probable clinical depression. They suggest that patients 
should be screened before and after surgery. The identification of patients with higher scores 
on the depression scale could be identified as this may improve the compliance of patients 
with rehabilitation programs and improve long-term outcome[2].
The results of this study may help us to inform patients about their expected recovery the 
first year after injury. The information can also assist clinicians in understanding the outcome 
of patients with peripheral nerve injuries of the forearm.
2. PART ii – evaluation
After nerve injury with subsequent reconstruction, the process of nerve regeneration begins. 
The outcome of peripheral nerve injury can be measured in various ways[3]. Validated out-
come measurements are important to aid clinical diagnosis, to assess and compare surgical 
techniques, to follow rehabilitation and to inform patient, surgeon and therapist about the 
outcome of treatment. In the case of peripheral nerve injury both sensory and motor function 
should be evaluated.
Clinical use of ultrasound;
In chapter 4, a new, non-invasive ultrasound method to longitudinally assess both early and 
late nerve injury recovery was investigated. Ultrasound is non-invasive, quick, low in cost and 
not painful for patients recovering from nerve injuries. The possibility to evaluate motor func-
tion recovery using ultrasound was first described by our group in 2013[4]. Confident with 
the good results a clinical study was established to assess motor function recovery in patients.
In the clinical setting, the method most frequently used to evaluate outcome of motor 
function of the hand is manual muscle testing (MRC), powergrip, pinchgrip and individual 
finger strength (by use of the intrinsic Rotterdam myometer)[5, 6]. However, these methods 
have some limitations. For instance, they can not be used with patients with a MRC score 
lower than 3 nor can they detect early muscle recovery. Therefore, there is a need for a diag-
nostic tool that can provide both patient and clinician with information regarding the early 
recovery phase. Non-invasive measurements to assess muscle reinnervation after nerve injury 
are needed for the longitudinal follow up of muscle reinnervation. Ultrasound may serve such 
a purpose. Other evaluation methods to visualize the muscle, as CT-scan or a MRI scan, are 
more expensive and time-consuming. The ultrasound measurements can be made in the 
outpatient clinic in less than 10 minutes and are inexpensive.
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In both healthy adults and patients with ulnar and median nerve injuries a strong correlation 
was found between the muscle cross-section area, as analyzed with ultrasound, and muscle 
force. This showed the usefulness of this technique to monitor muscle reinnervation in pa-
tients suffering from peripheral nerve injury.
Experimental use of ultrasound;
After establishing this method in the clinical setting we wanted to use this method in the 
experimental setting as well. For animal experiments, non-invasive methods to assess mo-
tor function are highly favorable. They allow for multiple measurements and longitudinal 
follow-up within the same animal without the need to sacrifice the animal. This minimizes 
inter-animal variability, yielding higher power with the same number of animals per studied 
group. This will ultimately reduce the required sample size and costs of those studies and 
improve animal welfare. The new technique is also easy and could be performed in less than 
10 minutes. This makes the new technique an easy applicable method.
To study functional motor recovery after nerve reconstruction in animal models the easily 
obtainable wet muscle weight is frequently used. Other commonly used established outcome 
measurements include electrophysiological testing, isometric tetanic force measurement and 
nerve histomorphometry [7-10]. However, all of those techniques require the animal to be 
killed for assessment, making a longitudinal analysis of the recovery impossible.
In chapters 5 and 6, the potential of ultrasound was investigated in the two most commonly 
used animal models in nerve injury research: the rat and the rabbit[11, 12]. Their fast neuro-
regenerative capacity makes the rat an efficient model to study nerve regeneration. However, 
the nerve gap length in rats is limited. The larger rabbit model overcomes many of these 
limitations, as nerve gaps up to 8 cm are feasible [7, 13]. Also, the rabbit’s neuro-regenerative 
properties more closely mimic the human setting [14]. Therefore, the rabbit is an important 
model to study new nerve reconstruction techniques before the step towards the clinical 
setting can be made.
To establish ultrasound as a new and valid tool to analyze functional recovery after nerve 
trauma, this technique was compared to the commonly used outcome measurements muscle 
weight and isometric tetanic force in a rat model. In addition, the neuromuscular junction in 
the muscle was examined histologically, to visualize denervation and reinnervation of the 
motor endplates. The intra- and interrater reliability of ultrasound was found to be strong 
(r=0.97 and r=0.88). The correlation between ultrasonographic recordings and the muscle 
weight were 0.85 and 0.89, again indicating a strong relation between ultrasound and muscle 
mass. The correlation between muscle strength, analyzed with isometric tetanic force mea-
surements, and ultrasound was lower, but still significant with 0.62. The explanation for the 
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better higher correlation between ultrasound and muscle weight compared with ultrasound 
and muscle strength may be that force does not directly relate to weight (i.e. more fibers 
does not mean more force). This hypothesis was further strengthened by the observation that 
during the first weeks of recovery, muscle weight gradually increased with delayed response 
intensity with the isometric tetanic force evaluation.
The ultrasound method was further validated in the rabbit model where a bigger nerve gap 
of 3 cm could be created (chapter 5). The inter- and intra-rater reliability of the ultrasound 
recordings in the rabbit were, like in the rat model, high (0.989 and 0.99 respectively). Impor-
tantly, the ultrasound measurements could be performed on the rabbits without the need for 
anesthesia by manual restrain with a harness. This may reduce the risk of anesthesia-related 
death of the rabbits, which is as high as 7%[15].
The importance of valid outcome measurements in experimental studies investigating 
peripheral nerve injuries was already stated by others. Several reviews showed the wide 
variety of different outcome measurements used and the lack of correlation between those 
measurements[9, 10, 16, 17]. Also, none of these outcome measurements could be used for 
longitudinal follow-up as all outcome measurements require the animal to be euthanized[3, 
7-10].
In summary, these studies demonstrate the value of ultrasound as a diagnostic tool. Ultrasound 
has a better discriminative power and lower variability, allows for repeated measurements in 
animal studies and reduces animal suffering. Therefore, we believe that ultrasound should 
be included in the standard diagnostic armamentarium of both experimental and human 
studies on nerve regeneration.
3. PART iii - engineering a nerve allograft
In Part III of this thesis, nerve reconstruction using a newly-engineered nerve allograft was 
studied both in vitro and in vivo. Within the wide variety of available surgical techniques to 
reconstruct a peripheral nerve gap, the nerve allograft has shown the greatest potential and 
most closely mimics the gold standard, the autograft. Nerve allografts have the advantage of 
mitigating donor side morbidity and potentially have an unlimited supply and length of the 
grafts.
Nerve allografts were first used in the clinical setting when immunosuppressive drugs were 
not available. Over the years, processing protocols for nerve allografts were improved. Hudson 
et al. described one of the first processing protocols for the nerve allograft[18, 19] in 2004, 
which has later been modified by several others[18-22]. After several improvements by Neu-
bauer et al. a nerve allograft was introduced in the clinic [20, 22, 23]. However, the currently 
available nerve allograft shows results that are not satisfactory, especially when focusing on 
motor nerve reconstruction[24]. Up to this day, there have been no clinical studies or high-
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level evidence (e.g. level I or II) studies published that challenged the allograft to the autograft 
or to conduits for the reconstruction of large peripheral (motor) nerve defects. The conclu-
sions are based on experimental animal studies and level III clinical studies[25]. In processing 
nerve allografts it is difficult to find the balance between remaining the structure of a graft 
while removing all cellular debris, which can cause an immune reaction after transplantation.
In chapter 7, the optimization of a novel nerve allograft was studied in vitro in rat sciatic nerve 
segments. The aim of this experiment was to decellularize the nerves more aggressively by re-
moving more cellular debris. Improvement on currently used decellularization protocols were 
tested by adding an extra enzymatic step, and by studying different storage temperatures. 
The enzyme Elastase was added to the decellularization process and was hypothesized to 
better decellularize the nerves by removing more cellular debris. In addition to the rat nerves, 
the nerve allograft process was also tested in human motor and sensory nerves (chapter 8).
Reduced immunogenicity by diminished cellular debris and the elimination of Schwann 
cells was observed when Elastase was added to the nerve processing while maintaining 
ultrastructure. Storage at -80°C after the decellularization process heavily damaged the nerve 
ultrastructure as compared to cold storage.
The same effects were observed when different processing techniques were tested on hu-
man nerves. Human motor nerves were better preserved when compared to sensory nerves. 
Especially the structure was better preserved in motor nerves. This could be explained by the 
fact that the basal lamina of the motor nerve is thicker and the endoneural tubes are bigger 
in motor nerves as compared to sensory nerves[26]. That could make the motor nerve more 
robust to the processing techniques.
After establishing the optimal processing and storage techniques for the nerve allograft, the 
next step was to implement the allograft in a rat model (chapter 9). The purpose of this study 
was to evaluate the elastase-decellularized allograft nerve in a 1-cm segmental rat sciatic 
nerve gap model. In these experiments the outcome was motor functional outcome at 12 
and 16 weeks post-surgery using different storage conditions of the decellularized allograft. 
When comparing our optimized nerve allografts we found that for all outcome measure-
ments investigated, the elastase processed cold preserved allograft showed no statistically 
significant differences with the gold standard, the nerve autograft, for both early and late 
regeneration at 12 and 16 weeks. In three out of five outcome measurements, cold storage 
of the processed allograft showed better results than the frozen stored allograft. We found 
an improvement at the 16-week time point compared to the 12 week follow-up. This may 
seem like a logical outcome, however in previous studies with nerve allografts this was not 
always observed. Giusti et al. evaluated early and late recovery at 12 and 16 weeks, using 
AxoGen processed allograft rat nerves and compared these to autograft nerves[27]. While 
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both the allograft and the autograft had comparable results at the early recovery time of 12 
weeks, 16 weeks post-surgery the autograft outperformed the AxoGen processed rat allograft 
nerve[27]. The hypothesis is that this could have been caused by fibrosis. If a nerve allograft is 
not entirely clear of cellular debris this can cause an reaction after implementation. Possibly 
fibrosis caused the decrease in muscle force at the late time point of 16 weeks.
In summary, the novel, elastase-processed cold stored nerve allograft has statistically similar 
functional outcomes compared with the gold standard, the nerve autograft, at both 12 and 
16 weeks follow-up. The regeneration potential of the cold stored elastase processed nerve 
allograft is superior to the frozen stored allograft with respect to motor functional outcome.
4. PART iV – improving the nerve allograft
In the quest to further improve nerve reconstruction techniques investigating nerve allograft 
transplantation, the next step was to investigate the effect of different cellular additives 
(chapter 10). We conducted a systematic review with meta-analysis to study the beneficial 
effect of stem cells in nerve regeneration with a nerve graft by looking at any nerve conduit 
with and without the addition of stem cells to solemnly evaluate the effect of the stem cells.
A total of 44 studies were investigated in this analysis. We found that the contribution of 
stem cells had a positive effect on the functional outcome compared to regeneration us-
ing a conduit alone. This effect was positive for bone marrow derived stem cells, adipose 
derived stem cells and other stem cells such as skin-derived stem cells. The mechanism be-
hind this positive effect is debatable. The transition from stem cell to Schwann cell has been 
encountered previously and thus indicates that this could be a vital factor in explaining the 
beneficial effect[28-31]. Schwann cells however, not only myelinate; Höke et al showed that 
the Schwann cell phenotype can be modulated, for example, into motor or sensory Schwann 
cells[32]. Others believe that the stem cells offer a more supporting and productive role by 
producing neural growth stimulating factors[29]. Also, mesenchymal stem cells are found to 
be immunosuppressive and could therefore have a positive effect on nerve regeneration us-
ing allografts[33]. The mechanism of the effect of stem cells should be investigated in further 
studies. These questions need to be answered before the step toward the clinical setting can 
be made.
5. Future perspectives
As demonstrated in this thesis the nerve allograft can be optimized by better decellularization 
and storage techniques. Further steps need to be taken to develop and further improve a new 
nerve allograft. After testing the nerve allograft in a rat model, the step towards a bigger ani-
mal is required when striving for clinical implementations. The rabbit model could be an ideal 
model for further testing. The rabbit model allows for a larger nerve gap to be reconstructed, 
i.e. nerve gaps up to 8 cm. Also, the rabbit is said to have a neuro-regenerative pace that 
more closely mimics the human nerve regeneration. The rabbit model furthermore allows for 
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immunological testing, which is in particular important for nerve allograft reconstruction. By 
investigating the immunological effect of implementation of a nerve allograft in the model, 
the hypothesis that the new allograft is immunological inert could be tested. This would be 
an important step in the development of a new nerve allograft. In this future study the use 
of non-invasive ultrasound in the longitudinal follow-up of motor nerve recovery should be 
used.
After testing in bigger animal models the next step in the development of the nerve al-
lograft would be to test the graft in clinical cases to examine functional recovery.
Future research should also be focused on other ways to create a nerve conduit that mimics 
the structure of a human nerve, as is the case in nerve allograft reconstruction. The introduc-
tion of new, innovative techniques can help in this development. With the aid of a 3D printer 
these nerve grafts can be created on a very small scale. A 3D-printed nerve conduit that 
resembles the structure of the inert nerve would potentially provide the ideal structure for 
a nerve graft. An artificial conduit with the same structural properties as the nerve autograft 
should be challenged by the nerve allograft. The addition of supportive cells like stem cells to 
the artificial graft and to the Elastase processed allograft should be executed to determine the 
beneficial effect. Interaction between the allograft and an artificial nerve conduit should give 
us more insight in the interaction between stem cells and nerve grafts.
Finally those two concepts should be combined: a structural conduit with the same struc-
tural properties as the inert nerve with the addition of stem cells as supportive cells or growth 
factors. The combination of these two factors should be the focus of future studies and could 
potentially revolutionize peripheral nerve reconstruction.
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mAiN cONcLusiONs OF This Thesis
- Sensibility of the hand, power grip, and DASH score (DASH, Disabilities of Arm, Shoulder 
and Hand) are the three best prognostic factors for outcome after peripheral nerve injury
- Peripheral nerve injury of the forearm is often accompanied by early posttraumatic psy-
chological stress, especially in female adults who suffered from combined nerve injuries
- Ultrasound is a valid and reliable method to assess the cross-sectional area of muscle in 
the hand to monitor muscle reinnervation in patients suffering from peripheral nerve 
injury.
- Ultrasound is a valid, non-invasive method to study motor nerve reconstruction on both 
the rat and rabbit model
- Ultrasound allows for a longitudinal follow-up within the same animal
- Nerve allograft processing in rat nerve can be optimized by the addition of the enzyme 
Elastase and by the use of cold storage
- Motor nerves are preferred over sensory nerves when optimizing nerve decellularization 
techniques
-  he elastase processed, cold preserved, allograft showed similar outcome to the gold 
standard, the nerve autograft, with regard to motor function outcome in a rat model
- The use of stem cells as a luminal additive has a beneficial effect on peripheral nerve 
reconstruction
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In chapter 1 a general introduction on peripheral nerve injury and an overview of the aims of 
this thesis called ‘the road to optimized nerve reconstruction’ is provided.
In the first part of this thesis the clinical problem of peripheral nerve injury of the median and 
ulnar nerves was investigated.
In chapter 2 prognostic factors predicting functional outcome after median, ulnar and com-
bined nerve injuries were analyzed. This study was based on a prospective, multi-center study 
that was conducted in the Netherlands and included a total of 61 patients. Gender, age, level 
of education, number of injured arteries and structures, the specific nerve damaged, the loca-
tion and type of nerve injury and the presence of post-traumatic stress at 1 and 3 months after 
repair of the peripheral nerve injury, were all found to be predictors of functional recovery. Of 
these factors, the sensibility of the hand, power grip and DASH (Disabilities of Arm, Shoulder 
and Hand) score were identified as the strongest predictors of the outcome 12 months after 
the peripheral nerve injury.
The objective of chapter 3 was to investigate early post-traumatic psychological stress 
after peripheral nerve injury. The same study population as in chapter 2 was investigated. 
Post-traumatic psychological stress was assessed with the Impact of Event Scale (IES) ques-
tionnaire, at month 1 and 3 following nerve repair. This questionnaire included 15 items 
that refer to ‘the past seven days’, across the subscales of avoidance and intrusion and taps 
dimensions that are similar to defining symptoms of posttraumatic stress disorder. The main 
finding was that as much as 92% of the study population experienced psychological stress 
in the first post-operative month. Three months after surgery this percentage decreased to 
83%. However, not all patients who experienced stress had IES scores indicating the need for 
psychological treatment. Psychological treatment is advised in 25% and 13% of the patients 
1 and 3 months post-operative, respectively. In addition, we found that other factors that are 
associated with the functional outcome of nerve injury including female gender, adult age 
and combined nerve injury were all associated with higher IES scores. Taken together, this 
study demonstrates that post-traumatic psychological stress frequently complicates periph-
eral nerve injury and suggests that it negatively influences the rehabilitation of these patients. 
Of all identified prognostic factors for peripheral nerve injury outcome, this is the only one 
that can potentially be influenced. Therefore we argue that early discovery of post-traumatic 
stress and timely psychological intervention has the potential to improve the outcome for 
these patients.
In the second part of this thesis the use of ultrasound as a non-invasive measurement 
method /tool of muscle mass and therefore nerve reinnervation, was studied. This technique 
was validated in both the clinical setting as well as in the experimental setting (rat and rabbit 
model).
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In chapter 4 ultrasound was used to assess the cross-sectional area of the intrinsic muscles of 
the hand, which was then correlated with muscle strength. A major limitation of the currently 
used muscle strength measurements is that patients need to have a MRC (Medical Research 
Council) score of 3 or higher to be able to perform the test. This makes this test inadequate 
to observe early nerve regeneration. Ultrasound has the advantage of being a non-invasive 
method and can be used directly after surgery. In the study described in chapter 4, healthy 
adults and patients suffering from ulnar and median nerve injuries were analyzed. In all par-
ticipants, the cross-sectional area of 4 muscles (the abductor digiti minimi, first dorsal interos-
seus, abductor pollicis brevis and oppones pollicis) was assessed using ultrasound. Strength 
was measured by use of a myometer. The correlation between the muscle strength and the 
ultrasound measurements was found to be strong in the healthy adults (r=0.82-0.93) and 
in patients (0.63-0.94). The intra-rater reliability was high (0.99-1.00) as well as the inter-rater 
reliability (0.88-0.95). This study shows that ultrasound is a valid and reproducible method to 
assess the strength of the muscles in the hand. We feel that ultrasound should therefore be 
included in the clinical care of patients suffering from peripheral nerve injuries of the upper 
extremity to assess early muscle reinnervation.
After establishing this method in patients, the efficacy of ultrasound to analyze functional 
recovery after nerve reconstruction in the experimental setting was investigated. In chapter 
5 the ultrasound technique was used for analysis of functional recovery after segmental nerve 
reconstruction of the peroneal nerve in a rabbit model. At several time points up to 16 weeks 
post-operatively, ultrasound measurements of the tibial muscle of the rabbit were obtained. 
At 12 and 16 weeks, the functional recovery of the tibial muscle was also evaluated with elec-
trophysiology, isometric tetanic strength, wet muscle weight and nerve histomorphometry. 
All these different outcome assessments of functional recovery after nerve reconstruction 
were compared to the newly-developed ultrasound technique. Good correlations were found 
between ultrasound and the force measurements, muscle weight and nerve histomorphom-
etry. In line with the findings described in Chapter 4, excellent intra-rater and inter-rater reli-
ability of the ultrasound technique was found (intra-class correlation 0.99). Another important 
finding of this study was that the ultrasound measurements of the rabbit tibial muscle could 
be obtained without the need for anesthesia. Especially in rabbit studies, with an anesthesia-
related risk of death of 7% this is a valuable finding as it may improve experimental animal 
welfare.
In addition to establishing the ultrasound method in rabbits, this method was validated in 
a rat model. In the study described in chapter 6, rats underwent an autograft sciatic nerve 
reconstruction. Every two weeks, up to a total follow-up period of 20 weeks, the animals un-
derwent ultrasound recordings of the tibial muscle. Functional recovery was tested by means 
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of wet muscle weight and isometric tetanic force. Furthermore, the neuromuscular junction 
in the tibial muscle was examined histologically, to visualize denervation and reinnervation of 
the motor endplates. Good correlations were observed between ultrasound and wet muscle 
weight (r=0.85). The correlation with force was lower but still statistically significant (r=0.62). 
In line with what we observed in our human and rabbit studies, also in the rat model, a high 
intra- (0.97) and inter-rater reliability (r=0.88) was found.
Taken together, the work described in Chapters 5 and 6 demonstrates that an ultrasound 
measurement of the tibial muscles is a valid and animal-friendly method to examine muscle 
atrophy in both rabbits and rats. An additional advantage of ultrasound over conventional 
techniques is the high reproducibility. This suggests that fewer animals are required per 
experiment without compromising the statistical power of such studies.
The goal of part three of this thesis was to investigate a newly-engineered nerve allograft. 
Ideally, this allograft could be implemented in clinical care. Nerve reconstruction using an 
engineered allograft has the advantage of a theoretically unlimited supply in terms of both 
length and diameter of the grafts without the donor site morbidity, which may occur when 
using nerve autografts. The novel nerve allograft was investigated first by studying its de-
cellularization in vitro (both rat and human nerves) and second by studying the functional 
outcome after grafting in a rat model.
In chapter 7, rat sciatic nerve segments were decellularized using different protocols and dif-
ferent storage temperatures. The main difference between these protocols was the addition 
of the enzyme elastase. By adding elastase as an extra enzymatic step of the decellularization 
protocol, we aimed to remove more cellular debris from the allografts. We postulated that 
this would lower the immunogenicity of the nerve grafts and that this would result in better 
results when implanted. Indeed, we found that the addition of elastase resulted in reduced im-
munogenicity, diminished cellular debris and elimination of Schwann cells while maintaining 
the ultrastructural properties of a nerve. Storage at -80 °C after the decellularization process, 
heavily damaged the nerve ultrastructure as compared to cold storage at -4 °C.
Next, the decellularization protocols were optimized for human nerve segments (chapter 8). 
Again, the addition of elastase improved the decellularization process and cold storage (-4 °C) 
was more beneficial compared with storage at -80°C. In this experiment, both human sensory 
and motor nerve were investigated. The latter were found to be better preserved under dif-
ferent cold storage conditions as compared to sensory nerves, especially in terms of structure.
After finding the best method to decellularize and store the nerve allograft (in vitro) the graft 
was tested in a rat model to study functional outcome following repair of a segmental nerve 
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defect (chapter 9). At 12 and 16 weeks post-surgery, the allograft was challenged to the 
gold standard, the nerve autograft. The newly-engineered elastase-processed, cold-preserved 
allograft produced results for all outcome measures that were comparable with the gold 
standard, the nerve autograft, for both early and late regeneration at 12 and 16 weeks. These 
results suggest that the allograft may result in comparable outcomes without the compli-
cations associated with the use of nerve autografts. Nonetheless, despite these promising 
results, further testing in a larger animal model is required prior to application in the clinical 
setting.
The fourth part of this thesis focused on the proposed beneficial effect of using stem cells for 
peripheral nerve reconstruction.
The possible beneficial effects of the addition of stem cells as a cellular adjunct to nerve grafts 
for the reconstruction of peripheral nerve defects was investigated in chapter 10 by means 
of a systematic review with meta-analysis. The systematic review included 44 studies, which 
used different types of stem cells, which were analyzed according to their origin (being either 
bone marrow, adipose tissue or from another source like skin, amniotic fluid or hair follicle). 
The functional outcomes of reconstruction using a nerve graft with stem cells was compared 
to a nerve graft alone. The outcome measurements studied were the sciatic functional index, 
muscle mass ratio and electrophysiology. The conclusion of this meta-analysis was that the 
addition of stem cells (independent to their source) in a nerve graft improved functional 
outcomes as compared with a “standard” nerve graft. Future research should focus on the use 
of stem cells to further improve the nerve allograft we developed and which are described in 
part III of this thesis.
In chapter 11 the results of our studies described in this thesis are discussed, conclusions are 
drawn and suggestions for future research are made. The road to optimized nerve reconstruc-
tion is far from reaching a dead end but is wide open.
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NedeRLANdse sAmeNVATTiNG
hoofdstuk 1 vormt een algemene introductie en beschrijft het klinisch probleem van peri-
feer zenuwletsel. De doelen van het promotieonderzoek zoals beschreven in dit proefschrift 
getiteld “De weg naar optimale zenuw reconstructie” worden uiteengezet.
In het eerste gedeelte van dit proefschrift word het klinisch probleem ontstaan door perifeer 
letsel van de nervus medianus en nervus ulnaris onderzocht.
Het onderzoek zoals beschreven in hoofdstuk 2 had tot doel om factoren te identificeren 
die het functionele herstel voorspellen van letsel van de nervus medianus, nervus ulnaris of 
een combinatie van deze twee. Dit onderzoek vormde een onderdeel van een Nederlandse, 
prospectieve, multicenter studie waaraan in totaal 61 patiënten deelnamen. Er werden di-
verse prognostische factoren geïdentificeerd, te weten: leeftijd, geslacht, opleidingsniveau, 
het aantal beschadigde arteriën en weefselstructuren, de specifieke (beschadigde) zenuw, 
de locatie en het type zenuwletsel en de aanwezigheid van post-traumatische stress 1 en 3 
maanden na chirurgisch herstel van het zenuwletsel. Van al deze factoren waren de sensibili-
teit van de hand, de knijpkracht van de hand en de zogenaamde DASH score (hetgeen staat 
voor “Disabilities of Arm, Shoulder and Hand”) de sterkste voorspellers voor het functionele 
herstel 12 maanden na het perifeer zenuwletsel.
Het doel van het onderzoek zoals beschreven in hoofdstuk 3 was het inventariseren van 
vroege post-traumatische stress na perifeer zenuwletsel. Dit werd onderzocht in dezelfde 
onderzoekspopulatie als in hoofdstuk 2. De aanwezigheid van post-traumatische stress 1 en 
3 maanden na chirurgisch herstel van het zenuwletsel werd onderzocht met behulp van een 
vragenlijst, de zogenaamde Impact of Event Scale (IES). Deze vragenlijst bestaat uit 15 vragen 
over ‘de afgelopen 7 dagen’ waarop gescoord word op de subschaal van vermijding en op-
dringen andere dimensies die gelijk zijn aan de symptomen van een post-traumatische stress 
stoornis. De belangrijkste bevinding van dit onderzoek was dat 92% van de onderzoekspo-
pulatie last had van psychologische stress in de eerste maand na de operatie. Drie maanden 
na de ingreep was dit percentage gedaald naar 83%. Echter, niet alle patiënten hadden een 
dusdanig hoge score op de IES schaal dat psychotherapie nodig was. Een psychologische 
behandeling was wel geïndiceerd in 25% en 13% van de patiënten na respectievelijk 1 en 3 
maanden na de reconstructie. Samenvattend toont dit onderzoek aan dat perifeer zenuwlet-
sel zeer frequent wordt gecompliceerd door post-traumatische psychologische stress. Deze 
stress lijkt het functioneel herstel na perifeer zenuwletsel negatief te beïnvloeden. Van alle 
factoren die het functioneel herstel na een dergelijk letsel voorspellen, is psychologische 
stress de enige die mogelijk kan worden beïnvloed. Wij denken daarom dat het nuttig is om 
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routinematig te onderzoeken of er sprake is van psychologische stress bij patiënten met een 
perifeer zenuwletsel. Indien dit het geval is, kan psychologische begeleiding worden aange-
boden. Hiermee kan de prognose van deze patiënten mogelijk verbeterd worden.
In het tweede gedeelte van het proefschrift werd de waarde onderzocht van echografie 
als een niet-invasief diagnosticum voor het meten van de spiermassa en daarmee zenuw 
reïnnervatie. Deze echografische techniek werd zowel in de kliniek als dierexperimenteel (in 
een konijn en rat proefdiermodel) onderzocht.
In het onderzoek zoals beschreven in hoofdstuk 4, werd de oppervlakte van de intrinsieke 
handspieren gemeten (in dwarsdoorsnede) en werd deze vervolgens gecorreleerd aan spier-
kracht. De meetmethoden die heden ten dage in de kliniek worden gebruikt om spierkracht 
te meten hebben als belangrijk nadeel dat de patiënten een zekere kracht moeten hebben 
om tot een betrouwbaar test resultaat te komen. Een score van 3 of hoger volgens de zoge-
naamde MRC (Medical Research Council) is daarom een vereiste. De huidige testmethoden 
zijn derhalve niet geschikt om vroege zenuw regeneratie te meten. Het voordeel van echo-
grafie is dat dit een niet-invasieve techniek is en dat deze direct na een zenuw herstel operatie 
kan worden gebruikt. In dit onderzoek (hoofdstuk 4) werden patiënten met een letsel van 
de nervus ulnaris en/of nervus medianus onderzocht. De oppervlakte van 4 intrinsieke hand-
spieren (de musculus abductor digiti minimi, interosseus dorsalis I, abductor pollicis brevis 
en opponens pollicis) werd bij alle deelnemers aan het onderzoek gemeten (in dwarsdoor-
snede). Vervolgens werd de spierkracht gemeten met behulp van een myometer. Wij vonden 
dat de correlatie tussen de echografische metingen en de spierkracht sterk was, zowel bij 
gezonde volwassenen (met een correlatie coëfficiënt, r van 0.82 – 0.93) als bij patiënten (r 
= 0.63 – 0.94). De meting was zeer reproduceerbaar, zowel binnen één observator als tus-
sen verschillende observatoren. De zogenaamde intra-rater en inter-rater betrouwbaarheid 
was hoog met waarden van respectievelijk 0.99 – 1.00 en 0.88 – 0.95. Samenvattend toont 
dit onderzoek aan dat echografie een betrouwbare en reproduceerbare methode is om de 
kracht van de intrinsieke handspieren te meten. Wij zijn van mening dat echografie daarom 
moeten worden toegevoegd aan het klinisch arsenaal om vroege reïnnervatie van de spieren 
na perifeer zenuwletsel van de bovenste extremiteit vast te kunnen stellen.
Nadat de meetmethode was gevalideerd in patiënten met perifeer zenuwletsel, werd de 
echografische techniek getest in een tweetal proefdiermodellen. In hoofdstuk 5 werd het 
functioneel herstel na een operatieve segmentele zenuwreconstructie van de nervus pero-
neus onderzocht in het konijn. Op gezette tijden na de operatie (tot en met week 16 posto-
peratief ) werd het oppervlak van de musculus tibialis van deze konijnen gemeten met behulp 
van echografie. Het functionele herstel van deze spier werd na 12 en 16 weken gemeten met 
elektrofysiologie, isometrische tetanische kracht, spiergewicht en zenuw histomorfometrie. Al 
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deze maten van functioneel herstel werden gecorreleerd aan de echografische meetresulta-
ten. De correlaties tussen de echo resultaten enerzijds en de krachtmeting, het spiergewicht 
en de zenuw histomorfometrie anderzijds waren sterk. Net als bij patiënten (zie Hoofdstuk 4) 
bleken de intra– en inter-observer reproduceerbaarheid van de echografische techniek hoog 
(een intra-class correlatie van 0.99). Een andere belangrijke bevinding van dit onderzoek was 
dat de echografische metingen konden worden verricht zonder dat de konijnen onder anes-
thesie hoefden te worden gebracht. Dit is namelijk een risicovolle procedure en ongeveer 7% 
van de konijnen overlijdt ten gevolge van de anesthesie. Door het gebruik van echografie kan 
daarom het welzijn van proefdieren worden verbeterd.
De echografische techniek werd ook onderzocht in een rattenmodel (hoofdstuk 6). In dit 
onderzoek werd een reconstructie uitgevoerd van de nervus ischiadicus met behulp van een 
zenuw autograft. Gedurende een periode van 20 weken werd elke 2 weken de m. tibialis 
gemeten met echografie. Het functionele herstel na de operatie werd gemeten door het 
nat spiergewicht en de isometrische tetanische kracht te bepalen. Daarnaast vond er histo-
logisch onderzoek plaats van de neuromusculaire verbindingen in de m. tibialis om de de 
–en reïnnervatie van de motorische eindplaten te visualiseren. Er werd een goede correlatie 
gevonden tussen de echografische meting en het nat spiergewicht (r = 0.85) en een minder 
sterke correlatie met spierkracht (r = 0.62). Net als bij de humane en konijnen studies waren de 
intra– en inter-observer betrouwbaarheid hoog (respectievelijk 0.97 en 0.88).
Samengevat toont het onderzoek zoals beschreven in Hoofdstukken 5 en 6 aan dat echogra-
fie van de m. tibialis een betrouwbare en diervriendelijke methode is om spieratrofie in zowel 
konijnen als ratten te meten. Een additioneel voordeel van echografie ten opzichte van con-
ventionele meetmethoden is de hoge reproduceerbaarheid. Hierdoor zijn er relatief minder 
proefdieren nodig voor dit soort experimenten zonder dat er aan statistisch onderscheidend 
vermogen wordt ingeboet.
In het derde deel van het proefschrift onderzoeken we een nieuw-ontwikkelde zenuw al-
lograft. Het uiteindelijke doel van dit onderzoek is de klinische introductie van deze zenuw 
allograft. Het grote voordeel van zenuw reconstructie met een dergelijke allograft is dat er 
theoretisch gezien een onuitputtelijke voorraad is van zenuwweefsel (zowel voor wat betreft 
de lengte als de diameter). Daarnaast resulteert het gebruik van een allograft niet in morbidi-
teit ter plaatse van het donorgebied, zoals deze kan optreden wanneer er een autograft wordt 
gebruikt. De zenuw allograft werd op twee manieren onderzocht: als eerste werd de decel-
lularisatie van zowel ratten als humane allografts in vitro onderzocht. Ten tweede werd het 
functionele resultaat na zenuwreconstructie met behulp van de allograft in een rattenmodel 
bestudeerd.
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hoofdstuk 7 beschrijft het onderzoek naar verschillende decellularisatie en bewaartech-
nieken voor het optimaliseren van de zenuw allograft. Verschillende protocollen werden 
vergeleken met als belangrijkste verschil de toevoeging van het enzym elastase. Het doel 
van het toevoegen van elastase was om meer cellulaire débris uit de allograft te verwijderen. 
De hypothese was dat hiermee de immunogeniciteit van de allograft zou worden verlaagd 
en dat dit zou leiden tot een beter functioneel resultaat. Deze hypothese bleek correct: de 
toevoeging van elastase verminderde de hoeveelheid cellulaire débris en het aantal Schwann 
cellen, verlaagde de immunogeniciteit van de allograft terwijl de kenmerkende ultrastructuur 
van een zenuw behouden bleef. Verder bleek een bewaartemperatuur van -4 °C beter te zijn 
dan een temperatuur van -80 °C. Opslag van de allograft bij laatstgenoemde temperatuur 
leidde tot een ernstige beschadiging van de ultrastructuur van het zenuwweefsel.
Vervolgens werd het decellularisatie protocol voor humane zenuwen geoptimaliseerd 
(hoofdstuk 8). Andermaal bleek de toevoeging van elastase een gunstig effect te hebben 
en bleek opslag bij -4 °C beter dan opslag bij -80 °C. In deze experimenten werden zowel 
sensibele als motorische (humane) zenuwen onderzocht. Motorische zenuwen bleken beter 
bestand tegen verschillende bewaartemperaturen dan sensorische zenuwen, met name voor 
wat betreft zenuwstructuur.
Nadat de optimale methode voor het decellulariseren en opslaan van de zenuwallograft 
in vitro was vastgesteld, werd deze functioneel getest in een proefdier model (hoofdstuk 
9). In dit experiment werd een perifeer zenuw defect in de rat gerepareerd met ófwel de 
nieuw-ontwikkelde allograft ófwel met de gouden standaard, te weten een autograft. De 
nieuw-ontwikkelde, met elastase gedecellulariseerde en bij -4 °C bewaarde allograft bleek 
een vergelijkbaar goede zenuw regeneratie te geven 12 en 16 weken na de hersteloperatie. 
Dit suggereert dat zenuwreconstructie met behulp van deze allograft in een vergelijkbaar 
functioneel herstel resulteert maar dan zonder de complicaties die worden gezien bij het 
gebruik van een autograft. Desalniettemin dienen deze bevindingen te worden bevestigd in 
een groter proefdiermodel alvorens zij in de kliniek kunnen worden getest.
Het vierde deel van dit proefschrift richt zich op de potentieel gunstige effecten van stamcel-
len op perifere zenuw reconstructie.
De toevoeging van stamcellen aan zenuwgrafts ten behoeve van de reconstructie van peri-
feer zenuwletsel heeft mogelijk een gunstig effect. hoofdstuk 10 beschrijft een systematisch 
review met een meta-analyse naar de effecten van stamcellen. Er werden in totaal 44 onder-
zoeken in het systematisch review geïncludeerd. Deze studies werden onderverdeeld naar 
het type stamcel dat werd onderzocht (stamcellen afkomstig uit het beenmerg, vetweefsel, 
de huid, amnion vloeistof of een haarfollikel). Het functionele herstel na zenuwreconstructie 
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werd vergeleken tussen een “gewone” zenuwgraft en een zenuwgraft met toegevoegde 
stamcellen. De bestudeerde uitkomstmaten waren de zogenaamde sciatic functional index, 
de spiermassa ratio en elektrofysiologische metingen. De conclusie van deze meta-analyse is 
dat de toevoeging van stamcellen aan een zenuwgraft, ongeacht hun origine, leidt tot een 
beter functioneel herstel in vergelijking met een zenuwgraft zonder toegevoegde stamcellen. 
Toekomstig onderzoek zal moeten uitwijzen of de toevoeging van stamcellen aan de nieuw-
ontwikkelde zenuw allograft (zoals beschreven in deel III van dit proefschrift) de gunstige 
resultaten behaald met deze graft nog verder zal kunnen verbeteren.
In hoofdstuk 11 worden de bevindingen van het onderzoek zoals beschreven in dit proef-
schrift bediscussieerd, worden conclusies getrokken en suggesties gedaan voor toekomstig 
onderzoek. De weg naar een optimale zenuwreconstructie is allesbehalve doodlopend maar 
strekt zich wijd voor ons uit.
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